Exercise, appetite and cardiometabolic risk markers in South Asian and European men by Benedetti, Simone
  
 
 
 
Exercise, appetite and cardiometabolic risk markers  
in South Asian and European Men 
 
 
 
      by 
 
 
 
 
                Simone Benedetti 
 
 
 
 
 
      A Doctoral Thesis 
 
 
Submitted in partial fulfilment of the requirements for the award of Doctor of Philosophy of 
Kingston University 
 
 
 
 
                                                                              © by S. Benedetti (2020) 
 
 
 
 
 i 
 
GENERAL ABSTRACT 
 
South Asians have a higher risk of cardiovascular disease (CVD) and type 2 diabetes 
(T2D) than white Europeans. The mechanisms responsible remain partially understood 
with physical activity and cardiorespiratory fitness possibly playing a role. Thus, this 
thesis examined ethnic differences in traditional and unconventional CVD and T2D risk 
markers including appetite-related hormones and inflammatory markers as well as free 
fatty acids based on metabolomics methods, between South Asian and white European 
men. Furthermore, this thesis explored associations with objectively-measured physical 
activity/cardiorespiratory fitness and examined effects of acute exercise on subjective 
appetite ratings, appetite-related hormones and ad libitum energy intake. 
In study 1 (Chapter 3), South Asians exhibited lower fasting acylated ghrelin, high-
density lipoprotein and V̇O2 max than white Europeans but higher body fat percentage, 
C-reactive protein, leptin, triacylglycerol, glucose and insulin concentrations. Study 2 
(Chapter 4), revealed higher laurate, myristate, palmitate, γ-linolenate and linoleate 
concentrations in South Asians than white Europeans. Free fatty acids were strongly 
correlated with body fat percentage and total area under the curve for glucose in South 
Asians and with total step counts in white Europeans. Study 3 (Chapter 5) revealed 
similar appetite perceptions, energy intake and appetite-related hormones between ethnic 
groups in response to exercise although subtle differences were identified with South 
Asians exhibiting lower appetite perceptions 2 h after the buffet meal, delta acylated 
ghrelin concentrations at 4 h and lower carbohydrate intake after the exercise. Acute 
exercise increased concentrations of delta acylated ghrelin and total peptide YY and 
induced a transient suppression in appetite perceptions at 4.5 h and stimulation at 6.5 h, 
without provoking energy compensation in both groups. 
 ii 
 
These data demonstrate that South Asian have an adverse cardiometabolic risk profile 
than white European men which may be linked to their lower physical activity and 
cardiorespiratory fitness. Furthermore, these show that South Asians exhibit different 
levels of acylated ghrelin and FFAs metabolic profile than white Europeans and provide 
evidence that acute exercise induces a short-term energy deficit irrespective of ethnicity. 
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Chapter 1 – Literature review 
 
1.1 Cardiovascular disease and Type 2 diabetes: definition and aetiology 
1.1.1  Cardiovascular disease 
Cardiovascular disease (CVD) or heart disease is a general term which relates to those 
conditions that affects the heart (cardio) and blood vessels (vascular) and comprises 
several types of disorders including coronary heart disease (CHD), cerebrovascular 
disease, peripheral arterial disease, rheumatic heart disease, congenital heart disease and 
deep vein thrombosis and pulmonary (WHO, 2017). Among all the CVD categories, 
CHD and cerebrovascular diseases are the primary causes of cardiovascular death in both 
developed and developing countries in men and women (Figure 1.1) (Wong, 2014). 
Coronary heart disease refers to a reduced blood flow to the heart mostly due to a 
progressive shrinkage and obstruction of the coronary arteries, condition known as 
cardiac ischemia. If ischemia is severe or lasts too long, it can cause chest pain (angina 
pectoris) or heart attack (myocardial infarction) which eventually leads to heart tissue 
death. Symptoms of a heart attack are various and may include pain or discomfort in the 
centre of the chest or in other areas including arms, left shoulder, elbows, jaw or back 
(WHO, 2017). 
Cerebrovascular disease includes a group of disorders causing limited or no blood supply 
to different areas of the brain. Vessel narrowing (e.g., carotid stenosis) refers to a 
decreased blood flow to the brain causing cerebral hypoxia, condition known as cerebral 
ischemia, which may lead to serious impairment of brain function if the lack of oxygen 
and nutrition is not restored promptly.  
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Figure 1.1. The proportions of cardiovascular deaths caused by ischaemic heart 
disease, cerebrovascular disease, inflammatory heart disease, rheumatic heart 
disease, hypertensive heart disease, and other cardiovascular diseases in 2011 in 
men (A) and in women (B) worldwide. Adapted from Wong (2014). 
 
Additionally, clot formation (cerebral thrombosis), blockage (cerebral embolism), and 
blood vessel rupture (cerebral haemorrhage) are other types of cerebrovascular disorders 
which may provoke a prolonged ischemia and death of brain tissue known as stroke or 
brain attack (WHO, 2017). The most common symptom of a stroke is sudden weakness 
or numbness of the face, arm or leg, most often on one side of the body. Nevertheless, 
other symptoms may include confusion, difficulty speaking or understanding speech, 
dizziness and loss of balance or coordination, severe headache with no known cause and 
fainting or unconsciousness. The effects of cerebrovascular disease depend on which part 
of the brain is injured and how severely it is affected. A very severe stroke, for instance, 
can cause sudden death (WHO, 2017). 
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Coronary heart disease and cerebrovascular disease are predominantly associated to a 
chronic low-grade inflammatory condition of the blood vessels known as 
“atherosclerosis” (Mallika et al. 2007). Atherosclerosis comes from the Greek words 
“athero” (meaning gruel or paste) and “sclerosis” (meaning hardness) and refers to the 
thickened and hardened lesions known as atherosclerotic plaques characterised by the 
progressive accumulation of lipids and fibrous elements in the intimae and media of 
elastic and muscular arteries (Mallika et al. 2007). As a consequence, arteries can be 
narrowed due to the build-up of fatty plaque, which can result in insufficient blood flow 
to organs such as heart and brain causing myocardial infarction or stroke (Lusis, 2000). 
Although a number of hypothesis have been made to explain the genesis of 
atherosclerosis, this condition may be initiated by damage to the endothelium known as 
“injury hypothesis” (Ross, 1993). According to this hypothesis, an intact endothelium 
releases antithrombotic and fibrinolytic factors as well as the vasodilator nitric oxide 
(NO). However, CVD risk factors such as hyperlipidaemia, hyperglycaemia, 
hypertension and smoking may contribute to induce an injury or damage to the 
endothelium cells of the arteries leading to endothelium disfunction and plaque 
formation. Particularly, the damaged endothelium causes abnormal responses such as 
increasing the production of vasoconstricting agents including thromboxane A2 and 
prostaglandins (Ross, 1993). Furthermore, endothelial damage triggers platelets to 
adhere and aggregate at the site of the damage that causes monocytes to enter the tunica 
intima and proliferate within the tunica-media junction of the artery, which contributes 
to the atherogenic changes within the arteries (Ross, 1993). Atherosclerosis is a slow and 
progressive disease that begins early in life with early lesions (fatty streaks) visible in 
childhood (Lusis, 2000). Age progression and prolonged exposure to atherosclerotic risk 
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factors result in the development of fatty streaks into more advanced lesions responsible 
for the artery stenosis and reduced blood flow to organs (Lusis, 2000). 
1.1.2  Type 2 diabetes 
Diabetes refers to a group of metabolic disorders characterised by higher levels of plasma 
glucose resulting from defects in insulin secretion, insulin action, or both (ADA, 2013). 
Diabetes is categorised into type 1 diabetes (T1D) and type 2 diabetes (T2D). Type 1 
diabetes, also known as insulin-dependent diabetes or juvenile-onset diabetes, accounts 
for only 10% of those with diabetes and results from a cellular-mediated autoimmune 
destruction of the pancreatic ß-cells (ADA, 2013). Type 2 diabetes (T2D), known as non–
insulin-dependent diabetes or adult-onset diabetes, accounts for 90% of those with 
diabetes and includes people with insulin resistance (e.g. the pancreas produces insulin, 
but the tissues are unresponsive to it) (WHO, 2016). Apart from these, there is gestational 
diabetes which relates to elevated blood glucose concentrations induced during 
pregnancy. The majority of patients with T2D are obese, and obesity itself is responsible 
for some degree of insulin resistance (ADA, 2013). However, individuals who are not 
obese by conventional weight criteria may have greater percentage of body fat distributed 
predominantly in the abdominal area, which is associated with greater insulin resistance 
(WHO, 2016). Type 2 diabetes leads to complications including blindness, amputation 
and kidney failure and represents a well-established risk factor for CHD and 
cerebrovascular disease with endothelial dysfunction reported to be greater in individuals 
with insulin resistance and associated hyperglycaemia compared with normoglycemic 
individuals (Huang et al. 2016). The mechanism responsible for the increased risk for 
endothelial dysfunction and atherosclerosis in diabetes remain controversial (Kuusisto et 
al. 1994). However, T2D and impaired glucose tolerance (IGT) are often associated with 
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other risk factors such as hypertension, dyslipidaemia and obesity, each of which may 
cause endothelial dysfunction (Meigs et al. 1997). 
1.2 Cardiovascular disease and Type 2 diabetes: statistics 
1.2.1  Global burden 
Cardiovascular disease accounts for more than 17.9 million deaths worldwide each year, 
(~ 31% of all deaths) with the majority of which occurring in low and middle-income 
countries and this figure is estimated to increase to 23.6 million by 2030 (WHO, 2017).  
In the United States, CVD is the leading cause of death killing more than 2000 people 
per day, an average of one person every 40 seconds (AHA, 2016). In addition, one or 
more types of CVD affect an estimated 82.6 million American adults and out of these, 
an estimated 40 400 000 are ≥ 60 years of age. CVD is responsible for half of all deaths 
in the United States with cancer (second largest killer) accounting for only half as many 
deaths. The American Heart Association also estimated that 68% of patients with 
diabetes die of some form of CVD (AHA, 2016). In Europe, CVD represents also the 
main cause of death causing each year 3.9 million deaths and over 1.8 million deaths in 
the European Union (EU) (EHN, 2017). Particularly, death rates from both CHD and 
stroke are generally greater in central and eastern Europe such as Germany, Hungary, 
Poland and Slovakia compared with northern countries such as Denmark, Finland, and 
Sweden and southern Europe including, Italy, Greece and Spain (EHN, 2017). However, 
CVD risk factors such as age-standardised rates of diabetes prevalence, as well as obesity 
and physical inactivity have gone up in Nordic and Southern Europe countries (EHN, 
2017). 
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The prevalence of CHD and stroke, once thought to be a disease of the ‘rich’ is growing 
in low - and middle - income countries which are experiencing a rapid increase of 
mortality and morbidity (Gijsberts et al. 2015). In this regard, CVD events have been 
reported to be more common in South Asia than in high income countries with acute 
myocardial infarction occurring six years earlier in South Asians than in Europe 
individuals, probably due to an earlier onset of risk factors including hyperinsulinemia 
and dyslipidaemia (Misra et al. 2017). Furthermore, the proportion of death, particularly 
in younger adults, is greater in South Asia which increases the years of life lost as a result 
of CVD (Yusuf et al. 2004). According to the Global Burden of disease study in 2015, 
CVD and diabetes in South Asia account for 27% and 4.0% of deaths, respectively, with 
CHD representing the leading cause of death in India, Pakistan, Nepal, and Sri Lanka, 
whereas stroke is the leading cause in Bangladesh (Misra et al. 2017). In India, the largest 
country of South Asia, CHD in the urban population was estimated to grow from 7% to 
13% and in the rural population from 2% to 7% (Prabhakaran and Yusuf, 2011). 
Increasing rates of urbanisation and major economic changes (such as improved 
transportation) have led to changes in lifestyle patterns for a large proportion of people 
in India resulting in lower physical activity and greater body fat and weight leading to 
diabetes, hypertension and dyslipidaemia (Reddy, 1999). 
 
Type 2 diabetes represents the main CVD risk factors and the proportion of people with 
T2D is alarmingly growing in most countries (Figure 2.2). According to the International 
Diabetes Federation, approximately 463 million adults (20-79 years) worldwide are 
living with diabetes, predominantly in low and middle-income countries and it is 
expected to grow to 700 million by 2045 (Figure 1.2) (IDF, 2019). 
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Figure 1.2. Number of adults (20-79 years) with diabetes worldwide. International 
Diabetes Federation, Diabetes Atlas, 9th edition. Copyright permission authorised by 
IDF (2019).  
  
In South Asia, 88 million of people (1 in 11 adults) have diabetes and this figure is 
estimated to increase to 153 million by 2045 (IDF, 2019). Furthermore, the actual number 
of deaths due to diabetes in South Asia has been estimated to be 1 150 3000 people, 
which is significantly greater compared to other western countries including North 
America (301 700 people) and Europe (465 900 people) (IDF, 2019). 
 
Prevalence data in South Asia, however, change according to the country or area of 
residence (urban vs. rural). The prevalence of T2D in urban areas in India is nearly five 
times higher than in rural areas, and this has been observed also in Pakistan, Bangladesh 
and Nepal (Hall et al. 2008). However, the increase rate of diabetes over the years was 
greater in the rural compared to the urban areas. For instance, between 1989 and 2005 
prevalence of diabetes in the urban areas of South India increased from 8.3% to 18.6%, 
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whereas in the rural populations the increase of diabetes was more than 3 times (from 
2.2% to 9.2%) (Misra et al. 2014). Furthermore, amongst all the Indian subcontinent 
countries, India exhibits 77 million cases of diabetes and occupies the first position for 
number of people with diabetes (20-79 years) followed by Bangladesh (8.4 million), Sri 
Lanka (1.2 million) and Nepal (0.7 million) (IDF, 2019). 
1.2.2  United Kingdom 
In the United Kingdom (UK), CVD is responsible for more deaths than any other single 
cause according to the British Heart Foundation (BHF, 2019). Particularly, 7.4 million 
people in the UK are living with CVD which cause 170,000 deaths every year, an average 
one death every three minutes (BHF, 2019). Half of all CVD cases in the UK are due to 
CHD and one-third are due to stroke. Coronary heart disease was responsible for 64,000 
deaths in 2016, one in seven in men and one in twelve in women (BHF, 2019). 
Additionally, CHD is the most common cause of premature death (under the age of 75) 
in the UK (18% in men and 10% in women) with nearly all deaths from CHD caused 
from a heart attack.	The mortality rate from CHD, however, has been decreasing since 
the 1970s, but CHD incidence has been on the rise from the 1980s, particularly in men 
aged 75 and older. 
 
The number of people experiencing complications or dying because of their diabetes in 
the UK is also growing. Type 2 diabetes accounts for around 90% of all diabetes cases 
whereas T1D accounts for only 10% (Diabetes UK, 2019). Approximately 4.7 million 
people in the UK have diabetes, and this include around one million of people who have 
diabetes but have not been diagnosed. The number of people diagnosed with diabetes in 
the UK has more than doubled in 20 years. In 1996 there were 1.4 million people 
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diagnosed while in 2019 there were 3.8 million, and this figure is estimated to increase 
to 5.5 million by 2030 (Diabetes UK, 2019). Compared to individuals without diabetes, 
people with diabetes are two times more likely to have a heart attack, heart failure or a 
stroke. Particularly, diabetes causes 27 000 heart attacks and almost 100 000 cases of 
heart failure (Diabetes UK, 2019). In the UK, diabetes is more common in men than 
women (9.6% compared with 7.6% women) and individuals with a South Asian 
background are two to four times more likely to develop T2D compared with white 
people (Diabetes UK, 2019). 
1.2.3  South Asian population in the UK 
The term South Asian refers to a heterogeneous group who have ancestral origin from 
the Indian subcontinent which includes India, Pakistan, Bangladesh, Nepal, Sri Lanka 
and Bhutan, representing almost a quarter of the world’s population (Sattar and Gill, 
2015). Many South Asians live outside the Indian subcontinent with a large 
representation living in western countries including the United Kingdom (UK), United 
States (USA), Canada and Europe (Sattar and Gill, 2015). According to the 2011 UK 
census, individuals classifying themselves as South Asians born in the UK or in one of 
the South Asian countries represented the largest ethnic minority group (Office for 
National Statistics 2013). Particularly, 4.9% of the entire population in the UK (~ 3 
million people) originates from one of the Indian subcontinent countries.  
 
Migrant South Asians as well as those living in the Indian subcontinent, exhibit greater 
CVD and T2D susceptibility than their western counterparts. Although there is not 
explicit data in the literature reporting comparison of CVD or T2D risk in South Asian 
native versus south Asian migrants, previous data report an increased cardiometabolic 
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risk in the Indian Subcontinent compared with western countries (Misra 2017, IDF, 2019) 
or a greater prevalence of CVD and T2D in South Asian migrants compared with the 
white populations in the countries where they move (Johns and Sattar, 2017). Indeed, in 
the UK, people from south Asian backgrounds are more likely to suffer from CVD and 
have an elevated risk of T2D compared with white European individuals or other ethnic 
groups (BHF, 2019; Johns and Sattar, 2017; SAHF, 2014). According to the South Asian 
Health Foundation (SAHF), 11.2% of the total South Asian population in the UK (~ 431, 
000 people) have diabetes, with T2D including 90% of all diabetes cases (~ 388, 000 
people) (SAHF, 2014). The higher prevalence of T2D amongst the South Asian 
population living in the UK was formally described for the first time in 1985 by Mather 
and Keen in the Southall Diabetes Survey showing a 5-fold higher prevalence of diabetes 
in South Asian than white European individuals living in London (Mather and Keen, 
1985). Nonetheless, more recent estimates revealed a decrease in the prevalence of 
diabetes in South Asians although the risk remains approximately 2 to 4-fold greater 
compared with the white population (Ntuk et al. 2014). Previous studies provide evidence 
of a trend towards greater insulin resistance in South Asians at a younger age than white 
Europeans (Sattar and Gill, 2015). A report from a prospective pregnancy cohort, showed 
10% greater umbilical cord insulin levels on South Asian neonates born in the UK, 
despite showing a lower birthweight, indicating elevated insulin resistance at birth 
(Lawlor et al. 2014). Similar results were also shown in an earlier report comparing South 
Asian babies born in India with white European babies born in the UK (Yajnik et al. 
2002). The greater risk of insulin resistance in South Asians compared to white European 
individuals continues throughout childhood and adulthood with glucose intolerance , 
T2D and CVD typically diagnosed 5 to 10 years earlier and at a lower BMI in South 
Asian than white European individuals (Sattar and Gill, 2015; Khunti et al. 2013; Gholap 
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et al. 2011). South Asians exhibit higher incidence of T2D also into later life than white 
Europeans with 30-40% of UK South Asians diagnosed with T2D by the age of 70 years 
old, at least twice the prevalence of their white European counterpart (Sattar and Gill, 
2015). South Asians have also shown higher prevalence of impaired glucose tolerance 
(IGT) and elevated fasting glucose concentrations compared with whites (Tziomalos et 
al. 2008). Furthermore, it has been reported that the transition from impaired glucose 
tolerance (IGF) to overt T2D is typically quicker in South Asian individuals which may 
explain, at least partially, the earlier onset on T2D in this population (SAHF, 2014).  
 
The higher prevalence of insulin resistance and T2D in the South Asian population 
appears to be the most relevant contributor for their elevated CVD risk (Tziomalos et al. 
2008). Cardiovascular complications such as myocardial infarction or stroke remain 
appreciably higher in the UK South Asian men and women than the white population, 
although the risk differences in diabetes-related cardiovascular complications between 
South Asians and white Europeans have decreased compared to a few decades ago (Johns 
and Sattar, 2017). The SABRE cohort study included 20-year follow-up data from 
patients recruited from the Southall study between 1988 and 1991 and reported greater 
risk of myocardial infarction and stroke in South Asian compared to white European 
participants (Tillin et al. 2013a).  Likewise, over 2 million patients with diabetes in 
England and Wales were included in the UK National Diabetes Audit 2010-2011 that 
reported elevated myocardial infarction, angina, heart failure and stroke in South Asian 
than white European individuals (Health and Social care Information Centre, 2012). 
Furthermore, previous studies have reported a narrower gender difference in CHD risk 
between South Asian women and men living in the UK compared to the overall UK 
population (Hall et al. 2008). Specifically, UK South Asian women experience 46% 
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higher CHD mortality than women in the general UK population whereas the CHD 
mortality in South Asian men is 36% greater men compared with men of other ethnic 
groups (Hall et al. 2008). As with cardiovascular complications, previous population-
based studies investigated ethnic differences in cardiovascular mortality, which 
consistently reported an elevated risk of mortality in South Asian than white European 
individuals (Mather et al. 1998). However, more recent studies have indicated a lower 
mortality risk in the South Asian diabetic population than their European counterparts 
probably due to an earlier detection and treatment of diabetes and CVD risk factors such 
as obesity, hypertension and dyslipidaemia (Johns and Sattar, 2017). Therefore, these 
data suggest that cardiovascular morbidity continues to be elevated compared to the white 
European counterpart whereas there has been a shift in the cardiovascular mortality 
pattern, which has been reversed positively in South Asians.  
 
In the context of describing the greater risk of CVD and T2D amongst South Asian 
individuals, there is not clear evidence suggesting genetic differences between south 
Asians and white Europeans (Bakker 2013; Sattar and Gill, 2015). Please refer to 
subsection 1.3.1.3.1, where an overview of the actual data has been reported. However, 
it is relevant to mention that migration to urban areas from rural areas in the Indian 
subcontinent or from south Asian to western countries, has been reported to induce 
changes in dietary intake and lifestyle which have been associated with greater CVD and 
T2D risk. For instance, assessment of dietary intake in South Asian migrated to western 
countries has shown an elevated consumption of products rich in energy, fat and refined 
carbohydrate in the host than in the country of origin (Shah and Kanaya, 2014). Culture 
also seems to have an impact on the low levels of physical activity amongst South Asian 
people. In this regard, Caperchione et al. (2009) reported that exercise is a foreign 
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concept to the cultural identity of South Asians, and it is seen as marginal in regard to 
the disease process. Additionally, cultural restrictions against South Asian women, 
language barriers, fear of racism or the view of exercise beyond daily work as selfish 
have all been cited as barriers to physical activity among South Asians (Caperchione et 
al. 2009). 
Finally, an additional consideration in the context of comparing the risk of CVD and T2D 
in UK South Asians versus white Europeans, is that the term “South Asian” refers to a 
heterogeneous group with significant differences in diet, culture, religion and lifestyle 
within the South Asian population. Thus, although South Asians generally have a greater 
risk of CHD and T2D than other groups in the UK, there is also a variation in risk for 
these conditions within the South Asian populations. Specifically, the prevalence of CVD 
and T2D risk has been reported to be higher in Bangladeshi men, followed by Pakistani 
and Indian men living in the UK compared with the other UK South Asian populations 
(BHF, 2019; Diabetes UK, 2012). However, for blood pressure, Indians have grater 
prevalence of hypertension followed by Pakistanis and Bangladeshis (Agyemang et al. 
2002). Furthermore, Pakistani and Bangladeshi men born in the Indian subcontinent but 
living in the UK now are more than two times more likely to die from CHD than the 
national average whereas Pakistani women are two and half times more susceptible to 
CHD than the national average (BHF 2019). 
1.3 Risk factors for cardiovascular disease and Type 2 diabetes in South Asians 
The term risk factors refer to those conditions that increase the chances of developing a 
specific disease and are typically classified into modifiable and non-modifiable risk 
factors. Concerning CVD and T2D, examples of conventional modifiable risk factors are 
smoking, physical inactivity, dyslipidaemia, obesity or hypertension whereas age, sex 
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and ethnicity are examples of non-modifiable risk factors. Conventional risk factors for 
CVD and T2D have been reported to not fully explain the heightened cardiometabolic 
risk in South Asian compared with white European individuals (Forouhi et al. 2006; Enas 
et al. 2007). For instance, data from South Asian and white European patients recruited 
from the Southall and Brent population-based study, both conducted between 1988 and 
1991, reported higher CHD mortality in South Asian than white European men after 
adjusting for conventional risk factors including smoking, age, total cholesterol, blood 
pressure, hyperglycaemia or insulin resistance, measured by homeostatic model 
assessment (HOMA) (Forouhi et al. 2006). Additionally, it is well-established that South 
Asians have	greater levels of total and abdominal adiposity, for a given BMI, than white 
Europeans and this has been linked to their excess insulin resistance and T2D (Sattar and 
Gill, 2015; Gholap et al. 2011). Nonetheless, South Asian individuals have shown to be 
more insulin resistant and greatly exposed to T2D even after adjustment for total and 
visceral fat (Chandalia et al. 1999; Sattar and Gill, 2015; Hall et al. 2010) suggesting that 
additional factors may contribute the elevated cardiometabolic risk in this population. 
Thus, continuous effort amongst the scientific community has been observed to examine 
unconventional markers, which may add further information of the elevated CVD and 
T2D susceptibility amongst the South Asian community. In this regard, given chronic 
surplus of energy intake as a possible contributor for body fat accumulation, it is plausible 
that ethnic differences in the short-term regulation of appetite and energy intake may 
underlie the elevated adiposity and associated cardiometabolic risk in the South Asian 
compared with the white population. Particularly, it is possible that the innate phenotype 
of increased adiposity in South Asians is linked with ethnic differences in appetite-related 
hormones such as acylated ghrelin and peptide YY (PYY) concentrations which play a 
key role in the acute regulation of appetite perceptions and food intake (Hussain and 
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Bloom, 2013). Furthermore, circulating concentrations of fasting ghrelin have been 
observed to be lower in individuals with elevated adiposity and exhibiting insulin 
resistance (Le Roux et al. 2005; McLaughlin et al. 2004). However, it is not known 
whether circulating acylated ghrelin and PYY concentrations are different between South 
Asian and white European individuals. Additional parameters including plasma leptin, 
C-reactive protein (CRP), interleukin-6 (IL-6) and free fatty acids (FFAs) have also been 
implicated as mechanisms, which may contribute to increase and accelerate the risk of 
T2D and CVD in South Asians compared with white Europeans (Bakker et al. 2013). It 
is well established that exercise can improve insulin sensitivity and cardiometabolic risk 
profile (ADA, 2013) and the vast majority of published literature advocates moderate-to-
vigorous exercise in promoting short-term energy deficit without inducing compensatory 
effects on appetite feelings, which may relate to the modulation of appetite gut-hormones 
including acylated ghrelin and PYY (Deighton and Stensel, 2014). Thus, physical 
activity may represent an effective strategy to enhance fat loss in South Asians and 
ameliorate their health outcomes if exercise is performed frequently. However, it remains 
unknown how differences in individual ethnicity background modulate appetite 
perceptions, energy intake and appetite-related hormones in response to exercise. Thus, 
the following sections will begin by defining the most relevant conventional risk factors 
related to the greater risk for CVD and T2D in South Asian than white European 
individuals, with a particular focus on those factors likely responsible for the greater 
insulin resistance and T2D risk in South Asians. After this, unconventional risk factors 
will be explored with a particular focus on studies that have been performed in South 
Asian individuals. Finally, the last section will examine appetite-related hormones 
involved in the regulation of appetite and energy intake such as leptin, acylated ghrelin 
and total PYY and review the evidence relating to the modulation of appetite perceptions, 
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energy intake and appetite-related hormones in response to exercise in the general 
population. 
1.3.1  Conventional risk factors 
According to the INTERHEART  report, a large epidemiological case-control study of 
risk factors for CVD conducted in 52 Countries (Asia, Europe, the Middle East, Africa, 
Australia, North America and South America), more than 80% of the person’s 
attributable risk for CHD can be explained by 9 modifiable risk factors, irrespective of 
ethnic background (Yusuf et al. 2004). They comprise low consumption of fruit and 
vegetables, smoking, alcohol consumption, psychological factors, sedentary lifestyle, 
hypertension, dyslipidaemia, abdominal adiposity and diabetes. Age, sex, hereditary and 
ethnicity are the non-modifiable CHD risk factors. Compared with white Europeans, 
South Asians have a higher prevalence of conventional risk factors for CHD, which 
largely explained their earlier onset of CHD (Tziomalos et al. 2008).  Thus, we will 
examine some of the most relevant ones which have been examined in this thesis. 
1.3.1.1 Dyslipidaemia 
Dyslipidaemia is a well-established CVD risk factor and refers to abnormal levels of 
blood lipids including high concentrations of triacylglycerol (TAG), low-density 
lipoprotein cholesterol (LDL-C) and low levels of high-density lipoprotein cholesterol 
(HDL-C) (AHA, 2016). South Asians appear to have an elevated atherogenic lipid profile 
compared with white European individuals. Particularly, they exhibit greater circulating 
TAG and lower HDL-C predisposing them to atherogenesis which may also reflect 
underlying insulin resistance (Chowdhury and Lasker, 2002; Anand et al, 2000; 
McKeigue et al, 1991; Chambers et al, 2001). Additionally, according to the Framingham 
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Offspring Study, concentrations of large HDL particles (more cardio protective) were 
lower in South Asians than white Europeans (Bhalodkar et al. 2004). In contrast, 
concentrations of LDL-C in South Asians are comparable with other populations, 
although LDL particles size has been reported to be smaller in South Asians (Bhalodkar 
et al. 2004). This is critical, as small LDL particles are more susceptible to oxidation, 
hence more atherogenic (Kulkarni et al, 1999). 
1.3.1.2 Hypertension   
Hypertension or elevated blood pressure may be related to different factors such as age, 
family history, obesity, physical inactivity, high sodium intake or ethnicity (AHA, 2016) 
and substantially contributes to high death rates from CHD, cerebrovascular disease and 
renal failure (Joshi et al, 2006). Hypertension is highly prevalent amongst the South 
Asian population (McKeigue et al, 1991; Agyemang and Bhopal, 2002). Specifically, the 
prevalence of hypertension in individuals aged between 18-75, is higher in South Asian 
than in European men whereas inconclusive results were found in relation to the 
prevalence rates of hypertension between South Asian and European women (Agyemang 
and Bhopal, 2002). Furthermore, mean blood pressure and the prevalence of 
hypertension also differed within the South Asian population (Bhopal et al, 1999). 
According to the Newcastle Heart Project study and the 1999 Health Survey of England, 
Bangladeshi males and females aged 25-74, exhibit lower mean systolic and diastolic 
blood pressure than their Pakistani and Indian counterparts (Bhopal et al, 1999). The 
same study also reported lower prevalence of hypertension in Bangladeshi men and 
women compared with Pakistani and Indian males and females.  
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1.3.1.3 Insulin resistance and Type 2 diabetes: current hypothesis for the elevated 
risk in South Asians 
Insulin is an anabolic peptide hormone produced by the β-cells of the pancreatic islets, 
which promotes glucose uptake and utilisation by muscle cells and other tissues. Insulin 
action is the consequence of the binding to its plasma membrane receptor (tyrosine 
kinase), which in turn activates a complex intracellular signalling network (e.g. insulin 
receptor substrate 1 or IRS-1) generating its biological response (Taylor et al. 2012). The 
inability of the target tissues to respond to a known quantity of exogenous or endogenous 
insulin, results in a condition known as insulin resistance which inhibits glucose 
transportation from the bloodstream into most tissues leading to hyperglycaemia and, 
ultimately, to T2D (Taylor et al. 2012). Insulin resistance is another well-established risk 
factor for CHD and ischaemic stroke with evidence showing greater risk of CVD in 
patients with insulin resistance and T2D compared with normoglycemic individuals 
(WHO, 2016).  
The elevated prevalence of insulin resistance and T2D amongst the South Asian 
population seems to be a key contributor to the observed elevated CVD risk in this 
population (Tziomalos et al. 2008). The reason explaining the increased prevalence of 
insulin resistance and T2D in individuals with South Asian background remain unclear, 
although it probably results from the combination of innate and environmental factors. 
Current hypothesis for the mechanisms responsible for increased insulin resistance and 
diabetes in South Asian individuals are summarised in the following sections. 
1.3.1.3.1 Genetic predisposition to diabetes 
Type 2 diabetes is considered as a polygenic condition that involves polymorphisms of 
different genes with a high gene–environment interaction (Radha and Mohan, 2007). 
 19 
 
Many loci associated with T2D in white Europeans have been verified in studies with 
South Asian individuals but only few differences between the ethnic groups have been 
identified and the differences were not all consistently reported (Bakker et al. 2013). For 
example, an attractive difference may lie in the fat-mass and obesity-associated (FTO) 
gene, which continues to be the strongest known obesity-susceptibility locus in white 
Europeans. Relationships between FTO and T2D have also been identified, although this 
appears to be secondary to obesity (Bakker et al. 2013). In South Asians, however, the 
FTO polymorphism was previously reported to be associated with T2D, independently 
of BMI (Sanghera et al. 2008; Li et al. 2012), suggesting that in South Asians there may 
be a distinctive association between BMI and T2D. Nonetheless, associations between 
FTO and T2D mediated by obesity have been also shown in South Asian individuals 
(Ramya et al. 2011), whereas data from another study conducted in India showed no 
associations between the FTO variants tested and T2D (Chauhan et al. 2011). Therefore, 
to date no clear genetic differences between south Asian and white European individuals 
have been found.  
1.3.1.3.2 Fetal programming 
The fetal programming theory is based on previous studies reporting strong associations 
between low birth size and risk to develop impaired glucose tolerance, T2D and CVD in 
adult life, known as thrifty phenotype or Barker's hypothesis (Hales and Barker, 1992). 
According to the thrifty phenotype hypothesis, there is a mismatch between intrauterine 
and adult life environments. Particularly, an intrauterine disadvantageous environment 
such as maternal malnutrition, induces thrifty mechanisms that sets the metabolism to 
cope with potential future food deficiencies such as reduced capacity for inulin synthesis 
and secretion (Hales and Barker, 1992). While this may be beneficial to cope with 
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potential future food shortages, it increases the risk of T2D later in life in a nutrient rich 
environment typical of the modern society (Hales and Barker, 1992). This theory is based 
on the association between low birth weight and increased risk of T2D later in life 
observed in different ethnic populations (Bakker et al. 2013). In this regard, a meta-
analysis has shown low birthweight (a marker of fetal undernutrition) to be associated 
with greater risk of T2D with each kg increase associated with roughly a 25% decrease 
in diabetes risk (Sattar andGill, 2015). Although South Asians have lower birthweights 
than European populations, an analysis from the Child Heart and Health Study (CHASE) 
conducted in the United Kingdom in people with different ethnicities did not support low 
birthweight per se as an explanation for the emerging ethnic difference in risk markers 
for diabetes (Nightingale et al. 2015). Specifically, in the CHASE study, which examined 
associations between birthweight and risk markers for T2D and CVD in UK-resident 
white European, South Asian and black African-Caribbean children, adjustment for 
birthweight had no effect on ethnic differences in diabetes and CVD markers 
(Nightingale et al. 2015). However, South Asian children demonstrate a greater body fat 
percent at birth compared with white European children (based on skin-folds or cord 
leptin levels, or both) often accompanied by elevated cord insulin levels commensurate 
with greater insulin resistance (Lawlor et al. 2014). In this study, when adjustment was 
made for maternal fasting glucose concentrations, which were greater in the South Asian 
than white European women, the difference between ethnicities in cord leptin halved and 
became non-significant (Lawlor et al. 2014). Therefore, because evidence supporting the 
fetal programming role on diabetes in South Asians remain inconclusive, future studies 
investigating the effects of lifestyle intervention in South Asian compared with white 
European pregnant women would seem worthwhile, with key endpoints including 
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incidence rate of gestational diabetes, birthweight, and importantly, neonatal body 
composition.  
1.3.1.3.3 Pancreatic ß-cell capacity 
Previous evidence has identified ethnic differences in pancreatic ß-cell capacity with 
South Asians experiencing earlier declines in ß-cell function compared with other ethnic 
groups, which may contribute to the greater T2D susceptibility in South Asians (Bakker 
et al. 2013). Petersen and colleagues (2006) investigated both insulin resistance and β-
cell function in young adults East Asian, South Asian, Black, and white Caucasian 
individuals and reported a threefold to fourfold greater prevalence of insulin resistance 
in South Asian men than men of other ethnic groups, despite being matched on lifestyle 
factors and BMI (Petersen et al. 2006). In the same study, the assessment of β-cell 
function in a subgroup of South Asian and white Caucasian men revealed a 30% increase 
in basal β-cell responsiveness in the South Asians group. Nonetheless, this increase in β-
cell function was not enough to compensate for the degree of insulin resistance, as shown 
by a 60% decrease in the insulin sensitivity index (ISI) (a measure of β-cell response to 
insulin resistance), in South Asian men (Petersen et al. 2006). Data from the Whitehall 
study in the UK, examining 230 South Asian and 5749 white European individuals (39-
79 years old), also suggested greater β-cell function in South Asians at age of 50 years 
than white Europeans (Ikehara et al. 2015). Similar findings were also observed in the 
UK Southall and Brent revisited (SABRE) study (Tillin et al. 2013b). However, although 
in the Whitehall study β-cell function increased with age in white Europeans to 
compensate for increasing insulin resistance, this pattern was not observed in South 
Asians who exhibited a decline in β-cell capacity by the age of 60 years onwards (Ikehara 
et al. 2015). These findings were corroborated by a cross-sectional study conducted in 
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the USA showing lower β-cell function in South Asians (mean age 57 years old) than 
white Europeans (mean age 63 years old) (Kanaya et al. 2014). Thus, taken together these 
data suggest greater β-cell insulin production in South Asians at a younger age to 
compensate their peripheral insulin resistance. This may lead with age to a subsequent 
early β-cell exhaustion, which seems to accompany the transition to dysglycaemia and 
eventually to diabetes (Sattar and Gill, 2015). However, it remains unknown whether the 
decline in β-cell function in South Asians results primarily from the adiposity-induced 
insulin resistance or reflects lower inherent β-cell capacity (Sattar and Gill, 2015). 
1.3.1.3.4  Dietary changes 
Urbanization across Asia and migration of South Asians to western countries resulted in 
changes in dietary intake and physical activity levels, which have been associated with 
the rising rates of CVD and T2D diabetes in South Asian individuals (Shah and Kanaya, 
2014). A previous study conducted in southern India reported lower prevalence of 
diabetes in villages (9.2%) compared with 18.6% in the main cities, although villages are 
experiencing an increase in diabetes rates due to the rapid urbanization (Ramachandran 
et al. 2008). Furthermore, previous evidence showed that people living in urban areas in 
India have greater prevalence of diabetes compared to people living in rural areas (7.9% 
vs 2.5%), which is comparable to those South Asians who have migrated to the UK 
(Cheema et al. 2014).  
A nutrition transition, which is mainly characterised by increased intakes of energy dense 
and ultra-processed foods rich in fats and refined carbohydrates, has initially started in 
high-income countries to then spread to low-income countries in the last decades, 
including the Indian subcontinent, as a result of the rapid urbanization in both urban and 
rural areas (Popkin, 2009). Assessment of dietary intake in South Asian migrants to 
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western countries has also shown elevated consumption of products rich in energy, fat 
and refined carbohydrate in the host than in the country of origin (Shah and Kanaya, 
2014). Particularly, the most remarkable changes after migration appear to be a 
substantial increase in energy and fat intake and a switch from whole grains to more 
refined sources of carbohydrates, resulting in a low intake of fibre, with these data 
suggesting that these dietary changes may contribute to their greater cardiometabolic risk 
(Holmboe-Ottesen and Wandel, 2012). A previous study investigating the impact of 
migration on CHD risk factors in British Gujaratis versus their counterparts living in 
Gujarat in India, also reported greater energy intake in the UK group, both in men and 
women (Patel et al. 2006). Furthermore, the high fat intake in South Asian migrants in 
the UK has also been reported in other studies with fat intakes providing 35 to 40% of 
the total energy intake (Landman and Cruickshank, 2001). Additionally, Bakker and 
colleagues (2014) demonstrated greater perturbations in insulin resistance in response to 
short-term high fat overfeeding than European men, which may contribute to 
exacerbating the excess insulin resistance and T2D risk in South Asians (Bakker et al. 
2014). Nonetheless, a few older investigations have shown reduced energy intake in UK 
South Asians than their European counterparts (Vyas et al. 2003; Smith et al. 1993) which 
confirms that the dietary intake patterns of South Asians living in high-income countries 
remain sparse (Holmboe-Ottesen and Wandel, 2012). A further consideration in the 
context of dietary intake assessment in South Asians, is that the aforementioned studies 
based their energy intake investigations on self-reported questionnaires, which represents 
a limitation due to issues of participant recall bias which makes it difficult to accurately 
correspond self-reported intake with actual intake (Dhurandhar et al. 2015).  
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1.3.1.3.5 Physical activity and fitness 
Physical activity refers to any bodily movement produced by skeletal muscles that results 
in energy expenditure. Numerous studies have examined the associations between levels 
of physical activity and risk of T2D, with all of them reporting consistently that regular 
physical activity markedly reduces the risk of this condition (Gill and Cooper, 2008), 
independent of BMI. In this regard, controlling for differences in BMI between active 
and inactive groups has shown to attenuate the magnitude of risk reduction, although 
greater levels of physical activity were still associated with a reduction in T2D risk of 
20–30%, even after adjustment for BMI (Jeon et al. 2007). Furthermore, data from 
interventional studies reported the potential for increasing physical activity to reduce the 
risk of diabetes even in individuals exhibiting no significant weight loss (Pan et al. 1997).  
 
Several studies conducted in UK South Asians reveal lower levels of physical activity 
than their white European counterparts, suggesting that South Asian individuals living in 
high-income countries engage in low habitual physical activity, which is likely to 
contribute to the excess T2D and CHD risk in this population (Fischbacher et al. 2004; 
Williams et al. 2011a; Williams et al. 2011b; Yates et al. 2010; Ghouri et al. 2013; Afaq 
et al. 2019). Lower levels of physical activity were also observed in UK South Asian 
children compared to their white European counterparts (Duncan et al. 2012). The 
reasons explaining the lower physical activity level among South Asian communities 
remain unclear, however it can be postulated that there may be barriers to engage in 
physical activities amongst South Asians. Particularly, physical activity is a foreign 
concept to the cultural identity of South Asians, and it is seen as marginal in regard to 
the disease process (Caperchione et al. 2009). Furthermore, cultural restrictions against 
South Asian women, language barriers, fear of racism or the view of exercise beyond 
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daily work as selfish have all been cited as barriers to physical activity among South 
Asians (Caperchione et al. 2009). 
 
Similarly to dietary intake, it is important to consider that the existing evidence on 
habitual physical activity levels in South Asians has largely been gleaned from self-report 
questionnaires, although data using objective measures is emerging (Afaq et al. 2019; 
Ghouri et al. 2013; Iliodromiti et al. 2016; Duncan et al. 2012). Yates and colleagues 
(2015) in their cross-sectional study investigated differences in levels of physical activity 
between South Asians and white Europeans in the UK, using both objective 
accelerometer and self-report questionnaires, and reported similar levels of physical 
activity between groups when measured objectively although self-reported estimates 
were 40% lower in the South Asian population (Yates et al. 2015). This highlights the 
limitations of using self-reported lifestyle measures and indicates the need of future 
studies using objectively-measured physical activity in South Asians.  
Although recent evidence reported a variation in physical activity levels in UK South 
Asians with second-generation South Asians engaging in greater physical activity than 
the first-generations, South Asians remain still less active than their white counterparts 
(Bhatnagar et al. 2015). According to the physical activity guidelines from the WHO, 30 
min of moderate physical activity per day, for a total of cumulative 150 min per week, 
shows a protective effect on cardiometabolic health in adults (WHO, 2016). However, 
recent findings suggest that South Asians may need to undertake approximately 230 
minutes of moderate intensity physical activity per week, an addition of 10 to15 minutes 
per day, to achieve a comparable CHD risk factor profile of white Europeans who are 
meeting the current WHO physical activity recommendations (Sattar and Gill, 2015). 
Therefore, given the heightened cardiometabolic risk and lower levels of physical activity 
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in South Asian individuals, educational programmes should aim to develop culturally 
suitable strategies to enhance physical activity levels in this ethnic group to optimise 
health outcomes.  
 
Although lower levels of physical activity are likely to contribute to the elevated insulin 
resistance and T2D risk, South Asians have been reported to be more insulin resistant 
than white Europeans even after adjustment for differences in physical activity level 
(Ghouri et al. 2013). A contributing factor that may relate to ethnic differences in 
cardiometabolic risk is the association between physical activity and cardiorespiratory 
fitness.	Cardiorespiratory or cardiovascular fitness, assessed by V̇O2 max, refers to the 
capability of the cardiovascular and respiratory systems to supply oxygen to working 
muscles during sustained physical activity. Increasing evidence suggests that South 
Asian have lower cardiovascular fitness levels compared white European people (Hall et 
al. 2010; Ghouri et al. 2010; Arjunan et al. 2013; Arjunan et al. 2015). Although levels 
of physical activity have shown to be strongly associated with cardiorespiratory fitness, 
there is further evidence that the lower V̇O2 max in South Asians is independent of 
physical activity levels (Hall et al. 2010; Ghouri et al. 2013). Additionally, previous 
studies suggest that cardiorespiratory fitness is an important T2D risk factor (Ghouri et 
al. 2013; Hall et al. 2010). In this regard, Ghouri and colleagues (2013) demonstrated 
that low cardiorespiratory fitness was the single strongest predictor of the excess insulin 
resistance and fasting glycaemia in middle-aged South Asian compared with white 
European men living in the UK (Ghouri et al. 2013). Particularly, this study revealed that 
the lower V̇O2 max explained 68% of the ethnic difference in HOMA-IR. However, 
similar studies are warranted in women. There is also evidence indicating that fat 
oxidation during exercise may be a key feature of the insulin resistance phenotype in 
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South Asians (Hall et al. 2010). Indeed, Hall and colleagues (2010) reported lower fat 
oxidation during submaximal exercise, but not at rest, in South Asian than white 
European men and demonstrated positive associations between lower fat oxidation and 
insulin sensitivity index (Hall et al. 2010). The same study also reported lower insulin 
sensitivity index in South Asians than white European participants, which was abolished 
after adjusting for fat oxidation during exercise. This difference in fat oxidation during 
submaximal exercise observed by Hall and colleagues, however, was not related to the 
reduced skeletal muscle expression of oxidative and lipid metabolism genes, which is in 
agreement with Nair and colleagues (Nair et al. 2008), demonstrating that mitochondrial 
dysfunction cannot account for the observed insulin resistance in South Asians. Although 
the lower fat oxidation seems promising and may contribute to the increased insulin 
resistance in South Asians, so far only two small studies (Hall et al. 2010; Nair et al. 
2008) have examined skeletal muscle oxidation in South Asians. Furthermore, the 
mechanisms underlying the lower fat oxidative capacity in South Asians and how this 
relates to their lower insulin sensitivity remain unknown. Thus, future studies are needed 
before any conclusion can be drawn.    
1.3.1.3.6 Lean and adipose tissue mass 
Skeletal muscle is quantitatively the most relevant site of insulin-mediated glucose 
uptake, most of which is directed towards glycogen synthesis when is not oxidised.  
Previous studies have shown have lower lean tissue in South Asians compared with white 
Europeans, and this may represent an important factor contributing to the elevated insulin 
resistance in this population (Sattar and Gill, 2015). Lear and co-workers (2009), in their 
study demonstrated lower lean mass, greater fat mass and fat-to-lean mass ratio in both 
South Asian male and female, compared with other ethnic groups, including white 
Europeans (Lear et al. 2009). In the same study, higher insulin concentrations and 
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HOMA-IR were observed in South Asians compared with other ethnic groups, even after 
adjusting for body fat, whereas the same ethnic difference disappeared after controlling 
for fat-to-lean mass ratio, suggesting a contribution of lower lean mass to the excess 
insulin resistance in this population (Lear et al. 2009). Similar findings were observed by 
previous studies suggesting that South Asians typically have higher body fat and lower 
skeletal muscle mass at the same or lower BMI in comparison with white Europeans, 
which is known as ‘high body fat-normal BMI-low muscle mass phenotype’ (Misra et al. 
2019).  
 
It is well-established that greater levels of total and abdominal adiposity contribute to the 
pathogenesis of insulin resistance increasing the risk to develop T2D and CHD (Diabetes 
UK, 2019; AHA, 2019). Many studies reported greater percent body fat and 
accumulation of visceral adipose tissue, for a given BMI, in South Asian than white 
European individuals, which contributes to their elevated cardiometabolic risk (Sattar 
and Gill, 2015; Bakker et al. 2013; Misra et al. 2014).  Such differences in adiposity have 
been also observed in childhood and adolescence (Gujral et al. 2013). Raj and colleagues 
(2001) reported greater amounts of total adiposity, visceral fat (measured by abdominal 
computed tomography scan), fasting insulin and lower insulin sensitivity (using the 
insulin clamp technique) in healthy South Asian than white Europeans, matched for age 
and BMI (Raj et al. 2001). In the same study, insulin-mediated glucose disposal was 
negatively associated with both total and visceral fat (VAT) suggesting that total and 
regional adiposity may account for the greater insulin resistance and hyperinsulinemia in 
this population (Raj et al. 2001). These findings corroborated previous data from Banerji 
and colleagues (1999), showing negative correlations between insulin-mediated glucose 
disposal and visceral adipose tissue in a cohort of healthy Asian Indians (Banerji et al. 
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1999). Therefore, considering the greater adiposity in South Asians than BMI-matched 
white Europeans and their greater risk of developing obesity related comorbidities (e.g. 
glucose intolerance and T2D) at lower levels of BMI and waist circumference (Tziomalos 
et al. 2008), the proposed cut-offs values for defining overweight and obesity appear to 
be unsuitable in South Asians. In this regard, the WHO proposed BMI cut off points of 
23 to 24.9 kg·m2 for overweight and ≥25 kg·m2 for obesity, endorsed as ‘public health 
action point’ for South Asian individuals (Tziomalos et al. 2008). These are lower than 
the general guidelines for overweight, (25 to 29.9·kg m2) and obesity (≥30 kg m2) (Misra 
et al. 2014; Tziomalos et al. 2008). Likewise, cut off points of ≥ 90 cm and ≥80 cm for 
waist circumference in South Asian men and women, respectively, have been proposed 
instead of the actual cut-off points of ≥102 cm in men and and ≥88 cm in women (Misra 
et al. 2014; Tziomalos et al. 2008).  
However, although South Asians have greater adiposity and central fat distribution, 
additional studies shown that South Asians remain more insulin resistant and have higher 
insulin concentrations (both fasting and after glucose load) than white Europeans after 
controlling for BMI, total and abdominal adiposity (Sattar and Gill, 2015). For example, 
the cross-sectional study from Chandalia and colleagues (1999), reported lower glucose 
disposal rate in South Asian than white European men, even after adjusting for total body 
fat and truncal skinfold thickness (Chandalia et al. 1999). These findings were also in 
agreement with other studies, suggesting that South Asians are more insulin resistant 
independently of generalised or truncal adiposity (Forouhi et al. 1999, Davey et al. 2000). 
However, according to previous studies, these crude adjustments without discriminating 
between superficial subcutaneous adipose tissue (SSAT) and deep subcutaneous adipose 
tissue (DSAT), may not explain the whole story (Bakker et al. 2013). Sniderman and 
colleagues (2007) suggest that the adipose tissue is divided into primary and secondary 
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compartments, with SSAT being the primary adipose tissue compartment and DSAT and 
VAT representing the secondary compartment, which has been linked with insulin 
resistance and associated adverse metabolic effects (Sniderman et al. 2007). According 
to the overflow hypothesis, South Asians have smaller SSAT compartment than white 
Europeans, resulting to the overflow of fat in the secondary compartments, which leads 
to an earlier and greater accumulation of fat in the DSAT and VAT, elevating the risk of 
T2D and CVD in South Asians (Sniderman et al. 2007). In support of this hypothesis, 
previous cross-sectional studies reported lower or similar SSAT and higher DSAT and 
VAT in South Asian than white European individuals (Anand et al. 2011; Kohli et al. 
2010; Chandalia et al. 2007; Lear et al. 2012). Besides the different adipose tissue 
compartments theorized by Sniderman et al. (2007), it is possible that ethnic differences 
in brown adipose tissue (BAT) volume or activity may also underlie the disadvantageous 
metabolic phenotype and susceptibility to T2D in south Asian individuals. Brown 
adipose tissue has been shown to have a role in energy homoeostasis in humans (Bakker 
et al. 2014). Particularly, in contrast to white adipose tissue, BAT burns triglycerides and 
glucose to generate heat through a process called mitochondrial uncoupling (Bakker et 
al. 2014). However, a limited number of studies have investigated potential differences 
in brown adipose tissue between south Asians and white Europeans with findings 
remaining sparse (Admiral et al. 2013; Bakker et al. 2014). Not only the total and 
distribution of body fat varies between South Asian and white Europeans, previous 
studies report ethnic differences in adipocyte size and functions (Bakker et al. 2013) with 
large adipocytes being shown to predict insulin resistance and type 2 diabetes 
independent of obesity (Weyer et al. 2000). Chandalia and co-workers (2007) reported 
greater abdominal subcutaneous adipocyte size in South Asian compared with white 
European men, with this difference remaining significant even after adjusting for total 
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body fat (Chandalia et al. 2007). In the same study, adipocyte size was also negatively 
correlated with glucose disposal rate (Chandalia et al. 2007). Likewise, Anand and co-
workers (2011) revealed increased adipocyte diameter in healthy South Asian than white 
Caucasian men, and adjustment for adipocyte area reduced the ethnic differences in 
insulin levels (Anand et al. 2011). Furthermore, previous evidence shown that South 
Asians exhibit a higher ratio of small-to-larger adipocytes than individuals of European 
descent (Balakrishnan et al. 2012). Taken together, these data have been interpreted as 
an incapability for small adipocytes to differentiate into mature cells, which leads to an 
increased size of the small pool of large adipose cells, reduced storage capacity of TAG 
in the adipose tissue and early storage in ectopic depots such as skeletal muscle and liver 
(Sattar and Gill, 2015; Bakker et al, 2013). Defect in adipose tissue cells maturation and 
hypertrophic adipocytes are considered dysfunctional which has been associated with 
insulin resistance and appears to be an independent predictor of T2D (Bakker at al. 2013). 
In this regard, ectopic fat can accumulate in the liver as a result of excess circulating free 
fatty acids via the portal vein and systemic circulation, which can lead to non-alcoholic 
fatty liver disease (NAFLD) and hepatic insulin resistance (Hall et al. 2008). Although 
the mechanisms underlying this are not fully clarified, it has been hypothesised that the 
elevated fatty acid delivery to hepatocytes results in hepatic accumulation of fatty acid 
intermediates including ceramides and diacylglycerol. This interferes with insulin 
signalling pathway and inhibits insulin action leading to a reduction of the hepatic 
glycogen synthase and stimulation of gluconeogenesis (Samuel et al. 2004). Limited 
evidence suggest that hepatic lipid accumulation can contribute to insulin resistance in 
South Asians. Particularly, a previous study shown that South Asian men display a three- 
to four-fold increase in the prevalence of insulin resistance than White, East Asian, Black 
and Hispanic groups and this was associated with  a two-fold increase in hepatic 
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triglyceride content in South Asians than the other ethnic groups (Petersen et al. 2006). 
Therefore, given the possible causal relationship between hepatic lipid accumulation and 
hepatic insulin resistance in South Asians, this represents an area where further research 
is needed. 
Dysfunctional adipocytes have been also related to greater levels of leptin and FFAs in 
South Asians (Bakker et al. 2013). In support of this, previous studies observed greater 
concentrations of plasma leptin and free fatty acids in healthy nondiabetic South Asian 
men compared with their white European counterparts of similar age and total and 
abdominal adiposity, suggesting abnormalities of the adipose tissue metabolism (Abate 
et al. 2004; Chandalia et al. 2007). Furthermore, elevated concentrations of the 
proinflammatory cytokines IL-6 and CRP, associated with greater CHD risk, have been 
observed to be higher in South Asians than Caucasians with a similar degree of adiposity, 
which may suggest associations with abnormalities in the adipose tissue metabolism 
(Bakker et al. 2013; Tziomalos et al. 2008).  
1.3.2  Unconventional risk markers 
Along with conventional risk markers, emerging or unconventional risk markers may 
represent significant predictors for CHD and T2D risk in South Asians. These are 
numerous, but we will describe CRP, IL-6, and FFAs which were examined in the present 
thesis.  
1.3.2.1 Inflammatory cytokines 
Inflammation seems to play a key role in all stages of the atherosclerosis process, from 
emergence of the lesion to occurrence of a coronary event (Verma et al. 2006). 
Particularly, elevated levels of inflammatory cytokines including CRP, a circulating 
acute phase protein of hepatic origin and IL-6, a pro-inflammatory cytokine produced in 
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different tissues, such as adipocytes and endothelial cells, can cause down regulation of 
NO production, by inhibiting endothelial nitric oxide synthase (eNOS).  This causes a 
reduction in vasodilation increasing the risk of endothelial dysfunction (Hein et al. 2009). 
Furthermore, elevated plasma CRP concentrations, which levels increase in response to 
primary stimulation from IL-6, reduces the concentration of tissue plasminogen activator 
(tPA), responsible for lysing clots at the vessel wall, and increases plasminogen activator 
inhibitor-1 (PAI-1) levels, which inhibits the fibrinolysis process. This facilitates 
synthesis of thrombi on the endothelial wall, which also increases the risk of 
cardiovascular events (Devaraj et al. 2003).  
The majority of previous studies report elevated plasma CRP concentrations in South 
Asian men and women compared with their white European counterparts (Gujral et al. 
2013; Tziomolas et al. 2008; Anand et al. 2004; Arjunan et al. 2015; Bastard et al. 1999), 
although this finding is not universal (Chatha et al. 2002). Furthermore, previous studies 
have reported elevated CHD risk in South Asian individuals associated with greater 
concentrations of CRP compared with white Europeans (Gujral et al. 2013; Tziomolas et 
al. 2008). In this regard, Chambers and colleagues estimated that higher CRP 
concentrations and related inflammation are associated with a 14% increase in CHD risk 
in Indian Asians compared with white Europeans (Chambers et al. 2001). Previous 
evidence also suggests that low-grade chronic inflammation in South Asians likely reflect 
their greater adiposity and visceral adipose tissue (Chambers et al. 2001; Forouhi et al. 
2006).  However, it has also been demonstrated previously that South Asian individuals 
exhibit greater CRP concentrations than Caucasians despite similar levels of body fat 
(Chandalia et al. 2003). Therefore, it is possible that ethnic differences in CRP 
concentrations may reflects abnormalities in the adipose tissue functions described in 
Chapter 1.3.1.3.6. However, additional work is required to determine independent 
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contribution of adiposity on CRP and associations with adipose cells dysfunction in 
South Asians before any conclusion can be drawn.  
Concentrations of IL-6 have been shown to be higher in individuals with IGT or type 2 
diabetes (Pradhan et al. 2001) and have been shown to modulate insulin resistance either 
by affecting directly the insulin signalling pathway or indirectly via stimulation of 
inflammatory pathways (Tilg et al. 2008). Furthermore, studies in rodents have shown 
that acute infusions of IL-6 induced insulin resistance in both liver and skeletal muscle 
(Kim et al. 2004). Previous studies have reported higher concentrations of IL-6 in South 
Asians than white Europeans (Arjunan et al. 2015) suggesting a possible implication of 
the increased prevalence of insulin resistance in South Asians, although this is not a 
universal finding (Peters et al. 2013). Considering IL-6 released from adipose tissue has 
been identified as a precursor for hepatic CRP secretion and that the greater IL-6 
production from the adipose tissue seems to be more associated with the increase of total 
adiposity (Bastard et al. 1999), it is possible that the ethnic differences in inflammation 
may be mediated by the higher body fat levels in South Asian individuals. In this regard, 
Arjunan and co-workers demonstrated greater plasma IL-6 concentrations in South Asian 
compared with white European, with the ethnic difference disappearing after adjusting 
for percent of body fat (Arjunan et al. 2015). Peters and colleagues (2013) did not observe 
ethnic differences in IL-6 between South Asian and white European men, although the 
same study revealed greater IL-6 in South Asian than white European women (Peters et 
al. 2013). In the same study, additionally, adjustment for visceral fat area or percentage 
body fat eliminated the differences in IL-6 between South Asian and white European 
women, with visceral fat area and body fat percentage explaining up to 30% of the 
difference in IL-6 (Peters et al. 2013). However, data on IL-6 in South Asian compared 
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with white European individuals remain limited and future work is required to ascertain 
the independent contribution of ethnicity and adiposity on IL-6 in South Asians. 
1.3.2.2 Free fatty acids 
Elevated concentrations of FFAs or non-esterified fatty acids (NEFA) has been proposed 
to be an important link between adipose tissue and skeletal muscle/liver insulin resistance 
and may contribute to β-cell dysfunction (Boden, 2002; Boden and Shulman, 2002; 
Abate et al. 2004; Karpe et al. 2011). Despite the mechanisms explaining the link 
between FFAs and insulin remain partly understood, FFAs have been reported to inhibit 
insulin action, particularly by inhibiting insulin-induced glucose transport and/or by 
inhibiting insulin-signalling pathways (Boden et al. 2011). Previous evidence also 
reported elevated circulating FFAs in individuals with T2D and obesity compared with 
individuals who are healthy and lean (Boden, 2011; Capurso and Capurso, 2012). In this 
regard, the contribution of chronically elevated FFA concentration on insulin resistance 
has been demonstrated by acutely normalising the elevated levels of FFA in obese 
patients with T2D, which ameliorated insulin sensitivity from approximately 25% to 50% 
(Boden et al. 2011). Furthermore, a considerable part of the insulin resistance lowering 
effect of thiazolidinediones (TZDs), typically prescribed for reducing insulin resistance 
and improving insulin sensitivity, can be attributed to their lowering of plasma FFA 
levels (Boden et al. 2006), which they do by increasing FFA oxidation (Boden et al. 
2005). 
 
Previous evidence reported higher total FFAs concentration in South Asian than white 
European individuals, which has been linked with the greater insulin resistance and T2D 
risk amongst the South Asian population (Chandalia et al. 2007; Abate et al. 2004). In 
respect of this, the study conducted by Chandalia and co-workers revealed higher total 
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non-esterified fatty acids (NEFA) in non-diabetic South Asian men compared with 
Caucasian men, with the South Asian group exhibiting also larger subcutaneous 
adipocytes size, independent of total or subcutaneous abdominal fat (Chandalia et al. 
2007). Furthermore, the same study exhibited a negative correlation between adipocyte 
size and glucose disposal rate, used as a measure of insulin sensitivity (Chandalia et al 
2007). In a similarly designed cross-sectional study, non-diabetic insulin resistant Asian 
Indian exhibited elevated total FFA concentrations compared with Caucasian men, with 
the ethnic difference in FFA remaining significant after adjusting for total adiposity, 
waist and truncal skinfold thickness (Abate et al. 2004). Thus, the elevated concentrations 
of FFAs and larger adipocyte size in South Asians seems to be irrespective of total body 
fat and adipose tissue distribution, suggesting possible abnormalities in the adipose tissue 
metabolism which may contribute to the elevated insulin resistance and T2D in South 
Asians (Bakker et al. 2013; Sattar and Gill, 2015) as described in Chapter 1.3.1.3.6. 
Previous evidence also suggests that adiposity dysfunction and elevated circulating FFAs 
may induce intracellular lipid deposition in ectopic depots (e.g. skeletal muscle and 
liver), which seems to play a causal role in insulin resistance and T2D in South Asians. 
As reported in Chapter 1.3.1.3.6, ectopic fat can accumulate in the liver as a result of 
excess circulating FFAs via the portal vein and systemic circulation, which can lead to 
non-alcoholic fatty liver disease (NAFLD) and hepatic insulin resistance (Hall et al. 
2008). This interferes with insulin signalling pathway and inhibits insulin action leading 
to a reduction of the hepatic glycogen synthase and stimulation of gluconeogenesis 
(Samuel et al. 2004). Likewise, high levels of circulating FFAs have been reported to 
cause an oversupply of lipid to skeletal muscle leading to an accumulation of 
intramuscular triglyceride and fatty acids metabolites such as long-chain acyl-CoA, 
diacylglyceride and ceramide, which inhibit insulin action (Hall et al. 2008). Evidence 
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from Forouhi and co-workers (1999) shown 30% greater intramuscular triglyceride 
concentrations in South Asian than BMI-matched white European men (Forouhi et al, 
1999). Although it is now accepted that intramuscular triglyceride does not induce 
directly insulin resistance (as opposed to lipid intermediates), it represents a marker of 
cytosolic lipid accumulation (Hall et al. 2010). Therefore, the fact that South Asians have 
exhibited elevated intramuscular triglyceride suggests an impaired skeletal muscle lipid 
metabolism. Furthermore, it has been suggested that the accumulation of lipid 
metabolites in insulin-resistant skeletal muscle is not only induced by elevated FFAs 
concentration and subsequent lipid oversupply, but also by a reduced lipid oxidation in 
skeletal muscles (Hall et al. 2008).  The findings by Hall and colleagues (2010) 
(described in Chapter 1.3.1.3.5) reporting lower fat oxidation during submaximal 
exercise in South Asians and positive associations between lower fat oxidation and 
insulin sensitivity index, appear to corroborate the causal role of lipid accumulation in 
skeletal muscle and insulin resistance in South Asians  (Hall et al. 2010).  
Although elevated concentrations of total FFAs may mediate the insulin resistance in 
South Asian individuals (Abate et al. 2004; Chandalia et al. 2007), not all FFAs 
contribute equally to the insulin resistance process. Indeed, high concentrations of 
saturated fatty acids (SFAs) and omega-6 polyunsaturated fatty acids (PUFAs) have been 
associated with increased levels of glucose and insulin whereas specific PUFA, such as 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been shown to 
improve insulin sensitivity (Rasic-Milutinovic et al. 2012). While previous cross-
sectional investigations have explored the association between individual fatty acids and 
markers of cardiometabolic risk (Imamura et al. 2012; Ferrucci et al. 2006), these studies 
have not investigated ethnic-specific between individual free fatty acids and markers of 
insulin resistance. To the author’s knowledge, only one study investigated ethnic-specific 
 38 
 
associations between plasma fatty acids and fasting glucose and insulin resistance, 
identifying significant associations in Caucasian, but not in South Asian individuals 
(Ralston et al. 2013). However, this previous study looked at esterified fatty acids (EFS), 
instead of free fatty acids, by carrying out hydrolysis of plasma TAG post-extraction and 
this ignores the fact the rate of lipolysis of triglycerides, which is controlled by 
glucocorticoids and catecholamines, might be important (Xu et al. 2009). Furthermore, 
while this study reported baseline levels of FFAs in South Asian and Caucasians, ethnic-
differences in FFAs were not explicitly examined while associations between fatty acids 
and physical activity/fitness level were not explored. Thus, the examination of individual 
FFAs, instead of total levels of FFAs, in relation to insulin resistance markers in South 
Asians needs further investigation. 
A further important consideration in the context of examination of individual plasma 
FFAs concerns the methods used for the quantification and identification of these 
metabolites. In this regard, the techniques employed to measure concentrations of FFAs 
has progressively grown over the years ranging from microfluorometric and colorimetric 
enzymatic methods, titrimetric determination, thin-layer chromatography (TLC) to 
metabolomics advanced technologies such as gas chromatography (GC) and liquid 
chromatography (LC) based approaches (Song et al. 2019). However, although the 
majority of previous studies examined total NEFA in South Asian compared with 
Caucasian individuals using colorimetric enzymatic methods (Abate et al. 2004; 
Chandalia et a. 2007), actual data suggest that metabolomics-based approaches are more 
appropriate when an accurate measurement of individual FFA concentrations is required 
(Song et al. 2019).  
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1.3.2.2.1 Application of metabolomics for the quantification of free fatty acids 
Metabolomics represents an evolving technology that enables the identification and 
quantification of low-molecular weight metabolites in an organism that are intermediates 
and products in metabolic pathways including lactate, fatty acids and branched-chain- 
and aromatic amino acids (Gonzales-Franquesa et al. 2016). The use of this approach is 
growing in popularity and has been successfully applied to different fields such as 
nutrition research, biomarker screening and disease aetiology (Liu et al. 2010). In this 
regard, the applications of metabolomics appear to be particularly relevant for the 
quantification of known metabolites and for the identification of new metabolites which 
may contribute to diagnose earlier specific diseases and understand the underlying 
mechanisms in addition to standard clinical biomarkers (Lu et al. 2016). 
The metabolic changes linked with a specific condition or disease can be examined by 
using mainly two different metabolomic approaches: targeted and untargeted approach 
(Dunn et al. 2011). Targeted metabolomic is a quantitative approach typically employed 
as a result of a specific question or hypothesis which aims to quantify known metabolites 
related to one or more pathways (Patti et al. 2012). Conversely, untargeted approaches 
are less quantitative as their main purpose is to detect as many metabolites/compounds 
as possible in a given biological sample having little or no knowledge of the expected 
metabolic profiles in order to generate hypothesis (Patti et al. 2012). 
Metabolites include a variety of chemical compounds of different molecular weights and 
functional groups. Although their examination may be achieved using similar techniques 
used in routine chemical analyses, the identification and quantification of individual 
metabolites in complex mixtures requires higher sensitivity and selectivity techniques 
(Dunn and Ellis, 2005). In this regard, LC and GC, coupled with mass spectrometers 
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(MS) represent the most advanced and frequently used techniques (Patti et al. 2012). 
Particularly, previous research examining FFAs in human plasma and associations with 
metabolic disorders such as insulin resistance and T2D, has made considerable use of 
GC and LC coupled with MS (Binbin et al. 2010; Yi et al. 2007; Dai et al. 2015; Liu et 
al. 2010; Ma et al. 2018; Lu et al. 2016; Serafim et al. 2019; Park et al. 2015; Gonzales-
Franquesa et al. 2016; Feng et al. 2017). For example, in the study from Lu and co-
workers (2016), baseline serum FFAs profile using LC-MS approach was compared 
between patients with T2D and healthy control with diabetic patients exhibiting elevated 
myristic, palmitic and stearic acid (Lu et al. 2016). The same study also demonstrated 
positive associations between diabetes risk with different FFAs including palmitic, 
stearic, oleic and linoleic acid (Lu et al. 2016). These studies, however, have not 
investigated ethnic-specific differences in plasma FFAs metabolic profile using between 
South Asian and white European individuals, which was a purpose of the present thesis. 
 
1.4 Regulation of appetite and energy intake 
This section will initially describe the physiological regulation of appetite, illustrating 
the role of peripheral signals and their integration with central mechanisms to regulate 
appetite and food intake. Furthermore, this section will describe leptin and its role in 
regulating long-term changes in energy homeostasis and body fat, but also its 
associations with insulin resistance in South Asian individuals. The roles of acylated 
ghrelin and total PYY in the short-term appetite and energy intake regulation will be 
subsequently described with the last section examining the acute effects of exercise on 
appetite feelings, energy intake and concentrations of acylated ghrelin and total PYY.  
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1.4.1  Physiological regulation of appetite and energy intake 
The regulation of appetite and energy intake results from the integration of central and 
peripheral signals in the hypothalamus and brainstem, which are the main regions of the 
brain involved in the regulation of energy homeostasis (Druce and Bloom, 2006). 
Particularly, neuro-hormonal signals from the gut and adipose tissue converge on the 
hypothalamus providing information about adiposity and acute nutritional state of the 
body (Wren and Bloom, 2007). A vital region of the hypothalamic regulatory system is 
the arcuate nucleus (ARC), which receives different inputs from other hypothalamic 
regions as well as from peripheral hormones which cross the blood-brain barrier at the 
median eminence (Figure 1.3). The neurons in the ARC of the hypothalamus, can be 
grouped into two main populations. They include orexigenic neurons neuropeptide Y 
(NPY) and agouti-related peptide (AgRP), which stimulate food intake and promote 
weight gain, and anorexigenic neurons pro-opiomelanocortin (POMC) and cocaine- and 
amphetamine-regulated transcript (CART), that inhibit feeding and promote weight loss 
(Wren and Bloom, 2007). Stimulation of POMC/CART neurons induces the expression 
of the neuropeptide α-melanocyte-stimulating hormone (α-MSH), which acts on 
melanocortin-3 receptor (MC3) and melanocortin-4 receptor (MC4) receptors in the 
paraventricular nucleus (PVN) (another region of the hypothalamic area), to reduce 
appetite. Conversely, AgRP blocks the actions of α-MSH by inducing antagonistic 
effects on MC3 and MC4 receptors while NPY stimulates feeding mostly through the 
activation of Y1 and Y5 receptors in the PVN (Neary et al. 2004). The nucleus of the 
solitary tract (NTS) is an additional key area in the control of appetite located within the 
brainstem receiving hormonal and neural inputs from the circulation and from vagal 
afferent nerves located in the gastrointestinal tract (Druce and Bloom, 2006) (Figure 1.3). 
In addition to the ARC, NTS and PVN, which have prominent roles in the central 
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regulation of appetite, other integrated pathways also exist (Schwartz et al. 2000). 
Nonetheless, a discussion of these additional pathways is beyond the aim of this thesis, 
but the reader is referred to Schwartz et al. (2000) for an expanded review of the 
hypothalamic neurocircuits regulating energy balance. Different hormones within the 
peripheral circulation provide information about the nutritional and adiposity state of the 
body and can be divided into two main groups: episodic and tonic hormones. Tonic 
hormones (leptin and insulin) produce chronic signals proportionally to adiposity, while 
episodic hormones, such as ghrelin or PYY, change acutely in response to food intake.  
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Figure 1.3. Schematic representation of appetite and energy intake control resulting from the 
integration of central and peripheral signals in the hypothalamus and brainstem. ARC, arcuate 
nucleus; PVN, paraventricular nucleus; LHA, lateral hypothalamic area; CRF, corticotroph 
releasing factor; TRH, thyrotropin releasing factor (form part of integration with energy 
expenditure); NPY, neuropeptide Y; AgRP, agouti related peptide; POMC, 
proopiomelanocortin; CART, cocaine and amphetamine regulated transcript; MCH, melanin 
concentrating hormone; CCK, cholecystokinin; GLP‐1, glucagon‐like peptide 1; PYY, peptide 
YY; Oxm, oxyntomodulin; PP, pancreatic polypeptide. Druce and Bloom (2006).	Copyright 
permission authorised by Professor S. R Bloom.  
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1.4.2  Tonic signals 
Tonic signals are long-acting signals which reflect the levels of energy stores and control 
body weight as well as the amount of energy stored as fat over the long term.  
Together with leptin, insulin is the only other hormone regarded as a tonic appetite 
regulator and although insulin is not secreted directly from the adipose tissue, its 
concentrations circulate in proportion with body fat mass, with phasic increments 
occurring during meals (Woods and Seeley, 1998). Insulin has shown to exert 
anorexigenic effects via the stimulation of POMC and inhibition of NPY and AgRP 
neurones in the ARC of the hypothalamus (Schwartz et al. 2000). Structure and function 
of this hormone as well as differences in circulating insulin concentrations and 
associations with cardiometabolic risk in South Asian and white European men have been 
described in detail in Chapters 1.2.3 and 1.3.1.3. 
1.4.2.1 Leptin 
Leptin is a peptide hormone principally secreted by adipocytes which circulates at 
concentrations proportional to body fat mass. In this regard, obese subjects typically 
exhibit elevated leptin concentrations than normal weight individuals with most of the 
previous evidence reporting positive associations of circulating leptin levels with BMI 
and adiposity (Considine et al. 1996). Leptin plays a key role in providing information 
about nutritional status and subcutaneous fat mass to neural centres located in the 
hypothalamus that control feeding behaviour and energy expenditure (Considine et al. 
1996). Particularly, leptin exerts anorexigenic effects in the ARC of the hypothalamus 
via stimulating POMC neurones and inhibiting NPY and AgRP neurones (Sahu 2003). 
Furthermore, leptin has shown to play a key role in glucose homeostasis, independent of 
body weight, food intake and energy expenditure, promoting insulin-sensitising effect on 
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the whole-body level and glucose uptake (Denroche et al. 2012). It is therefore plausible 
that differences in leptin levels explain, at least partly, the ethnic variations in insulin 
resistance and T2D in South Asian compared with white European individuals. 
Previous studies reported higher leptin levels in South Asian men, women and neonates 
compared with their white European counterparts (Kalhan et al. 2001; Abate et al. 2004; 
Lilja et al. 2010; Mente et al. 2010). The SHARE study, a cross-sectional study of CVD 
risk factors conducted between 1996 and 1998 in 1176 Canadians of South Asian, 
Chinese, Aboriginal and European origin, reported elevated plasma leptin in South 
Asian, men and women, compared with individuals of European descent and revealed 
positive associations of plasma leptin with insulin resistance (Mente et al. 2010). These 
findings were similar with smaller studies conducted previously (Abate et al. 2004; 
Chandalia et al. 2007; Liew et al. 2003). For example, in the report from Liew and 
colleagues (2003) plasma leptin concentrations were elevated in Asian Indian than white 
European men and significantly associated with insulin clearance and fasting insulin 
(Liew et al. 2003).  
Considering circulating leptin levels are directly proportional to body fat mas (Considine 
et al. 1996), it has been suggested that the greater leptin concentrations in South Asian 
than white Europeans is mediated, at least partly, by differences in adiposity (Bakker et 
al. 2013). In support of this, Banerji and colleagues (1999) revealed positive associations 
of plasma leptin with BMI and subcutaneous adipose tissue in healthy Asian Indian male 
(Banerji et al. 1999). Likewise, Liew and colleagues (2003) reported that fasting leptin 
reflected the higher body fat percentage as evidenced by the positive associations 
between leptin and body fat (Liew et al. 2003). However, BMI, waist circumference as 
well as total adiposity and fat distribution appear to not exhaustively explain the higher 
leptin levels amongst South Asians (Gujral et al. 2013).  In the cross-sectional study 
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conducted by Abate and colleagues (2004), South Asian revealed elevated fasting plasma 
leptin concentrations compared with white European men exhibiting similar total and 
abdominal fat (truncal skinfold thickness) than white European men suggesting elevated 
leptin production from adipose tissue irrespective of total/abdominal adiposity (Abate et 
al. 2004). Furthermore, in the SHARE study the waist-to-hip ratio (WHR) and leptin 
showed similar correlation values in both South Asian and European groups (Mente et 
al. 2010), suggesting the possibility of abnormalities in the adipose tissue metabolism in 
South Asians that extend beyond the greater total and abdominal fat (Gujral et al. 2013; 
Mente et al. 2010; Abate et al. 2004). Elevated plasma leptin levels in obesity appear to 
be linked with leptin resistance and may be involved in the pathogenesis of obesity-
related insulin resistance (Abate et al. 2004). Leptin induces lipid oxidation in cells, 
therefore decreased leptin action may predispose to lipids accumulation in skeletal 
muscle, which has been associated with impaired skeletal muscle insulin resistance (Hall 
et al. 2008). While the mechanisms explaining the link between hyperleptinemia and 
insulin resistance is not completely understood, prolonged hyperinsulinemia may induce 
an increase in leptin levels suggesting that insulin resistance and higher concentrations 
of insulin may have a role in promoting hyperleptinemia (Wang et al. 1999). In support 
of this, Abate et al. (2004) demonstrated positive correlation between leptin levels and 
AUC insulin during OGTT in South Asians and white European men, suggesting that the 
elevated insulin concentrations in the South Asian group may have contributed to the 
greater leptin concentrations in South Asian than white European men.  
1.4.3  Episodic signals 
Despite the fact that leptin and insulin play an important role in the tonic regulation of 
appetite, changes in the concentrations of these hormones cannot explain the increase or 
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decrease in appetite perceptions around the meal, which control initiation and termination 
of the meal. In this regard, acute appetite-regulation seems to be mostly mediated by 
neuroendocrine signalling from the gastrointestinal (GI) tract (Druce and Bloom, 2006). 
Short-acting GI signals are characterised by gut hormones such as cholecystokinin 
(CCK) and mechanical factors, such as gastric distension, which typically convey a sense 
of “fullness” leading to postprandial satiation and meal cessation. Additional appetite 
regulating hormones from the gut have been identified, including the appetite-stimulating 
hormone ghrelin and a variety of appetite inhibiting hormones such as PYY, pancreatic 
polypeptide (PP), glucagon-like peptide 1 (GLP-1) or oxyntomodulin (OXM) (Wren and 
Bloom, 2007). The studies in this thesis focused on the measurement of ghrelin and PYY 
and, thus the following sections will describe the structure and function of these two 
hormones, particularly in relation to appetite and energy intake control.   
1.4.3.1 Ghrelin 
Ghrelin is a 28-amino-acid hormone which is mainly synthesised by the endocrine X/A 
cells of the oxyntic glands of the gastric mucosa, responsible for approximately 50 to 
70% of the systemic ghrelin production (Kojima and Kangawa, 2005). To exert its 
biological function and to cross the blood-brain barrier, this peptide requires post-
translational acylation with a medium chain fatty acid, typically octanoic acid, which 
reaction is catalysed by the ghrelin-O-acyltransferase (GOAT) (Ghigo et al. 2005).  
Ghrelin circulates in the bloodstream predominantly in a non-acylated form (80-90% of 
total circulating ghrelin), which is likely to be explained by the abundance of ghrelin than 
GOAT within the ghrelin-producing cells (Ghigo et al. 2005). However, the orexigenic 
actions of ghrelin are exclusively mediated by the acylated form of this gut peptide 
(Neary et al. 2004) whereas the measurement of total ghrelin has been reported to mask 
changes in acylated ghrelin (Hosoda et al. 2004). Therefore, acylated ghrelin is typically 
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targeted in studies examining the effect of exercise on circulating plasma ghrelin 
concentrations in humans (Hosoda et al. 2004).  
 
Ghrelin is the only known orexigenic gut hormone identified so far and it is well-
established that feeding represents the main factor regulating ghrelin secretion 
considering that its circulating levels decline with food intake and rise in response to 
short-term fasting (Cummings et al. 2001). Ghrelin is the natural ligand for the growth 
hormone secretagogue type 1a receptor (GHS-R1a) and appears to be a potent stimulus 
for the growth hormone release (Ukkola et al. 2005). However, ghrelin has received 
specific attention as the only peripheral hormone to stimulate appetite and food intake. 
Particularly, when administered into the central nervous system (CNS), ghrelin 
stimulates food intake more powerfully compared with any other substance investigated 
including NPY, considered previously the most powerful orexigenic factor (Wren and 
Bloom, 2007). Although its signalling mechanisms remain partly unknown, previous 
evidence suggest that ghrelin acts predominantly via arcuate NPY/AgRP neurons, which 
express the GHS-R1a (Wren and Bloom, 2007). Additionally, ghrelin has shown to 
increase appetite and food intake when administered also systemically in both rodents 
and humans (Wren and Bloom, 2007).  
 
Ghrelin has been shown to affect chronic energy homeostasis as frequent central and 
peripheral injections of ghrelin significantly induced body weight and fat mass gain in 
rodents as a result of an increase in food intake and decrease in fat oxidation (Tschöp et 
al. 2000). Furthermore, circulating ghrelin concentrations also appear to reflect body 
weight changes over the longer term, which may suggest a possible role of ghrelin in 
body weight regulation as an adiposity signal in humans. In this regard, ghrelin has been 
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shown to respond to chronic changes in energy balance as circulating ghrelin levels are 
inversely associated with adiposity (William and Cummings, 2005) with previous studies 
reporting low levels in obese populations and elevated in individuals with anorexia 
nervosa (Tschöp et al. 2001). Furthermore, Ravussin and co-workers (2001) reported a 
down-regulation of ghrelin concentrations in response to approximately three months of 
overfeeding and an up-regulation in response to an energy deficit induced via exercise 
for a similar duration (Ravussin et al. 2001). In a different study conducted in female 
mice, Moesgaard and co-workers (2004) reported that obesity induced by 10 weeks of 
high-fat diet markedly suppressed fasting plasma ghrelin concentrations and ghrelin 
mRNA expression in the GI tract, suggesting that feeding and/or weight gain reduced 
ghrelin release (Moesgaard et al. 2004). However, it remains difficult to establish 
whether the changes in plasma ghrelin in these studies are related to weight gain or to 
increased fat in the diet. Nonetheless, although the mechanisms explaining the fluctuation 
of ghrelin concentrations related to changes in body weight are not completely 
understood, there is evidence that the low concentrations of ghrelin observed in obese 
individuals may be related more to insulin resistance than to higher BMI or fat mass 
(Flanagan et al. 2003; McLaughlin et al. 2004). In this regard, McLaughlin and 
colleagues (2004) compared ghrelin concentrations in obese individuals classified as 
either insulin-resistant or insulin-sensitive, based on steady-state plasma glucose 
concentrations (McLaughlin et al. 2004). The results of this study revealed significantly 
lower ghrelin concentrations in the insulin-resistant group and exhibited negative 
correlations of ghrelin with insulin resistance and insulin concentrations. Additionally, 
in the same study multivariate analysis confirmed that both insulin resistance and 
hyperinsulinemia, independently, predicted low ghrelin levels (McLaughlin et al. 2004), 
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with these data suggesting that insulin resistance and hyperinsulinemia may be associated 
with ghrelin suppression independently of adiposity.  
1.4.3.2 Peptide YY 
Peptide YY is a 36-amino-acid peptide which is primarily synthesised and secreted from 
entero-endocrine L cells of the distal GI tract with concentrations increasing from the 
pylorus to the rectum (Adrian et al. 1985). Peptide YY exists in two different forms: the 
integral 36 amino acid peptide PYY1-36, which is cleaved after secretion to give the 
truncated and active 34 amino acid form PYY3-36. In the circulation, PYY3-36 is the 
abundant form of circulating hormone (~65%) whereas PYY1-36 represents ~35% of the 
total circulating PYY (Batterham et al. 2006). In terms of biological effect, PYY1-36 binds 
with similar affinity to all of the functional Y receptor subtypes in humans (Y1-5) while 
PYY3-36 favourably binds to the Y2 receptor (Cabrele and Beck-Sickinger, 2000). In this 
regard, although the appetite-suppressing effects of PYY are thought to be mediated 
particularly by PYY3-36 (Sloth et al. 2007), previous studies have reported strong positive 
correlations between changes in total PYY and PYY3-36 in response to food intake and 
exercise (Tsilchorozidou et al. 2008; Broom et al. 2009). Thus, consistently with the 
available evidence suggesting that total PYY measurements reflect changes in PYY3-36 
(Broom et al. 2009), total PYY was examined in the studies presented in this thesis.  
 
PYY secretion is mainly stimulated by food ingestion, with concentrations starting to 
increase within 15 min of food ingestion, reaching a peak at ~90 min and remaining high 
for approximately 6 hours (Adrian et al. 1985). However, PYY exerts a variety of effects 
on the GI tract. Administration of PYY, for instance, has been shown to increase the 
absorption of water and electrolytes from the ileum after food ingestion and inhibits 
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secretions from the pancreas, stomach and gallbladder as well as delaying gastric 
emptying (Wren and Bloom, 2007). Additionally, peripheral administration of PYY also 
exerts effects on other body systems including reduction of cardiac output, glomerular 
filtration rate, plasma renin, and aldosterone activity (Adrian et al. 1985). However, the 
significance of these numerous physiological actions has not been elucidated. The pattern 
of PYY secretion after a meal suggests that it may be a satiety signal, inducing 
termination of the meal and promoting coordinated GI responses to assist digestion and 
absorption. In humans, intravenous administration of PYY3–36 has demonstrated to 
inhibit food intake in both lean and obese individuals (Batterham et al. 2002). For 
instance, in normal weight men and women, intravenous injections of 0.8 pmol.kg-1.min-
1 PYY3-36 for 90 min exhibited a significant decrease in hunger feelings and an 
approximate 36 % decline in energy intake at an ad libitum buffet meal given two hours 
after the infusion (Batterham et al. 2006). In the same study, examination of food diaries 
revealed inhibition of food intake throughout the 12 h after infusion without any 
compensatory increases thereafter, which resulted in a substantial lower 24 h energy 
intake in comparison with a saline infusion control trial (Batterham et al. 2002). These 
findings have been confirmed to obese participants (Batterham et al. 2003). However, 
the same physiological effects do not occur at similar doses of PYY1-36, which suggests 
that the appetite suppressing effects are mainly mediated by the active form PYY3-36 
(Sloth et al. 2007). The mechanisms whereby PYY3–36 inhibits appetite and food intake 
is thought to be mediated predominantly by acting directly on Y2 receptors (Y2R) in the 
ARC of the hypothalamus (Karra & Batterham 2010). The binding of PYY to the Y2R 
seems to reduce appetite and food intake by inhibiting NPY neurones, which reduces 
orexigenic signalling and also disinhibits POMC neurones to increase anorexigenic 
outputs (Batterham et al. 2002).  
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Peptide YY may also influence chronic energy homeostasis as repeated peripheral 
infusions of PYY3-36 has revealed to significantly decrease adiposity and body weight 
rodents as a result of a reduction in food intake as well as an increase in fat oxidation at 
whole body (Adams et al. 2006). In humans, PYY also responds to chronic changes in 
energy balance as obese individuals have been shown to exhibit reduced fasting and 
postprandial circulating PYY than lean individuals (Le Roux et al. 2006;	Batterham et al. 
2003), although this is not a universal finding (Cahill et al. 2011; Stock et al. 2005). The 
mechanisms underlying a blunted PYY response in obesity, however, are unclear but 
studies conducted in obese mice suggests that circulating levels are decreased as a result 
of impaired postprandial secretion, rather than synthesis, of PYY (Chandarana et al. 
2011). Regardless of the mechanisms, the blunted PYY and satiety response to food 
consumption may contribute to the exacerbation of obesity.			
Given the implication of PYY and ghrelin in the energy homeostasis and body weight/fat 
mass control, it is possible that ethnic differences in these hormones as well as in the 
regulation of appetite and energy intake may underlie the well-established elevated 
adiposity and associated cardiometabolic risk in South Asian compared with white 
European individuals. However, no studies to the author’s knowledge have been 
conducted to compare the levels of these hormones between South Asian and white 
European individuals.  
1.5 Effect of exercise on appetite, food intake and appetite related hormones 
 
1.5.1 Appetite and energy intake assessment 
 
Appetite represents the qualitative aspect of feeding behaviour and can be described as 
the momentary disposition of an individual to ingest food and is experienced as perceived 
hunger and desire to eat. Alternatively, although food intake responds to the same stimuli, 
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it refers to the quantitative aspect of the feeding behaviour. The relationship between 
appetite and food intake, however, is not always perfect and actual recommendations 
suggest that both parameters are examined within the same experiment (Gregersen et al. 
2008; Stubbs et al. 2000). 
 
Appetite feelings are normally assessed using visual analogue scales (VAS) measuring 
four different aspects of appetite: hunger, satisfaction, fullness and prospective food 
consumption (Flint et al. 2000). These scales require participants to mark with a 
horizontal line, that is typically 100 mm or 150 mm in length with specific statements at 
each end (e.g. ‘not at all full’/ ‘totally full’). On the other hand, acute appetite studies 
typically measure ad libitum food intake using either a free choice buffet meal or a single 
meal with a predetermined macronutrient composition. Both options can be used within 
the laboratory setting, which allows precise quantifications of food intake by weighing 
food items before and after ingestion. However, some intervention studies may monitor 
food intake using food diaries although self-report measures are particularly prone to 
individual bias, which limits the validity of this method (Livingstone & Black 2003). 
 
Interest in the effects of exercise on appetite and energy intake arises from the 
acknowledgement that physical activity may enhance weight and fat loss (Donnelly et al. 
2009), representing a good strategy for the management of obesity and associated 
complications. Nonetheless, the weight/fat loss response to physical activity is 
determined by the subsequent energy intake, as an increase in food ingestion may negate 
the energy deficit of exercise. Likewise, any compensatory increases in appetite 
perceptions after exercise may contribute to the difficult of maintaining a negative energy 
balance and weight loss. In this regard, although previous evidence suggest that South 
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Asian individuals engage in less habitual physical activity than white Europeans (Sattar 
and Gill, 2015), which is likely to contribute to the excess of adiposity and associated 
cardiometabolic risk in this population (Fischbacher et al. 2004; Williams et al. 2011a; 
Williams et al. 2011b; Sattar and Gill, 2015), no studies have investigated ethnic 
differences in appetite perceptions and food intake responses to acute exercise in South 
Asian and white European individuals.  
 
The following sections will discuss the most relevant studies that investigated the acute 
and chronic effects of exercise on appetite perceptions, food intake and appetite-related 
hormones in the general population 
 
1.5.1.1 Appetite perceptions in response to exercise 
A plethora of studies have examined the effects of single bouts of continuous aerobic 
exercise (≥ 60 % V̇O2 max) on appetite perceptions, with the majority of these studies 
performed in lean and physically active males. The majority of these study have shown 
a transient suppression of appetite perceptions during and shortly after exercise, which 
typically returns to resting control values within 30 to 60 min of exercise cessation 
(Broom et al. 2007; Deighton et al. 2013a; King et al. 2010a); a phenomenon known as 
‘exercise-induced anorexia’ (King et al. 1994). Appetite suppression has been also 
observed during a variety of exercise modes including cycling (Deighton et al. 2013a; 
Douglas et al. 2017), running (Broom et al. 2017; King et al. 2010a) and resistance 
exercise (Broom et al. 2009).  
Most of the studies that have examined appetite feelings in response to exercise have 
adopted an observation period of 2 h post exercise. The majority of these studies have 
shown no differences in appetite during the post-exercise period, after the recovery from 
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exercise-induced anorexia, compared with the resting control trial in both males and 
females (Martins et al. 2007; Hagobian et al. 2013; Larson-Meyer et al. 2012). Additional 
studies have employed longer observation period post exercise (2 – 9 h), and the 
consensus amongst these studies is that appetite does not increase above control values 
(Wasse et al. 2012; Wasse et al. 2013; Broom et al. 2009), although this is not universal 
(King et al. 2011a). Particularly, King and colleagues (2011a) observed higher appetite 
perceptions after 60 min of intermittent swimming compared with the resting control trial 
from 1.5 to 6 h post exercise (King et al. 2011a). These data, however, differed from 
previous studies from the same author using a similar study protocol and participant 
population, but employing running or brisk walking as exercise type (King et al. 2010a; 
King et al. 2010b), suggesting an influence of the exercise mode on the subsequent 
appetite response. 
Excess in adipose tissue is typically characterised by a chronic excess of energy intake 
over energy expenditure, thus it is plausible that appetite regulation in response to 
exercise may differ obese compared with lean individuals. Nonetheless, current evidence 
suggests that aerobic exercise fails to induce acute compensatory changes in appetite 
perceptions in overweight and obese men and women (Martins et al. 2015; Douglas et al 
2017). 
The majority of the aforementioned studies investigated the effects of exercise on 
subsequent appetite and food intake following an overnight fast. This probably stems 
from the fact that performing aerobic exercise following an overnight fast has been 
shown to create a favourable lipolytic hormonal environment, such as reduced plasma 
insulin levels and elevated cortisol and epinephrine concentrations, which enhance 
weight and fat loss (Maughan et al. 2010). However, postprandial exercise has been 
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suggested as more beneficial for weight control, which seems to exhibit more favourable 
effects on appetite regulation than fasted exercise. In this regard, Deighton and colleagues 
demonstrated that 60 min of running at ~70% of V̇O2 max resulted in more prolonged 
hunger suppression when performed ~2 h after a high carbohydrate breakfast (72.9% 
carbohydrate, 9.5% protein, 17.6% protein) rather than after a 10 h overnight fast 
(Deighton et al. 2012). Similar findings were observed by Cheng and colleagues (2009) 
who demonstrated that 50 min of cycling at ~60% of V̇O2 max resulted in a longer 
appetite suppression when performed after breakfast than an overnight fast (Cheng et al. 
2009). Therefore, although more studies are needed before definitive conclusions can be 
drawn, exercising after a meal may represent a viable strategy, in alternative to exercise 
in fasted conditions, for the treatment and management of weight loss.  
1.5.1.2 Energy intake in response to exercise 
Most of the studies mentioned in the previous section also examined the food intake 
response to exercise in a laboratory setting by providing participants with an ad libitum 
meal within 2 h after the exercise test. In agreement with the appetite feeling responses 
reported in the previous section, most of these studies reported no significant changes in 
absolute energy intake after performing aerobic exercise (Douglas et al. 2017; Alajmi et 
al. 2015; King et al. 2010a) or resistance exercise (Broom et al. 2009; Jokisch et al. 2012; 
Balaguera-Cortes et al. 2011) compared with the control trial, in males and females. 
Furthermore, additional studies have also shown no changes in energy intake even when 
the ad libitum meal was provided in a laboratory setting closer (≤ 1 h) (Balaguera-Cortes 
et al. 2011; Gonzalez et al. 2013; Kelly et al. 2012) or more than 2 h after the exercise 
bout (King et al. 2010a; King et al. 2010b; Wasse et al. 2012) in males and females. With 
respect to the latter, previous studies suggest that exercise does not induce energy intake 
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compensation up to 22.5 h after exercise (King et al. 2010a) and this finding is also in 
agreement with those studies that used self-reported measures of food intake which have 
failed to identify any changes in energy intake up to 72 h after exercise (Pomerleau et al. 
2004). The examination of food intake in response to exercise in a laboratory setting also 
allows the quantification of macronutrient intakes which represents an important factor 
considering that an over consumption of a high calories fat may overturn the energy 
deficit of exercise (Lluch et al. 1998). However, a plethora of studies in this regard did 
not observe changes in macronutrients in response to exercise (Shorten et al. 2009; 
Douglas et al. 2017; Kelly et al. 2012; Deighton et al. 2014; King et al. 2010a; King et 
al. 2010b). 
Considering the weight loss response to physical activity depends on subsequent energy 
intake, as elevated food intake may negate the energy deficit induced by exercise, there 
has been a growing interest in examining food intake responses to exercise in overweight 
and obese individuals. In this regard, Douglas and co-workers (2017) demonstrated no 
change in ad libitum absolute energy and macronutrient intake in lean and 
overweight/obese, men and women, aged on average between 37.5 and 45 years old, 6 h 
after performing 60 min running at 60% of peak oxygen uptake (Douglas et al. 2017), 
with this finding corroborating previous evidence (Martins et al. 2015; Hopkins et al. 
2014). Additionally, previous evidence comparing lean and overweight/obese 
individuals have demonstrated that energy intake remains unchanged even when food 
intake is examined closely after exercise (≤ 1 h). In this regard, a previous study reported 
no energy compensations in overweight obese and normal weight females aged on 
average 35 years old, when an ad libitum meal was provided within 1 h after walking on 
a treadmill at moderate intensity (60% maximum heart rate) (George and Morganstein, 
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2003), suggesting that acute exercise induces a short-term energy deficit regardless of 
weight and adiposity status (Dorling et al. 2018).  
Evidence from cross-sectional studies have suggested that energy and macronutrient 
intake may vary after acute exercise according to individual physical activity level 
(Dorling et al. 2018). Although studies comparing energy intake between inactive and 
active individuals after exercise bouts are sparse, low active individuals may increase 
their energy and fat intakes after acute exercise (Dorling et al. 2018). In this regard, 
Larson-Meyer and colleagues (2012) observed that ad libitum energy as well as fat 
intakes after 60 min moderate-to-vigorous running were higher in the low active than the 
high active group (Larson-Mayer et al. 2012). These findings were also in agreement 
with Finlayson and co-workers (2009) who demonstrated higher energy intake and 
greater preference for energy-dense foods in low self-reported physically active 
individuals after performing 60 min moderate-to-vigorous cycling (Finlayson et al. 
2009). Although the reasons explaining the greater energy compensation in low active 
people in response to acute exercise is not completely understood, it may be possible that 
low active individuals perceive exercise as a less enjoyable activity, thus the acutely 
increased food intake post exercise can be experienced as a reward (Dorling et al 2018). 
Alternatively, it is possible that active individuals are better informed on nutrition 
guidelines and opt for more sensible and healthier food choices (Dorling et al. 2018). 
Additional studies have also examined energy intake responses between individuals with 
different habitual physical activity levels, with previous evidence suggesting better 
energy intake adjustment in response to energy balance perturbations in habitual active 
individuals (Dorling et al. 2018). In this regard, different authors reported that individuals 
who habitually exercise exhibit reduced satiety and increased hunger in response to a 
standardised meal than low active individuals (Gregersen et al. 2011; Van Walleghen et 
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al. 2007). This seems to suggest that physically active individuals may ingest greater 
amount of food to compensate for the energy expenditure induced by the habitual 
exercise (Dorling et al. 2018). 
1.5.2  Effects of exercise on ghrelin and PYY 
Observations of the exercise-induced anorexia phenomenon and the short-term energy 
deficit in response to exercise has stimulated considerable interest in in the underlying 
mechanisms explaining these effects. In this regard, an increasing number of studies have 
examined a variety of episodic appetite-regulated gut hormones, which appear to regulate 
feelings of hunger and satiety including ghrelin, known as the only orexigenic gut peptide 
and PYY due to its effects on appetite suppression. However, there are no studies to the 
author’s knowledge that investigated whether differences in individual ethnicity 
background may modulate differently appetite-related hormones in response to exercise. 
In the next section, we will examine the studies that investigated the effects of acute and 
chronic exercise on these hormones in the general population. 
1.5.2.1 Ghrelin 
Earlier research investigating the underlying mechanisms linking physical activity, 
appetite and food intake examined the effects of exercise on total ghrelin concentrations 
which has produced inconsistent findings with studies reporting elevation (Borer et al. 
2009; Christ et al. 2006; Cheng et al. 2009), decrease (Vestergaard et al. 2007; Toshinai 
et al. 2007) and no change (Dall et al. 2002; Martins et al. 2007) of total ghrelin 
concentrations in response to a single bout of exercise. However, total ghrelin has been 
shown to not reflect changes in the active acylated form which is more susceptible to 
acute energy deficit induced by exercise or reduction in food intake (Mackelvie et al. 
2007). In this regard, Marzullo and co-workers (2008) examined differences in acylated 
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ghrelin and total ghrelin concentrations in response to an incremental cycle test to 
exhaustion with acylated ghrelin being suppressed immediately after the cycle test 
whereas total ghrelin remained unchanged (Marzullo et al. 2008). Many studies that 
examined the effect of acute moderate-to-vigorous exercise (≥ 60 % V̇O2 max) on 
acylated ghrelin demonstrated acylated ghrelin suppression during exercise with 
perturbations typically returning to control values within 30 min (Deighton et al. 2013; 
Broom et al. 2009; Kawano et al. 2013; Wasse et al. 2013). However, this is not a 
universal finding with other studies observing no changes in acylated ghrelin in response 
to acute moderate-to-vigorous exercise (Douglas et al. 2017; Douglas et al. 2015; 
Hagobian et al. 2009) with only one study, to our knowledge, exhibiting an elevation in 
acylated ghrelin during the two hours post exercise (Larson-Meyer et al. 2012). On the 
other hand, the acylated ghrelin responses to acute resistance training seem less 
definitive, with limited studies showing either suppression or no change in circulating 
acylated ghrelin concentrations (Dorling et al. 2018).  
Furthermore, many studies demonstrated a simultaneous suppression of acylated ghrelin 
and appetite which may suggest a mediating influence of this episodic gut hormone on 
appetite feelings (King et al. 2010b; Kawano et al. 2013; Unick et al. 2010; Ueda et al. 
2009; Wasse et al. 2012). However, although these studies observed a concordance 
between appetite perceptions and acylated ghrelin in response to exercise, additional 
studies observed different patterns (Wasse et al. 2013; Douglas et al. 2017; Broom et al. 
2017).  For example, in their investigation Douglas and colleagues (2017) did not observe 
acylated ghrelin suppression in response to 60 min of moderate intensity running (59% 
peak V̇O2), whereas there was a marked suppression of appetite perceptions during and 
immediately after exercise (Douglas et al. 2017). The lack of acylated ghrelin suppression 
in this study may be linked to the insufficient intensity of the exercise with previous 
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research identifying exercise intensity as an important determinant of the acylated ghrelin 
response to exercise (Broom et al. 2009; King et al. 2010a).  In this regard, acylated 
ghrelin suppression is typically reported in response to exercise intensity above 60% of 
V̇O2 max (Shubert et al. 2014). Conversely, Broom and colleagues (2017) observed a 
reduction of acylated ghrelin during a single bout of moderate-to-vigorous running (75% 
V̇O2 max) but hunger did not differ between the exercise and control trial (Broom et al. 
2017), which contrasts with previous studies reporting a simultaneous reductions in 
hunger and acylated ghrelin previously described. These dissociations between acylated 
ghrelin and hunger perceptions, however, highlights the complexity of the appetite 
regulation in which different appetite-related hormones and physiological factors are 
involved (Broom et al. 2017). 
The majority of the aforementioned studies investigated the effects of exercise on 
acylated ghrelin following an overnight fast.  However, considering the longer hunger 
suppression induced by exercise performed after a meal compared with exercising after 
an overnight fast previously reported (Cheng et al. 2009; Deighton et al. 2012), it is 
possible that this effect may be mediated, at least partly, by the different concentrations 
of acylated ghrelin. In this regard, however, Cheng and colleagues (2009) did not observe 
any difference in acylated ghrelin between fast and fed exercise whereas Deighton and 
colleagues (2012) did not examine differences in this gut peptide in their study. Although 
the evidence from Cheng and colleagues (2009) appears to suggest no differences in 
acylated ghrelin responses after manipulation of the study protocol, additional 
investigations comparing the appetite responses to fed versus fast exercise may be useful 
for a greater understanding of acylated ghrelin in response to exercise. 
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Very few investigations have explored the effects of chronic exercise on ghrelin 
concentrations by examining differences in acylated ghrelin levels between habitual 
physical active and inactive individuals. For example, Lund et colleague (2013) 
examined appetite-related hormone changes after the ingestion of a standardised liquid 
meal between young inactive men, who had not performed exercise in the last six months, 
and endurance-trained athletes (Lund et al. 2013). In this report, concentrations of fasting 
acylated ghrelin were greater in the active group than the inactive group, whereas 
concentrations of postprandial acylated ghrelin did not differ between groups (Lund et 
al. 2013). In a previous study, middle aged sedentary postmenopausal women, who 
typically exhibit similar fasting ghrelin concentrations than premenopausal women 
(Stojiljkovic-Drobnjak et al. 2018; Iwamoto et al. 2005), exhibited 18% increase in 
fasting total ghrelin concentrations after one year of a regular exercise programme (45 
min of moderate intensity aerobic exercise, for 5 days per week) compared with a group 
of women who only performed 45 min of stretching sessions once per week for one year 
(Foster-Schubert et al. 2004). However, in the same study the authors did not observe a 
significant association between increased physical activity with plasma ghrelin, and the 
elevation of ghrelin was concomitant with the reduction of body weight which may have 
confounded the results. Furthermore, in both studies levels of habitual physical activity 
were measured using self-reported physical activity, which represents a limitation due to 
issues of participant recall bias which makes it difficult to accurately correspond self-
reported with actual physical activity (Prince et al. 2008). Thus, because only a few 
studies have examined acylated ghrelin concentrations in relation to chronic exercise and 
because the actual evidence are based on self-reported physical activity, future studies 
investigating relations between acylated ghrelin concentrations and physical activity 
objectively-measured are needed.   
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1.5.2.2 Peptide YY 
As stated previously, peptide YY is an anorexigenic gastrointestinal hormone acting in 
opposition to acylated ghrelin. The first study to investigate circulating concentrations of 
PYY in response to exercise was performed by Martins and colleagues (2007). In this 
study, 60 min of continuous cycling at 65 % of maximum heart rate induced an elevation 
in plasma total PYY concentrations during and upon completion of cycling in healthy 
males and females. In the same study, a reduction in hunger occurred in parallel with the 
increase of PYY with both parameters returning to control values within 30 min after 
exercise, which suggested a causal role of this satiety hormone in exercise-induced 
anorexia. Similar transient increases in total PYY have been then replicated by other 
studies which have examined the effect of moderate-to-vigorous aerobic exercise (≥ 60% 
V̇O2 max) on total PYY (Broom et al. 2009; Deighton et al. 2013a; Douglas 2015; Wasse 
et al. 2012; Kawano et al. 2013; Douglas et al. 2017). Such transient increases in 
circulating total PYY levels have been also shown in other studies which employed a 
lower exercise intensity (≤ 60% V̇O2 max) (Cooper et al. 2011; Ueda et al. 2009).  
In contrast to the aforementioned studies, other studies have reported no changes in total 
PYY levels after 40 - 45 min of exercise at 70 % of VO2 max (Balaguera-Cortes et al. 
2011; Kelly et al. 2012; Shorten et al. 2009). Although the reasons for such disparity are 
unclear, exercise duration may cause this as these studies used shorter exercise protocols 
than those that have shown an increase in PYY after exercise. Additionally, Balaguera-
Cortes and colleagues (2011) confirmed previous studies in which concentrations of total 
PYY do not change in response to intermittent resistance exercise (Broom et al. 2009). 
Although these findings appear to suggest that a prolonged exercise protocol is needed 
to elevate circulating PYY concentrations, Kawano et al. (2013) demonstrated that 30 
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min of skipping and cycling exercise at approximately 65% of VO2 max induced a 
transient elevation in total PYY upon completion of exercise. Additionally, according 
with the anorexigenic effect of PYY, appetite perceptions appear to decrease during 
exercise when PYY levels are increased (Kawano et al. 2013) but remain unchanged 
when circulating concentrations of PYY are unaffected (Kelly et al. 2012). 
Increase in total PYY in response to exercise have been also observed in 
overweight/obese individuals. In this regard, Ueda and co-workers (2009) investigated 
whether changes in total PYY levels in response to acute aerobic exercise differ between 
obese and normal weight males. Levels of total PYY were reported higher in response to 
exercise in both groups, suggesting an effect of exercise on PYY independent of 
bodyweight. However, this contrasts with a more recent study which reported greater 
total PYY elevation in lean compared to overweight/obese, males and females, in 
response to 60 min running at 59 % peak oxygen uptake (Douglas et al. 2017). The 
implications of this disparity, however, remain unclear and additional work is definitely 
required to ascertain whether total PYY in response to exercise may be mediated by 
differences in adiposity (Dorling et al. 2018).  
A further important consideration is that the aforementioned investigations measured 
total PYY which includes concentrations of both forms: PYY1-36 and PYY3-36. 
Nonetheless, the appetite-suppressing effects of PYY are thought to be mediated 
particularly by PYY3-36 (Sloth et al. 2007). Thus, although strong correlations between 
changes in total PYY and PYY3-36 have been reported (Tsilchorozidou et al. 2008), some 
studies have specifically examined the effect of exercise on PYY3-36. In this regard, the 
effect of exercise on PYY3-36 seems to be similar to total PYY as transient elevations 
have been shown upon completion of prolonged exhaustive running (Russel et al. 2009) 
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but also during and immediately after 60 min of walking and running exercise at 70 % of 
VO2 max (Larson-Meyer et al. 2012). Furthermore, the association between PYY3-36 and 
appetite feelings during exercise also needs additional investigation as an inverse 
temporal pattern has been shown in some (King et al. 2011b; Ueda et al. 2009a) but not 
all studies (Hagobian et al. 2013; Larson-Meyer et al. 2012). 
A limitation concerning the examination of the effect of exercise on circulating PYY 
concentrations, is that the majority of previous work has focused merely on the effect of 
acute exercise with only one study to our knowledge examining the impact of chronic 
exercise on this gut peptide (Lund et al. 2013).  In this report, concentrations of fasting 
and post-prandial total PYY were similar between active and inactive individuals (Lund 
et al. 2013). Therefore, future studies investigating the influence of chronic exercise on 
plasma PYY levels may be relevant in determining how different levels of physical 
activity modulate this gut hormone and appetite and energy intake responses. 
1.6 Summary 
The elevated risk of CVD and T2D in South Asians has been linked to the higher 
prevalence of different traditional risk factors including greater adiposity, insulin 
resistance or dyslipidaemia. However, these risk factors do not exhaustively explain the 
excess cardiometabolic risk in South Asians compared with white Europeans. 
Considering chronic surplus of energy intake as a possible contributor leading to body 
fat accumulation, we theorized that the elevated adiposity and associated cardiometabolic 
risk in South Asians than white Europeans may be linked with ethnic differences in eating 
behaviour and appetite-regulating hormones such as acylated ghrelin and peptide YY 
(PYY) concentrations. Furthermore, fasting ghrelin concentrations have been shown to 
be lower in individuals with elevated adiposity and exhibiting insulin resistance (Le Roux 
 66 
 
et al. 2005; McLaughlin et al. 2004). Thus, we hypothesised ethnic differences in 
circulating appetite-regulating hormones concentrations, particularly lower levels of 
acylated ghrelin in South Asian than white European men. Furthermore, the examination 
of additional parameters including appetite-related hormones, CRP, IL-6, leptin as well 
as FFAs, based on advanced metabolomics analytical methods, may add further 
information of the elevated CVD and T2D susceptibility amongst the South Asian 
community. Low levels of physical activity and fitness levels in South Asians may 
contribute to exacerbate the elevated adiposity and associated cardiometabolic risk, 
which may be also linked to ethnic differences in appetite regulation and food intake. 
Conversely, acute moderate-to-vigorous exercise has shown to promote short-term 
energy deficit suggesting an important role of physical activity to enhance weight and fat 
loss if exercise is performed frequently; however, the effects of exercise on short-term 
energy balance in South Asians remain unknown. Thus, the aims of the present thesis 
were threefold: (1) investigate ethnic differences in traditional risk markers and 
unconventional parameters for CVD and T2D including acylated ghrelin, PYY, leptin, 
glucose tolerance, insulin, TC, TAG, HDL-C, LDL-C, CRP and IL-6 and explore 
relationships of these parameters with  objectively-measured physical activity and 
cardiorespiratory fitness; (2) examine ethnic differences in the FFA metabolic profile 
based on advanced metabolomics analytical methods such as GC-MS and LC-MS and 
explore relationships with objectively-measured physical activity and cardiorespiratory 
fitness and risk markers for CVD and T2D; and (3) investigate the effects of acute 
exercise on subjective appetite ratings, appetite-related hormones and ad libitum energy 
intake in healthy South Asian and white European men. 
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Chapter 2 – General Methods 
 
This chapter describes the experimental methods employed in the three studies presented 
within this thesis. Specifically, the aims of the present thesis were to: 
• investigate ethnic differences in unconventional parameters for CVD and T2D 
including fasting concentrations of plasma acylated ghrelin and total PYY 
(primary aim). Study 1 (Chapter 3); 
• investigate ethnic differences in traditional risk markers for CVD and T2D such 
as metabolic markers (i.e. plasma concentrations of glucose and insulin) and 
inflammatory markers (i.e. plasma concentrations of CRP and IL-6) (secondary 
aim). Study 1 (Chapter 3);  
• explore associations of unconventional and traditional risk markers for CVD and 
T2D with adiposity and physical activity/cardiorespiratory fitness in South Asian 
and white European men (secondary aim). Study 1 (Chapter 3); 
• examine ethnic differences in the FFA metabolic profile based on metabolomics 
methods (primary aim). Study 2 (Chapter 4); 
• explore relationships of FFA concentrations with adiposity and physical 
activity/cardiorespiratory fitness in South Asian and white European men 
(secondary aims). Study 2 (Chapter 4); 
• investigate the effects of acute exercise on subjective appetite-related hormones, 
appetite feelings and ad libitum energy intake in healthy South Asian and white 
European men (primary aims). Study 3 (Chapter 5); 
• explore associations of appetite measures with adiposity and physical activity/ 
cardiorespiratory fitness in South Asian and white European men (secondary 
aims). Study 3 (Chapter 5). 
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All studies were conducted following the approval of Kingston University’s Ethics 
Advisory Committee, and all volunteers were fully informed about the aims, procedures 
and potential risks before participating in these experiments 
2.1 Participants 
Participants were voluntarily recruited from Kingston University and the general public 
via general notices such as posters, university notice board, social media and by word of 
mouth. Study 1 (Chapter 3) and study 2 (Chapter 4) included the same participant cohort 
whereas in study 3 (Chapter 5) different participants were recruited. Before attending the 
laboratory, participants received by email or by post the following documents: 
§ participation informed consent form (Appendix A) 
§ health screening questionnaire (Appendix B)  
§ pre-screening form for blood sampling (Appendix C)  
§ physical activity readiness questionnaire (PARQ) for exercise screening 
(Appendix D) which is routinely used in exercise studies prior undertaking an 
exercise testing (Thomas et al. 1992) 
§ Standardised breakfast and buffet meal food list (Appendix E) 
Participants were asked to sign and fill the above documents prior to participating in the 
experimental studies to ensure they were suitable to take part in these experiments. 
Furthermore, participants were free to contact the investigators for any clarification 
related to the study before attending the laboratory and it was also reiterated to them that 
they were free to withdraw from the study at any point during the study without giving 
reason. 
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As described in subsection 1.2.2, males are reported to experience greater 
cardiometabolic risk than female individuals in the United Kingdom thus, in all studies 
we targeted male volunteers and aged 19 – 50 years to ensure health suitability for 
undertaking the incremental exercise test to volitional exhaustion for the determination 
of cardiorespiratory fitness (V̇O2 max). Additionally, the inclusion criteria for 
participation were as follows: 
§ non-smoker 
§ no personal history of cardiovascular disease or metabolic disorders 
§ not taking anticoagulant or anti-inflammatory medication 
§ fit and well to participate in the maximal testing following Physical Activity 
Readiness Questionnaire clearance 
§ not dieting or undertaking any extreme dietary habits 
§ weight stable for the last three months, i.e. < 2.3 kg change in body weight (St 
Jeor et al. 1997). 
 
2.2 Anthropometry  
Body mass was measured to the nearest 0.1 kg using a digital scale (Seca Ltd, Hamburg, 
Germany), and stature was measured to the nearest 0.1 cm using a portable stadiometer 
(Seca Ltd, Birmingham, UK). Participants wore light clothing and removed shoes, 
jewellery and all items from pockets for body mass and height measurements. Body mass 
index (BMI) was subsequently calculated as mass (kg) divided by stature squared (m2). 
Waist circumference was measured in duplicate to the nearest 0.1 cm at the midpoint 
between the xiphoid process and the iliac crest using a standard anthropometric 
measuring tape (HaB International Ltd., Southam, UK), and the mean of the two 
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measurements was recorded. Body composition was assessed using air displacement 
plethysmography (BodPod; software version 5.2.0, COSMED, Rome, Italy).  
2.3 Heart rate measurement 
During preliminary tests and main trials, heart rate was monitored using a short-range 
radio telemetry system (Polar FT1, Polar Electro, Kempele, Finland). 
2.4 Rating of perceived exertion 
Rating of perceived exertion was assessed periodically during preliminary exercise tests 
and main trials using the Borg scale (Borg 1973) to determine participant’s level of 
exertion. This scale ranges from six (no exertion) to 20 (maximal exertion). 
2.5 Blood pressure measurement 
Arterial blood pressure	was measured using a digital monitor (Omron M10-IT, Omron 
Healthcare Co. Ltd., Japan) during preliminary screening and measurements were taken 
after a 10 min of seated rest in a semi-supine position in duplicate from the left arm. The 
mean of these measurements was used as the final value. 
2.6 Cardiorespiratory tests 
In all studies, after familiarisation with the electromagnetically braked cycle ergometer 
(Lode Excalibur Sport, Groningen, Netherlands), participants performed an incremental 
exercise test to volitional exhaustion for the determination of maximum oxygen 
consumption (V̇O2 max). In Study 1 (Chapter 3), participants cycled at a self-selected 
pedal rate between 70 to 90 revolutions per minute for 3 min at 50 watts (warm up), 
followed by increments of 6 watts every 15 s until volitional fatigue. However, using this 
protocol most of participants reached their V̇O2 max beyond twelve minutes whereas 
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existing research in the literature suggests that measurement of maximal responses 
should last between 8 and 12 minutes (Pierce et al. 1999). Therefore, the V̇O2 max 
protocol in Study 3 (Chapter 5) was optimised by increasing the initial work rate to 80 
watts per 3 min (warm up), instead of 50 watts, followed by increments of 30 watts every 
3 min until volitional fatigue, which provided V̇O2 max readings within recommended 
protocols time.   
Expired air samples were monitored continuously using an online breath-by-breath gas 
analysis system (Oxycon Pro, Viasys Healthcare Gmbh, Höchberg, Germany). An 
average of the breath-by-breath V̇O2 data was calculated every 15 s, and V̇O2 max was 
recorded as the highest 15 s average. Prior to testing, the gas analysis system was 
calibrated using a 3 L syringe (series 5530, Hans Rudolph Inc, Shawnee, KS, USA) with 
certified reference gases according to the manufacturer’s instruction. Throughout the 
V̇O2 max test, heart rate and rating of perceived exertion were monitored. Oxygen 
consumption, heart rate and peak watts were used to determine the appropriate intensity 
of work during the exercise trial in Study 3. 
2.7 Environmental temperature and humidity 
Prior commencement and throughout each trial, environmental temperature and humidity 
were assessed using a hand-held sensor (THGR810, Oregon Scientific UK Ltd., 
Berkshire, UK). 
2.8 Calculation of energy expenditure  
Oxygen consumption and carbon dioxide production values during exercise trials in 
Study 3 were used to determine energy expenditure and substrate oxidation using the 
equations described by Weir (1990). 
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2.9 Physical activity and dietary control 
Participants were asked to refrain from consuming alcohol, caffeinated drinks and from 
participating in strenuous exercise during the 24 h prior to each visit. Participants were 
also asked to exert themselves minimally when travelling to the laboratory, using 
motorised transport where possible. Prior to visit 1 in Study 1 (Chapter 3), and prior to 
the main trials in Study 3 (Chapter 5), volunteers fasted overnight (no food or drink 
except water) for 9 hours whereas they were required to fast for 3 hours before 
performing the incremental exercise test on the second visit in Study 1. Participants were 
encouraged to consume at least 500 mL of plain water the night before the experimental 
trials to ensure euhydration.  
 
In Study 3 (Chapter 5), a food diary (Appendix F) was completed in the 24 h prior to the 
first trial, with participants required to replicate food and drink intake as closely as 
possible for the 24 h prior to the subsequent trial. Participants were instructed to consume 
identical amounts of food and drink items at identical times during this period to ensure 
dietary standardisation before each trial. 
2.10  Blood sample collection 
On the morning of visit 1 in Study 1 (Chapter 3 and 4) and main trials in Study 3 (Chapter 
5), a fasting venous blood sample was collected from volunteers by a trained 
phlebotomist after resting in a semi-supine position for 15 min. 
 
In Study 1, blood samples were collected from the antecubital vein using a 25 g butterfly 
needle (BD Vacutainer®, Plymouth, UK) whilst participants were in a semi-supine 
position for the measurement of total cholesterol, high density lipoprotein cholesterol, 
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low density lipoprotein cholesterol, triacylglycerol, C-Reactive protein, interleukin 6, 
leptin, acylated ghrelin and total PYY concentrations. Samples were collected into four 
pre-cooled vacutainers: 10.0 mL EDTA, 4.0 mL EDTA, 5.0 mL SST and 6.0 mL heparin 
(BD Vacutainer®, Plymouth, UK). To prevent the degradation of acylated ghrelin, a 40 
μL solution containing potassium phosphate buffer (PBS), p-hydroxymercuribenzoic 
acid (PHMB) and sodium hydroxide (NaOH) was added immediately to the 4.0 mL 
EDTA vacutainer which was then centrifuged at 1500 × g for 10 min at 4°C (Rotina 
420R, Andreas Hettich GmbH & Co., Berlin, Germany). The plasma supernatant was 
dispensed into a storage tube and 100 µL of 1 M hydrochloric acid was added per 
millilitre of plasma to preserve acylated ghrelin (Hosoda et al. 2004). Thereafter, samples 
were spun at 1500 × g for 5 min at 4°C prior to storage at -80ºC. The 6.0 mL heparin and 
10 mL EDTA vacutainers were centrifuged immediately, while the 5.0 mL SST 
vacutainer was left at room temperature for 30 min before centrifugation using the same 
conditions. During the OGTT, whole blood was collected using the finger-prick 
technique into a 20 µL heparin capillary tube (Sanguis Counting, Nümbrecht, Germany) 
for glucose analysis and into a 300 µL EDTA Microvette tube (Microvette® CB 300 K2E, 
Starstedt, Leicester, UK) for insulin analysis. The heparin tube was immediately mixed 
into a separate 1 mL haemolysing solution and then analysed. The EDTA tube was 
immediately centrifuged at 1500 × g for 10 min at 4°C (Eppendorf® Microcentrifuge 
5415R, Eppendorf AG, Hamburg, Germany) and the plasma supernatant was then 
dispensed into aliquots and stored at -80 °C for later analysis. 
 
In Study 3, venous blood samples were collected via a cannula (Vasofix® Safety, B. 
Braun, Melsungen, Germany) inserted into an antecubital vein for the determination of 
acylated ghrelin, PYY, insulin and glucose.  During each trial, all blood samples were 
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collected with the participants rested in a semi supine position with the exception of the 
sample at 3 h time point in the exercise trial, which was taken with the participant seated, 
but not pedalling, on the cycle ergometer at the end of the exercise. Samples were 
collected into four pre-cooled vacutainers: 6.0 mL heparin, 10.0 mL EDTA and two, 4.0 
mL EDTA (BD Vacutainer®, Plymouth, UK). To prevent the degradation of acylated 
ghrelin, same procedure as above was followed for one 4.0 mL EDTA vacutainer. The 
6.0 mL heparin and 10 mL EDTA vacutainers were centrifuged immediately at 1500 × g 
for 10 min at 4°C prior to storage at -80ºC. The other 4.0 mL EDTA vacutainer was 
immediately analysed for determination of haemoglobin and haematocrit. 
To avoid blood clot, the cannula was kept cleaned by flushing it with 10 mL 0.9% Sodium 
Chloride syringe (Becton Dickinson UK Ltd., Berkshire, UK) after each blood sample. 
To avoid dilution of subsequent samples, residual saline was drawn off immediately prior 
to blood collection. 
2.11 Blood analysis 
2.11.1 Haemoglobin and haematocrit  
Blood haemoglobin and haematocrit concentrations were analysed in duplicate using a 
haematology blood counter (Yuminez H500-CT, HORIBA ABX Diagnostic, 
Northampton, UK) to determine plasma volume changes over time (Dill and Costill, 
1974).  
2.11.2 Free fatty acids 
The examination of the free fatty acid metabolic profile was initially conducted at 
Kingston University based on gas chromatography–mass spectrometry (GC-MS). The 
blood samples for the FFA analysis were obtained from the same set of participants 
recruited in Study 1 (Chapter 3). Full details of the FFA analysis based on GC-MS is 
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described in Chapter 4.2.7.1. However, due to inadequate results, liquid 
chromatography–mass spectrometry (LC-MS) was subsequently employed for the 
identification and quantification of FFAs in South Asian and white European participants 
and the analysis was conducted at the University of Strathclyde. Details of the FFA 
analysis based on LC-MS are fully described in Chapter 4.2.7.2. 
2.11.2.1 Chemicals and Solvents 
High-performance liquid chromatography (HPLC) grade acetonitrile (ACN), water, 
acetic acid and hexane were obtained from Fisher Scientific (Leicestershire, UK). A 
mixture of fatty acid methyl ester standards (Supelco 37-component fatty acid methyl 
ester mix) was obtained from Sigma Aldrich (Dorset, UK). The methyl esters were 
hydrolysed with 1 M KOH by heating at 60ºC for 15 minutes, the mixture was acidified 
and extracted into hexane. The hexane stock solution was diluted to the levels required 
for the calibration curves with ethanol. 31H2-palmitic acid which was used as an internal 
standard was obtained from Sigma Aldrich (Dorset, UK). Plasma samples were prepared 
by mixing aliquots of plasma (0.3 ml) with 0.2 ml of acetonitrile containing 8 µg · mL-1 
of internal standard. A calibration series was prepared by mixing the diluted fatty acid 
stock solution with the internal standard to give an internal standard concentration of 4.8 
µg · mL-1 mixed with fatty acid standards in the range 0.8-38. µg · mL-1 (the original 
standard mixture contained fatty acids at different concentrations: 0.2, 0.4 or 0.6 mg · 
mL-1). 
2.11.2.2 Instrumental techniques and column 
Free fatty acids were profiled by using a Dionex 3000 HPLC system interfaced to an 
Exactive Orbitrap mass spectrometer (Thermo Fisher Scientific, Bremen, Germany) with 
the aid of a reversed phase column (ACE C4, 150 × 3.0 mm, 3 µm, HiChrom, Reading 
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UK). The mobile phase for the elution of the ACE C4 column consisted of 1 mM acetic 
acid in water (A) and 1 mM acetic acid in acetonitrile (B) at a flow rate of 0.4 mL ∙ min1. 
The elution gradient was as follows: A:B ratio 40:60 at 0 min, 0:100 at 30 min, 0:100 at 
36 min, 40:60 at 37 min and 40:60 at 41 min. 
 
2.11.2.3 Mass spectrometry run conditions 
The nitrogen sheath and auxiliary gas flow rates were maintained at 50 and 17 arbitrary 
units. The electrospray ionisation (ESI) interface was operated in both positive and 
negative modes. The spray voltage was 4.5 kV for the positive mode and 4.0 kV for 
negative mode, while the ion transfer capillary temperature was 275°C. Full scan data 
was obtained in the mass-to-charge range of m/z 75 to m/z 1200 for both ionisation 
modes. The MS system was fully calibrated prior to running the samples according to the 
manufacturer’s guidelines. The resulting data was acquired using the XCalibur 2.1.0 
software package (Thermo Fisher Scientific, Bremen, Germany). 
2.11.3 Appetite-related hormones 
Commercially available enzyme-linked immunosorbent assay kits were used to 
determine concentrations of key appetite regulating hormones such as appetite-
stimulating plasma acylated ghrelin (Bertin Bioreagent, Montigny le Bretonneux, France 
for Study 1; Sceti K.K., Tokyo, Japan for Study 3) and appetite inhibiting hormones 
including total PYY and leptin (Millipore, Billerica, USA). Absorbance was measured 
using a plate reader (Infinite M200 PRO, Tecan Group Ltd., Männedorf, Switzerland) at 
specific wavelengths as specified by the manufacturer. Precision of analysis for acylated 
ghrelin was ensured by the quantification of an internal quality control and for total PYY 
and leptin by the quantification of internal quality controls exhibiting low and high 
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values. The within-batch coefficients of variation for the assays are reported in detail in 
Chapter 3 and 5. 
2.11.4 Metabolic parameters 
Plasma glucose concentrations were analysed in singular using a glucose analyser 
(Biosen C-Line Clinic, EKF Diagnostic, Germany) whereas plasma concentrations of 
insulin was measured using a commercially available enzyme-linked immunosorbent 
assay kit (Mercodia, Uppsala, Sweden) with the aid of a plate reader (Infinite M200 PRO, 
Tecan Group Ltd., Männedorf, Switzerland) to measure absorbance at specific 
wavelengths as specified by the manufacturer. Precision of analysis for insulin was 
ensured by the quantification of internal quality controls (Mercodia diabetic antigen 
control) exhibiting low and high values. The within-batch coefficients of variation 
relating to the assays are reported in Chapters 3 and 5. 
2.11.5 Lipid parameters 
Plasma total cholesterol, high density lipoprotein cholesterol, low density lipoprotein 
cholesterol and triacylglycerol concentrations were analysed in duplicate by enzymatic, 
colorimetric methods using an automated bench top analyser (Pentra 400; HORIBA ABX 
Diagnostics, Montpellier, France). To ensure precision of analysis, internal quality 
controls exhibiting low and high values were run prior to sample analysis. The within-
batch coefficients of variation for the assays are reported in detail in Chapter 3. 
2.11.6 Inflammatory markers 
Commercially available enzyme-linked immunosorbent assay kit was used to determine 
concentrations of plasma C-Reactive protein and Interleukin 6 (high sensitivity kit, IBL 
International, Hamburg, Germany) with the aid of a plate reader (Infinite M200 PRO, 
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Tecan Group Ltd., Männedorf, Switzerland) to measure absorbance at specific 
wavelengths as specified by the manufacturer. Precision of analysis was ensured by the 
quantification of internal quality controls exhibiting low and high values. The within-
batch coefficients of variation relating to the assays are reported in Chapter 3. 
2.12 Data processing and statistical analysis 
The Quan Browser in Xcalibur was used to plot calibration curves (weighted with 1/x) 
and quantify the responses for the samples against the calibration curves in Study 2 
(Chapter 4). Then the levels of FFAs in the samples were calculated from the calibration 
curves by Quan Browser. P values and ratios of the mean values for the fatty acids were 
determined by using Microsoft Excel (Microsoft Office 2013). SIMCA-P version 14.1 
(Umetrics, Umeå, Sweden) was used for multivariate analysis (Trivedi et al. 2012) which 
included Principle Components Analysis (PCA), Orthogonal Partial Least Squares 
Discriminant Analysis (OPLS-DA) and Orthogonal Partial Least Square (OPLSA). PCA 
and OPLS-DA models are powerful statistical modelling tools that provide insights into 
separations between experimental groups and are routinely used in metabolomics studies 
to better support the visualization and interpretation of the data (Yamamoto et al. 2009). 
Particularly, PCA is an unsupervised model employed to explore how variables cluster 
and is considered the main tool used for data reduction to extract meaningful information 
which is achieved by combining variables that correlate with each other into few latent 
variables (components) (Kirwan et al. 2012). PCA is normally employed as the first step 
in the analysis of metabolomics data in order to visualise data and detect outliers (Kirwan 
et al. 2012). OPLS-DA is an unsupervised model used as an alternative method when 
PCA fails to expose group separation and is employed to identify reliable biomarkers that 
have a strong association with separation between groups (Kirwan et al. 2012). The 
 79 
 
quality of the supervised model is typically assessed via cross-validation procedures to 
determine the degree of significance of the model using internal and external diagnosis 
tools (Triba et al. 2015). In internal validation, R2 represents the percentage of variation 
explained by the model whereas Q2 indicates the percentage of variation in response to 
cross validation. In addition to internal validation tools, the permutation test and cross 
validated analysis of variance (CV-ANOVA) as external diagnosis tools are performed 
to validate supervision model (Worley and Powers, 2013).  
 
Statistical analyses for all the other data in were conducted using the analytical software 
SPSS version 23.0 for Windows (SPSS 23.0, IBM Corp, Armonk, NY, USA). Normality 
of these data were checked using Shapiro-Wilk tests	before statistical analysis. Normally 
distributed data are presented as mean (SD) in text and tables whereas data were natural 
log transformed before analysis if they were not normally distributed. These data are 
presented as geometric mean (95% confidence interval) in text and tables and analysis is 
based on ratios of geometric means and 95% confidence intervals (CI) for ratios. 
Graphical representation of results is presented as mean (SEM) for clarity. Linear mixed 
model (LMM) was used as a statistical model instead of two-way analysis of variance 
(ANOVA). An important assumption of ANOVA is that the covariate is independent 
from the treatment effect (Field, 2017). In Study 1 (Chapter 3) this assumption was 
violated because body fat percentage, used as a covariate in the analysis of the fasting 
plasma concentrations, was significantly different between South Asian and white 
European men. Thus, because the use of this model may not be robust enough when 
assumptions are violated, any effects from the ANOVA such as ethnic differences 
between groups are more likely to disappear (Field, 2017). Conversely, LMM are less 
reliant on assumptions and more robust, thus in study 1 (Chapter 3) it was decided to 
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present both the unadjusted and adjusted models for transparency. The other data were 
also analysed based on the LMM modelling for consistency. Particularly, LMM 
including fixed factors such as ethnicity in Study 1 (Chapter 3) and ethnicity, time and 
trial in Study 3 (Chapter 5) were used to examine differences between ethnic groups. 
Detailed description of the statistical tests used for data analysis are presented in Chapter 
3, 4 and 5, respectively. In study 3 (Chapter 5), appetite perceptions and appetite-related 
hormones concentrations were reported as delta changes instead of absolute values. 
Given the great day to day variability in appetite-related hormones, the use of delta 
changes appears to be more meaningful and indicative of appetite changes throughout 
the day than the raw absolute values themselves. In study 3 (Chapter 5), glucose 
concentrations were also reported as delta changes for consistency. Pearson’s correlation 
(Study 1, Chapter 3) and Spearman’s correlation (Study 3, Chapter 5) coefficients were 
used to examine relationships between variables and statistical significance was accepted 
as P < 0.05. 
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Chapter 3 – Study 1: Ethnic differences in appetite-related hormones 
and risk markers for cardiovascular disease and type 2 diabetes in 
healthy South Asian and white European men 
 
3.1 Introduction 
South Asians represent the largest ethnic minority group in the United Kingdom (UK) 
(~3 million, 4.9% of the population) (Office for National Statistics 2013), and comprise 
individuals originating from the Indian subcontinent. It is well established that South 
Asians have an elevated risk of CVD and T2D both on the Indian subcontinent and after 
migration to Western nations (Sattar and Gill, 2015; Gholap et al. 2011; Khunti et al. 
2013). Furthermore, CVD and T2D manifest 5 to 10 years earlier, at a lower body mass 
index, and are associated with premature complications and mortality in South Asian 
compared with white European individuals (Sattar and Gill, 2015; Gholap et al. 2011). 
 
The elevated risk of CVD and T2D in South Asians has been linked to the higher 
prevalence of insulin resistance and associated CVD risk factors including differences in 
adiposity as well as markers of inflammation and metabolic health (Gholap et al. 2011; 
Joshi et al. 2007). Specifically, South Asians have a greater percent body fat and 
accumulation of visceral adipose tissue for a given BMI compared with white Europeans 
(Lear et al. 2007). Furthermore, compared with other ethnic groups, South Asians are 
more insulin resistant, glucose intolerant, dyslipidaemic and exhibit a less favourable 
inflammatory profile CRP and IL-6 (Gholap et al. 2011; Tziomalos et al. 2008).  
However, these risk markers seem to explain only partially the greater cardiometabolic 
risk in the South Asian population and the mechanisms underlying increased 
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susceptibility of CVD and T2D remain poorly understood (Forouhi et al. 2006). 
Therefore, profiling a greater array of parameters may provide a more holistic insight 
into cardiometabolic health outcomes in South Asian and white European individuals.  
 
A well-established postulation for the increased CVD and T2D risk in South Asians is 
their higher levels of body fatness which may be linked with differences in appetite 
between South Asian and other ethnicities. Several appetite-related hormones have been 
implicated in the short-term regulation of food intake, including acylated ghrelin and 
PYY which exert orexigenic and anorexigenic effects, respectively (Hussain and Bloom, 
2013). However, it is not known whether circulating acylated ghrelin and PYY 
concentrations are different between South Asian and white European individuals. 
Previous evidence has identified ethnic differences in circulating adipokines with 
individuals of South Asian descent exhibiting elevated leptin concentrations compared 
with white European individuals (Mente et al. 2010). Leptin circulates at concentrations 
proportional to body fatness (Considine et al. 1996) and plays a central role in regulating 
long-term changes in energy homeostasis and body fat. 
 
Physical inactivity is estimated to explain >20% of the excess coronary heart disease 
(CHD) mortality in UK South Asians after adjustment for potential confounding factors 
such as socioeconomic status, smoking, diabetes and existing CVD (Williams et al. 
2011a). Low levels of physical activity and cardiorespiratory fitness amongst South 
Asians are likely to contribute to exacerbating the excess insulin resistance and CVD risk 
in this population (Yates et al. 2015; Williams et al. 2011b). Previous observational 
evidence suggests that a higher level of self-reported physical activity is associated with 
a lower risk of CVD and T2D in South Asian individuals (Rastogi et al. 2004; Mohan et 
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al. 2005). However, there is limited evidence examining cardiorespiratory fitness and 
objectively-measured physical activity in South Asians whereas associations between 
these factors and appetite-related hormones remain unknown.  
 
Therefore, the aim of this study was to investigate ethnic differences in appetite-related 
hormones and a variety of traditional risk markers for CVD and T2D such as glucose 
tolerance, insulin, TAG, HDL-C, CRP, IL-6 and leptin in South Asian compared with 
white European men. In addition, this study aimed to quantify objectively the levels of 
physical activity and cardiorespiratory fitness in South Asian and white European men 
and to examine relationships with appetite-related hormones and risk markers for CVD 
and T2D. 
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3.2 Methods 
3.2.1  Participants 
A total of 16 South Asian and 16 white European men matching the inclusion criteria 
listed in Chapter 2.1, volunteered to participate in this study. The study was approved by 
Kingston University’s Faculty Ethics Committee (Ethic approval code: 1516/017) and 
written informed consent was provided by participants before the study commenced. The 
sample size was calculated using G*Power (Faul et al. 2007). Based on previous data 
(Chandalia et al. 2007), it was estimated that a sample size of 16 participants per group 
would have 89% power at the 0.05 level to detect a between-group difference in fasting 
leptin of 1.05 between-subject SDs. The South Asian group comprised eight British 
Asians born in the UK (UK Indian n=5; UK Pakistani n=1; UK Sri Lankan n=2) and 
eight individuals born in South Asia (India n=5; Pakistan n=1; Sri Lanka n=1; Nepal 
n=1). Conversely, the white European group comprised nine British born participants 
and seven individuals originating from European countries (Spain n=1; Italy n=2; France 
n=1; Germany n=1; Poland n=1; Check Republic n=1). Groups were matched for BMI. 
3.2.2  Study design 
Using a cross-sectional observational design, participants attended the laboratory on two 
occasions separated by an interval of 7 to 14 days (Figure 3.1). As described in Chapter 
2.9, participants were asked to avoid strenuous exercise and not to consume caffeine or 
alcohol in the 24 h period prior to visits 1 and 2. Participants were also asked to exert 
themselves minimally when travelling to the laboratory, using motorised transport when 
possible.	Participants also consumed 500 mL of plain water the night before visit 2 to 
ensure euhydration before the exercise test. 
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3.2.3   Visit 1 
3.2.3.1  Anthropometry and blood pressure 
Participants arrived at the laboratory between 08:00 and 09:00 after a 9 h overnight fast 
and completed a 4 h trial. After familiarisation with the laboratory equipment and 
completing the written informed consent form (Appendix A) and screening 
questionnaires (Appendix B, C and D) as detailed in Chapter 2.1, volunteers were asked 
to undergo anthropometric measurement and blood pressure measurements. Body mass, 
stature, waist circumference, BMI, body composition and blood pressure were then 
measured as described in Chapter 2.2 and 2.5.  
3.2.3.2 Fasting metabolic assessment and oral glucose tolerance test 
After completion of the anthropometric and blood pressure measurements, a fasting 
venous blood sample was obtained from the antecubital vein by a trained phlebotomist 
for the measurement of appetite-related hormones, inflammatory markers and lipid 
profiling. A fasting fingertip capillary blood sample was taken to determine insulin and 
glucose concentrations. Participants then consumed a 75 g glucose load (100% dextrose, 
BulkPowderTM, Colchester, UK) dissolved in 300 mL of water, marking the start of the 
oral glucose tolerance test (OGTT). Subsequent fingertip capillary blood samples were 
collected every 30 minutes for two hours (0.5, 1, 1.5 and 2 h) to quantify glucose and 
insulin concentrations whilst participants rested in the semi-supine position. Before 
leaving the laboratory, participants were given an accelerometer, food diary and food 
scale and instructed how to use them to record their physical activity and food intake 
before returning for the second visit.  
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3.2.4 Visit 2 
3.2.4.1 Maximum oxygen uptake test 
After a 3 h fast, participants performed an incremental exercise test to volitional 
exhaustion on an electromagnetically braked cycle ergometer (Lode Excalibur Sport, 
Groningen, Netherlands) for the determination of maximum oxygen consumption (V̇O2 
max) as described in Chapter 2.6. 
3.2.5 Habitual physical activity and sedentary time 
Between visits 1 and 2, participants wore an ActiGraph GT3X+ accelerometer 
(ActiGraph, Pensacola, USA) on the right hip (posterior to the anterior superior iliac 
spine), attached to an elastic belt supplied by the manufacturer for seven consecutive 
days during waking hours (except water-based activities). All devices were initialised to 
record counts and steps and raw data files were analysed using the manufacturer’s 
software (ActiLife v6.2; ActiGraph, Pensacola, USA). Data from participants with at 
least 10 h of daily wear time for at least four days were included in the analysis. A 60 s 
sampling epoch was used throughout and non-wear time, defined as ≥ 60 min of 
consecutive zero counts, was removed from the analysis (Troiano et al. 2008). Physical 
activity was expressed as average counts per minute (CPM) and standard cut-points for 
adults were applied to quantify sedentary time (<100 CPM), light activity (100–1951 
CPM) and moderate-to-vigorous activity (> 1951 CPM) (Freedson et al. 1998). 
3.2.6 Dietary intake 
Participants weighed and recorded their dietary intake on three consecutive days 
including two weekdays and one weekend day. Participants were also asked to take a 
digital photograph of all food and drink items consumed during the three-day assessment 
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period which were matched to the diet record. Three-day diet records were analysed using 
Dietplan 6 software (Forestfield Software Ltd, Horsham, UK). 
3.2.7 Blood sample collection 
Fasting venous blood samples were collected for the measurement of total cholesterol 
(TC), HDL-C, LDL-C, TAG, CRP, IL-6, leptin, acylated ghrelin and total PYY 
concentrations. Full details of blood sample collection are reported in Chapter 2.10. 
A fasting fingertip capillary blood sample was collected to determine baseline insulin 
and glucose concentrations before participants consumed a 75 g glucose load dissolved 
in 300 mL of water, marking the start of the OGTT. Full details of blood sample 
collection for the OGTT are reported in Chapter 2.10. 
3.2.8 Blood analysis 
Plasma concentrations of insulin, acylated ghrelin, total PYY and leptin were measured 
using commercially available enzyme-linked immunosorbent assays. Specifications of 
the analysis and details of the commercially available enzyme-linked immunosorbent 
assay kits are reported in Chapter 2.11.3 and 2.11.4. Data for plasma insulin 
concentrations were analysed in a sub-sample of 8 South Asian and 8 white European 
participants matched for BMI. Plasma TC, HDL-C, LDL-C and TAG concentrations 
were determined by enzymatic, colorimetric methods using a bench top analyser 
(specifications of the analysis and details of the automated bench top analyser reported 
in Chapter 2.11.5). Plasma glucose concentrations were analysed immediately in singular 
using a glucose analyser (specifications of the analysis and details of the glucose analyser 
are reported in Chapter 2.11.4). Samples from each participant were analysed in the same 
run to avoid inter-assay variation. Coefficients of variation for the assay duplicates were 
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as follows: 3.8% acylated ghrelin, 5.1% total PYY, 4.0% leptin, 4.6% CRP, 8.8% IL-6, 
0.4% total cholesterol, 0.9% HDL-C, 0.8% LDL-C, 2.0% TAG and 6.8% insulin. 
3.2.9 Statistical analysis 
Data analyses were conducted using the analytical software SPSS version 23.0 for 
Windows (SPSS 23.0, IBM Corp, Armonk, NY, USA). The homeostasis model 
assessment of insulin resistance (HOMA-IR) (Matthews et al. 1985) and insulin 
sensitivity index (Matsuda et al. 1999) were calculated. Normality of the data was 
checked using Shapiro-Wilk tests. Normally distributed data are presented as mean (SD). 
Data for appetite-related hormones, inflammatory markers and metabolic markers were 
not normally distributed and were natural log transformed before analysis. These data are 
presented as geometric mean (95% confidence interval) and analysis is based on ratios 
of geometric means and 95% confidence intervals (CI) for ratios.  
 
Physical and physiological characteristics and dietary intake were compared between the 
South Asian and white European men using linear mixed models with ethnic group 
included as a fixed factor. Habitual physical activity levels and sedentary time were 
compared between ethnic groups using linear mixed models with wear time included as 
a covariate. The trapezium rule was used to calculate the total area under the curve (AUC) 
for glucose and insulin during the OGTT. Linear mixed models, both unadjusted and 
adjusted for percentage body fat, were employed to examine between-group differences 
in fasting plasma constituents, 2 h glucose and insulin concentrations and AUC values. 
Differences in glucose and insulin concentrations over the 2 h OGTT were examined 
using 2 x 5 (group x time) linear mixed models (unadjusted and adjusted for percentage 
body fat). Absolute standardised effect sizes (ES) (Cohen’s d) were calculated for each 
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variable by dividing the difference between the mean values (South Asian versus white 
European) with the pooled SD. An ES of 0.2 was considered the minimum important 
difference, 0.5 moderate and 0.8 large (Cohen et al. 1988). Ethnicity-specific Pearson’s 
correlation coefficients were used to examine the magnitude of linear association 
between the various predictors (age, body fat percentage, V̇O2 max, sedentary time, 
MVPA) and outcome measures (acylated ghrelin, leptin, insulin sensitivity index, CRP, 
HDL-C). Statistical significance was accepted as P < 0.05. 
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3.3 Results 
3.3.1 Participants characteristics 
The physical and physiological characteristics of the South Asian and white European 
participants are shown in Table 3.1. There were no significant differences between 
groups in stature, body mass, BMI, waist circumference, resting systolic blood pressure 
and resting diastolic blood pressure (all P ≥ 0.172). Compared with white European 
participants, South Asian participants exhibited higher fat mass (ES = 0.66, P = 0.071) 
and body fat percentage (ES = 0.86, P = 0.021). Fat free mass (ES= 1.29, P = 0.001), age 
(ES = 0.72, P = 0.052) and V̇O2 max expressed in absolute (ES = 1.79, P <0.001) and 
relative (ES = 1.36, P = 0.001) terms were lower in South Asians compared with white 
European participants. 
3.3.2 Habitual physical activity and sedentary time 
Habitual physical activity levels and sedentary time in the South Asian and white 
European participants are displayed in Table 3.2. No significant differences were seen 
between the groups for wear time adjusted sedentary time, light activity or MVPA (all P 
≥ 0.169). Wear time adjusted average CPM (ES = 0.65, P = 0.109) and total step counts 
(ES = 0.71, P = 0.142) were meaningfully, albeit not significantly, lower in the South 
Asian compared with white European participants. 
3.3.3 Dietary intake 
Average protein intake tended to be lower in South Asian compared with white European 
participants (ES = 0.64, P = 0.079), resulting in a lower contribution of protein (ES = 
0.70, P = 0.064) and a higher contribution of carbohydrate (ES = 0.65, P = 0.069) to total 
energy intake in the South Asian men. No other significant differences in energy, 
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macronutrient or micronutrient intakes were observed between the South Asian and white 
European participants (all P ≥ 0.083) (Table 3.3). 
3.3.4 Fasting plasma concentrations of appetite-related hormones, inflammatory 
markers and lipid parameters 
Fasting plasma concentrations of appetite-related hormones, inflammatory markers and 
lipid parameters are shown in Table 3.4. Linear mixed models revealed higher fasting 
plasma concentrations in the South Asian compared with white European participants for 
CRP (113%, ES = 0.87, P = 0.019), leptin (187%, ES = 1.11, P = 0.004), TC/HDL-C 
ratio (22%, ES = 0.80, P = 0.030) and TAG (43%, ES = 0.74, P = 0.044). Compared with 
white European participants, South Asian participants exhibited lower concentrations of 
fasting acylated ghrelin (-47%, ES = 1.00, P = 0.008) and HDL-C (-17%, ES = 0.78, P = 
0.035). Fasting plasma concentrations of IL-6 were meaningfully, albeit not significantly, 
higher in South Asian compared with white European participants (57%, ES = 0.86, P = 
0.074). No between-group differences were seen in fasting plasma total PYY, TC or 
LDL-C concentrations (all P ≥ 0.215). Between-group differences in fasting plasma 
constituents were attenuated after adjustment for body fat percentage (P ≥ 0.080), 
although a tendency for a higher leptin concentration in South Asians remained (37%; 
ES = 0.33, P = 0.061). 
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Table 3.1.  Participant characteristics.  
 South Asians (n=16) White Europeans (n=16) 
White Europeans vs. South Asians 
95% CIa Effect size 
Age (years) 30 (8) 36 (8) -11 to 0.04 0.72 
Stature (cm) 176.3 (6.9) 179.3 (4.7) -7.2 to 1.3 0.49 
Body mass (kg) 79.4 (14.6) 80.5 (8.4) -9.7 to 7.5 0.09 
Body mass index (kg·m-2) 25.7 (5.2) 25.2 (3.3) -2.6 to 3.7 0.12 
Fat free mass (kg) 57.4 (5.3) 64.5 (5.7) -11.2 to -3.2b 1.29 
Fat mass (kg) 22.1 (11.0) 16.0 (6.9) -0.5 to 12.7 0.66 
Body fat (%) 26.4 (9.0) 19.5 (7.0) 1.1 to 12.8b 0.86 
Waist Circumference (cm) 87.8 (13.4) 85.5 (6.6) -5.4 to 9.9 0.21 
Resting sBP (mmHg) 120 (11) 122 (10) -10 to 5 0.23 
Resting dBP (mmHg) 78 (8) 77 (11) -6 to 7 0.05 
V̇O2 max (L·min-1) 2.97 (0.55) 4.00 (0.60) -1.44 to -0.61b 1.79 
V̇O2 max (mL·kg-1·min-1) 38 (9) 50 (8) -18 to -5b 1.36 
All values are mean (SD). Data were analysed using linear mixed models.  
sBP, systolic blood pressure; dBP, diastolic blood pressure; V̇O2 max, maximum oxygen uptake. 
a 95% confidence interval of the mean absolute difference between groups. 
b Significant difference between South Asians and white Europeans (P < 0.05). 
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Table 3.2.  Habitual physical activity levels and sedentary time in South Asian and white European men.  
 South Asians (n=13) White Europeans (n=13) White Europeans vs. South Asians 95% CIa Effect size 
Wear time (min·day-1) 828 (87) 858 (64) -92 to 32 0.39 
Total activity (counts·min-1·day-1) 396 (115) 474 (124) -182 to 19 0.65 
Sedentary time (min·day-1) 546 (82) 528 (66) -16 to 87 0.25 
Light physical activity (min·day-1) 172 (73) 197 (47) -62 to 32 0.41 
MVPA (min·day-1) 53 (15) 57 (24) -21 to 14 0.18 
Total steps (per day) 8759 (1935) 10157 (1981) -2725 to 417 0.71 
All values are mean (SD). Data were analysed using linear mixed models. Models for total activity, sedentary time, light physical activity, MVPA 
and total steps included wear time as a covariate. 
MVPA moderate-to-vigorous physical activity. 
a 95% confidence interval of the mean absolute difference between groups. 
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Table 3.3.  Average daily energy, macronutrient and micronutrient intakes in South Asian and white European men. 
 South Asians (n=16) White Europeans (n=16) White Europeans vs. South Asians 95% CIa Effect size 
Energy (kcal·day-1) 2136 (527) 2060 (603) -333 to 486 0.12 
Carbohydrate (g·day-1) 252 (75) 217 (105) -31 to 100 0.38 
Fat (g·day-1) 81.5 (30.9) 77.4 (37.5) -20.6 to 29.0 0.12 
Protein (g·day-1) 98.7 (28.5) 123.7 (46.8) -53.0 to 3.1 0.64 
% energy from carbohydrate 48 (19) 41 (10) -0.5 to 13 0.65 
% energy from fat 34 (8) 33 (12) -7 to 8 0.02 
% energy from protein 19 (6) 26 (13) -14 to 0.4 0.70 
Dietary fibre (g·day-1) 15.9 (7.6) 18.8 (13.1) -10.6 to 4.9 0.21 
Calcium (mg·day-1) 723 (470) 691 (311) -256 to 319 0.08 
Magnesium (mg·day-1) 262 (113) 311 (81) -120 to 22 0.50 
Sodium (mg·day-1) 1976 (1066) 2154 (884) -885 to 529 0.18 
Folate (µg·day-1) 256 (142) 229 (66) -53 to 107 0.24 
Vitamin D (µg·day-1) 2.2 (1.9) 5.9 (8.1) -8.0 to 0.5 0.63 
Vitamin C (mg·day-1) 116.3 (83.0) 132.4 (169.9) -112.7 to 80.4 0.12 
All values are mean (SD). Data were analysed using linear mixed models. Energy, macronutrient and micronutrient values were recorded for 3 
days (2 weekdays and 1 weekend). 
a 95% confidence interval of the mean absolute difference between group. 
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Table 3.4.  Fasting plasma concentrations in South Asian and white European men. 
 South Asians (n=16) 
White Europeans 
(n=16) 
Model 1a Model 2b 
White 
Europeans vs. 
South Asians 
95% CIc 
Effect size 
White 
Europeans vs. 
South Asians 
95% CIc 
Effect size 
Acylated ghrelin (pg·mL-1) 35.7 (25.8 to 49.4) 67.7 (48.8 to 93.7) -67 to -16%e 1.00 -59 to 5% 0.65 
Total peptide YY (pg·mL-1) 90.3 (80.0 to 101.8) 83.8 (74.3 to 94.5) -9 to 28% 0.31 -9 to 33% 0.39 
Leptin (ng·mL-1) 6.11 (3.76 to 9.92) 2.13 (1.31 to 3.46) 44 to 470%e 1.11 -1 to 91% 0.33 
C-reactive protein (µg·mL-1) 0.89 (0.57 to 1.38) 0.42 (0.27 to 0.65) 14 to 298%e 0.87 -17 to 197% 0.52 
Interleukin-6 (pg·mL-1)d 0.71 (0.49 to 1.03) 0.45 (0.32 to 0.64) -5 to 161% 0.86 -19 to 119% 0.54 
TC (mmol·L-1) 4.37 (4.04 to 4.73) 4.28 (3.96 to 4.63) -9 to 14% 0.13 -11 to 14% 0.03 
HDL-C (mmol·L-1) 1.10 (0.98 to 1.24) 1.32 (1.17 to 1.48) -29 to -1%e 0.78 -22 to 8% 0.36 
TC/HDL-C ratio 3.97 (3.50 to 4.51) 3.25 (2.86 to 3.69) 2 to 47%e 0.80 -8 to 30% 0.35 
LDL-C (mmol·L-1) 2.72 (2.42 to 3.06) 2.45 (2.18 to 2.76) -6 to 31% 0.45 -12 to 25% 0.20 
Triacylglycerol (mmol·L-1) 1.16 (0.91 to 1.48) 0.81 (0.63 to 1.03) 1 to 102%e 0.74 -18 to 48% 0.20 
All values are geometric mean (95% confidence interval). Statistical analyses are based on log-transformed data. Data were analysed using linear mixed 
models. 
 TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol. 
a Model 1: unadjusted, b Model 2: adjusted for body fat percentage; c 95% confidence interval for the ratio of geometric means 
d Data for interleukin-6 available for n = 9 South Asian and n = 10 white European; e Significant difference between South Asian and white European (P < 0.
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3.3.5 Plasma glucose and insulin concentrations during the OGTT 
Plasma glucose concentrations in the fasted state and 2 h post-challenge were not 
significantly different between South Asian and white European participants in the 
unadjusted or body fat adjusted models (all P ≥ 0.190) (Table 3.5). South Asian 
participants exhibited higher insulin concentrations in the fasted state (71%; ES = 1.06, 
P = 0.053) and at 2 h post-challenge (303%; ES = 1.28, P = 0.022) (Table 5). Between-
group differences in fasting (34%; ES = 0.58, P = 0.218) and 2 h post-challenge (110%; 
ES = 0.68, P = 0.082) insulin were diminished after controlling for body fat percentage 
(Table 5). The HOMA-IR was meaningfully, albeit not significantly, higher in the South 
Asian compared with white European participants (66%; ES = 0.94, P = 0.081) (Table 
3.5). The insulin sensitivity index was lower in the South Asian compared with white 
European participants in the unadjusted (61%; ES = 1.22, P = 0.016) and body fat 
adjusted (41%; ES = 0.68, P = 0.055) models (Table 3.5). 
Linear mixed model for glucose OGTT identified a main effect of time (P < 0.001) and 
group-by-time interaction (P = 0.047) but not a main effect of group (95% CI -2 to 26%, 
P = 0.086) (Figure 3.2). Post-hoc analysis of the group-by-time interaction revealed 
higher glucose concentrations in the South Asian compared with white European 
participants at 1.5 h (22%; 95% CI 4 to 44%, ES = 0.77, P = 0.014). The total area under 
the curve for glucose was higher in the South Asian compared with white European 
participants (14%; 95% CI -1 to 30%, ES = 0.69, P = 0.060), but this difference was 
attenuated after adjusting for body fat percentage (5%; 95% CI -8 to 20%, ES = 0.27, P 
= 0.434) (Figure 3.2).  
Linear mixed models for insulin OGTT identified a main effect of group (P = 0.010), 
time (P < 0.001) and a group-by-time interaction (P = 0.025) (Figure 3.2). The main 
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effect of group revealed higher insulin concentrations in the South Asian compared with 
white European participants (211%; 95% CI 38 to 602%, ES = 1.11). The ethnic group 
difference was diminished but remained significant after adjustment for body fat 
percentage (100%; 95% CI 8 to 269%, ES = 0.68, P = 0.030). Post hoc analysis of the 
group-by-time interaction revealed higher insulin concentrations in the South Asian 
compared with white European participants at 0.5, 1, 1.5 and 2 h (all ES ≥ 1.28, P ≤ 
0.013). The total area under the curve for insulin was higher in the South Asian compared 
with white European participants in unadjusted (245%; 95% CI 51 to 690%, ES = 1.61, 
P = 0.006) and body fat adjusted (123%; 95% CI 17 to 326%, ES = 1.04, P = 0.019) 
models (Figure 3.2). 
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Table 3.5.  Plasma glucose and insulin concentrations during the OGTT in South Asian and white European men.  
 South Asians  (n=16) 
White Europeans 
(n=16) 
Model 1a Model 2b 
White Europeans 
vs. South Asians 
95% CIc 
Effect 
size 
White Europeans 
vs. South Asians 
95% CIc 
Effect 
size 
Glucose       
    Fasted (mmol·L-1) 4.50 (4.28 to 4.74) 4.71 (4.47 to 4.96) -11 to 3% 0.45 -12 to 3% 0.51 
         2 h (mmol·L-1) 4.78 (4.11 to 5.56) 4.16 (3.58 to 4.83) -7 to 42% 0.47 -14 to 35% 0.25 
Insulin       
     Fasted (µU·mL-1) 7.21 (4.90 to 10.60) 4.22 (2.87 to 6.20) -1 to 195% 1.06 -18 to 118% 0.58 
          2 h (µU·mL-1) 23.49 (10.32 to 53.49) 5.84 (2.56 to 13.29) 26 to 1188%d 1.28 -10 to 391% 0.68 
HOMA-IR 1.50 (1.00 to 2.26) 0.91 (0.60 to 1.36) -7 to 195% 0.94 -23 to 109% 0.44 
Insulin sensitivity index 5.62 (3.32 to 9.49) 14.41 (8.53 to 24.36) -81 to -18%d 1.22 -65 to 1% 0.68 
All values are geometric mean (95% confidence interval) for n=32 (glucose) and n=16 (insulin, HOMA-IR, insulin sensitivity index). Statistical 
analyses are based on log-transformed data. Data were analysed using linear mixed models. 
OGTT, oral glucose tolerance test; HOMA-IR, homeostasis model assessment of insulin resistance. 
a Model 1: unadjusted, b Model 2: adjusted for body fat percentage.  
c 95% confidence interval for the ratio of geometric means. 
d Significant difference between South Asians and white Europeans (P < 0.05).
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 Figure 3.2.  Plasma concentrations of (a) insulin (top panels; South Asian n=8, white 
European n=8) and (b) glucose (bottom panels; South Asian n=16; white European 
n=16) during the oral glucose tolerance test. Data points on left panels represent mean 
(SEM) for the South Asian (■) and white European (○) men. Black rectangle indicates 
consumption of glucose load. Data points on right panels represent individual data 
values (○) and the solid line indicates the median (▬).  
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3.3.6 Correlations 
Body fat percentage was positively associated with leptin (r = 0.84 in white Europeans 
and r = 0.88 in South Asians, P ≤ 0.001), and negatively associated with insulin 
sensitivity index in South Asian and white European men (r = -0.76 in white Europeans 
and r = -0.83 in South Asians, P ≤ 0.024) (Table 3.6). Body fat percentage was negatively 
associated with acylated ghrelin (r = -0.73, P = 0.002) and HDL-C (r = -0.81, P = 0.001) 
in white European men, and positively associated with CRP in South Asian men (r = 
0.52, P = 0.035) (Table 3.6). A positive association was also identified between V̇O2 
max and insulin sensitivity index in white European men (r = 0.80, P = 0.016), whereas 
MVPA was negatively associated with leptin in white European men (r = -0.50, P = 
0.044) (Table 6). Sedentary time was positively associated with CRP in South Asian men 
only (r = 0.50, P = 0.041). 
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Table 3.6.  Ethnicity-specific Pearson’s correlation coefficients between the various predictors and metabolic risk markers. 
 Acylated ghrelina Leptin Insulin sensitivity index C-reactive protein
a HDL-Ca 
 South Asian 
White 
European 
South 
Asian 
White 
European 
South 
Asian 
White 
European 
South 
Asian 
White 
European 
South 
Asian 
White 
European 
Age 0.05 0.40   0.07 -0.03 0.11 -0.14 0.45 -0.01 -0.09 0.38 
Body fat -0.25 -0.73b  0.88c    0.84c -0.83b -0.76b  0.52b 0.16 -0.28 -0.81b 
V̇O2 max 0.37 0.27  -0.01 -0.12 0.28 0.80b 0.29 0.38 -0.06 0.24 
Sedentary time 0.20 -0.13   0.47 0.05 0.04 -0.27  0.50b 0.11 -0.06 -0.19 
MVPA 0.05 0.04  -0.18 -0.50b 0.14 0.42 -0.43 -0.02 0.39 0.18 
a Statistical analysis are based on log-transformed data. 
HDL-C, high-density lipoprotein cholesterol; V̇O2 max, maximum oxygen uptake; MVPA moderate-to-vigorous physical activity. 
b P < 0.05; c P < 0.001. 
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3.4 Discussion 
The novel finding of this study is that healthy South Asian men exhibited lower fasting 
acylated ghrelin concentrations compared with BMI-matched white European men. 
Furthermore, South Asian men exhibited impaired CVD and T2D risk markers compared 
with white European men comprising: (1) elevated fasting concentrations of insulin, 
leptin, CRP, IL-6 and TAG and a higher TC/HDL-C ratio; (2) lower fasting 
concentrations of HDL-C; and (3) higher glucose and insulin concentrations during the 
OGTT. A further key finding is that cardiorespiratory fitness was substantially lower in 
the South Asian men than in the white European men, but no differences between the 
ethnicities was observed in objective levels of physical activity or sedentary behaviour. 
The lower fasting acylated ghrelin concentration in the South Asian compared with white 
European men represents a novel finding of this study. Although the reason for this 
finding is unclear, it may be linked to the ethnic group differences in adiposity. Previous 
research has demonstrated that individuals with obesity exhibit lower circulating 
concentrations of fasting ghrelin than lean individuals (Le Roux et al. 2005). Although 
our findings only revealed a large inverse correlation between body fat percentage and 
acylated ghrelin in the white European men, the ethnic group difference in fasting 
acylated ghrelin concentrations was mitigated after controlling for body fat percentage. 
Therefore, it seems plausible that the lower acylated ghrelin concentration in the South 
Asian men may be linked to the higher body fat levels. These findings appears to support 
the data in Study 3 (Chapter 5), where concentrations of fasting acylated ghrelin were 
not statistically different between South Asian and white European men, with both 
groups exhibiting similar percentage of body fat.  
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Similar to previous findings, circulating concentrations of plasma leptin were 
substantially elevated in the South Asian compared with white European men (Mente et 
al. 2010; Abate et al. 2004). Considering circulating leptin concentrations are directly 
proportional to body fat mass (Considine et al. 1996), it is likely that the elevated leptin 
concentrations in South Asian individuals is, at least partly, mediated by differences in 
body fat. In support of this, plasma leptin concentrations were positively associated with 
body fat percentage in the present study, replicating previous findings in South Asian 
individuals (Banerji et al. 1999; Abate et al. 2004). However, South Asian individuals 
have also been shown to exhibit higher concentrations of leptin than Caucasian 
individuals despite a similar body fat percentage (Abate et al. 2004), and the between-
group difference in leptin concentrations in this study was diminished, but not eliminated 
completely, after controlling for body fat percentage. Consequently, it is possible that 
irregularities in adipose tissue metabolism concomitant with insulin resistance may 
contribute to the elevated CVD and T2D risk in South Asians. Despite the between-group 
differences in acylated ghrelin and leptin, the current study did not find any significant 
differences in plasma total PYY between South Asian and white European participants. 
In support of previous findings, higher fasting insulin and elevated glucose and insulin 
OGTT concentrations were also observed in South Asian participants compared with 
white European men (Chandalia et al. 1999; Raji et al 2001; Peters et al 2013). These 
differences are indicative of a greater degree of insulin resistance and are further 
supported by the higher HOMA-IR and lower insulin sensitivity index observed in the 
South Asian participants. It is well established that insulin resistance is a primary 
determinant of the elevated propensity for CVD and T2D in individuals of South Asian 
descent (Sattar and Gill, 2015; Gholap et al. 2011; Tziomalos et al. 2008). One factor 
suggested to contribute to the excess insulin resistance in South Asian individuals 
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represents differences in adiposity and body fat distribution (Sattar and Gill, 2015). In 
accord with our findings, South Asian individuals exhibit a higher body fat percentage 
and lower lean body mass for a given BMI compared with white European individuals 
(Lear et al. 2007). Furthermore, it has been suggested previously that insulin-mediated 
glucose disposal is inversely correlated with total and regional body fat in South Asian 
individuals (Raji et al. 2001; Banerji et al. 1999). However, the greater insulin resistance 
in South Asian individuals has also been shown to persist after adjustment for adiposity 
(Chandalia et al. 1999), and the lower insulin sensitivity index and insulin OGTT in the 
South Asian participants in this study remained after controlling for body fat percentage, 
albeit the magnitude of difference was diminished. This is also in agreement with our 
findings reported in Study 3 (Chapter 5) where South Asians exhibited markedly higher 
fasting insulin and elevated glucose and insulin post-prandial despite having similar 
levels of body fat than white European men. 
The present study also measured circulating concentrations of fasting IL-6 and CRP 
which represent key indicators of chronic low-grade inflammation and have been 
implicated in explaining the excess CHD risk in South Asian individuals (Tziomalos et 
al. 2008). The elevated fasting IL-6 and CRP concentration in South Asian compared 
with white European men supports several previous studies (Anand et al. 2004; Arjunan 
et al. 2015; Bastard et al. 1999), although this finding is not universal (Peters et al. 2013). 
Considering pro-inflammatory IL-6 released from adipose tissue has been identified as a 
precursor for hepatic CRP secretion (Bastard et al. 1999), it is possible that the ethnic 
differences in inflammation may be mediated by the higher body fat levels in South Asian 
individuals. In this regard, the divergent inflammatory profiles between ethnicities in the 
present study were diminished after controlling for body fat percentage, supporting 
previous findings in South Asian and white European individuals (Chambers et al. 2001; 
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Arjunan et al. 2015). However, it has also been demonstrated previously that South Asian 
individuals exhibit higher CRP concentrations than Caucasians despite similar levels of 
body fat (Chandalia et al. 2003). Future work is required to determine the independent 
contribution of ethnicity and adiposity on inflammatory markers in South Asians.  
Consistent with previous studies (Arjunan et al. 2013; Arjunan et al. 2015; Anand et al. 
2000), the South Asian men exhibited a more unfavourable fasted lipid profile compared 
with the white European men encompassing lower concentrations of HDL-C coupled 
with an elevated TC/HDL-C ratio and higher TAG concentration. The reasons explaining 
the adverse lipid profile in South Asian participants have not been fully elucidated, but 
it is proposed that the greater insulin resistance experienced by South Asians may be 
implicated (Gholap et al. 2011; Tziomalos et al. 2008). Specifically, hyperinsulinaemia 
associated with insulin resistance appears to downregulate skeletal muscle lipoprotein 
lipase activity (Pollare et al. 1991), thereby diminishing the clearance of TAG from the 
circulation. Furthermore, insulin resistance is suggested to impair the ability of insulin to 
suppress hepatic release of very low-density lipoprotein (Malmström et al. 1997). 
Regardless of the mechanism, our findings contribute to existing knowledge regarding 
the differential lipid profiles between individuals of South Asian and white European 
descent.  
Previous research suggests that South Asian individuals engage in less habitual physical 
activity than white European individuals, which is likely to contribute to the excess CHD 
and T2D risk in this population (Williams et al. 2011a; Yates et al. 2015; Ghouri et al. 
2013). The existing evidence on habitual physical activity levels in South Asians has 
largely been gleaned from self-report questionnaires (Yates et al. 2015; Williams et al. 
2011b), but data using accelerometry is emerging (Ghouri et al. 2013; Iliodromiti et al. 
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2016) and the objective accelerometer measurement represents a strength of this study. 
Although the similar levels of MVPA and sedentary time between the ethnicities in this 
study appears to contradict the aforementioned studies, the South Asian participants 
accumulated less total activity (CPM) and fewer steps, and stark differences in CVD and 
T2D risk markers were still apparent between the ethnic groups. This is in line with 
previous evidence suggesting that South Asian individuals are more insulin resistant than 
white European individuals even after adjustment for habitual physical activity levels 
(Ghouri et al. 2013). Furthermore, it has been suggested recently that South Asians may 
need to accumulate higher levels of moderate physical activity equating to an additional 
10 to 15 minutes per day to achieve a comparable CHD risk factor profile of white 
Europeans who are meeting the current physical activity recommendations (Iliodromiti 
et al. 2016).  
Despite the similar levels of habitual physical activity between the ethnicities, 
cardiorespiratory fitness assessed by V̇O2 max was markedly lower in the South Asian 
compared with white European participants. This corroborates previous findings 
(Arjunan et al. 2013; Bastard et al. 1999; Hall et al. 2010), and there is further evidence 
that the lower V̇O2 max in South Asian individuals is independent of physical activity 
levels (Ghouri et al. 2013). Given the importance of physical activity as a method of 
enhancing V̇O2 max, these findings add further weight to the proposition that South 
Asians may need to engage in greater physical activity levels than white Europeans to 
optimise health outcomes (Iliodromiti et al. 2016). In addition, it has been demonstrated 
that low V̇O2 max was the strongest predictor of the excess insulin resistance seen in UK 
South Asian compared with white European men (Ghouri et al. 2013), although our 
findings only revealed a positive association between V̇O2 max and insulin sensitivity 
index in the white European men. Nevertheless, it is likely that the lower V̇O2 max in the 
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South Asian individuals may contribute to the heighted cardio-metabolic health risk in 
this population considering that low cardiorespiratory fitness is a well-established and 
strong predictor of all-cause mortality and CVD events (Kodama et al. 2009). 
A further important consideration in the context of chronic disease risk concerns dietary 
intake. Although studies comparing dietary intake patterns between South Asian and 
white European individuals are sparse, South Asians typically increase energy and fat 
intake but also exhibit a switch from whole grains and pulses to more refined sources of 
carbohydrates, which results in a low intake of fibre after migration to European 
countries (Holmboe-Ottesen and Wandel, 2012). In addition, South Asian men have been 
shown to respond to short-term high fat overfeeding with greater perturbations in insulin 
resistance than European men (Bakker et al. 2014). Whilst the current study identified 
lower protein intake in the South Asian men, the assessment of dietary intake using self-
report represents a limitation due to issues of participant recall bias which makes it 
difficult to accurately correspond self-reported intake with actual intake (Dhurandhar et 
al. 2015).  
A limitation of this study concerns the potentially confounding effects of body fat 
percentage which may have accentuated the differences in CVD and T2D risk markers 
between the ethnicities. Although South Asians are known to exhibit a higher body fat 
percentage for a given BMI (Lear et al. 2007), further research is needed to clarify the 
role of adiposity and ethnicity in modulating CVD and T2D risk in South Asians. 
Furthermore, the number of participants in the study was small and the South Asian and 
white European men were not matched for age. However, our findings revealed marked 
differences in CVD and T2D risk markers between the ethnicities despite the South Asian 
men being, on average, six years younger than the white European men, and age was not 
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significantly associated with any of the outcome variables in either ethnic group. Finally, 
the population sample was mostly limited to South Asian men originating from India 
and, therefore, further investigations are required in other South Asian groups (e.g., 
Bangladeshis, Sri Lankan and Bhutanese) and in South Asian women.  
In conclusion, the present study provides evidence that healthy South Asian men exhibit 
lower concentrations of acylated ghrelin and an adverse CVD and T2D risk marker 
profile compared with BMI-matched white European men including higher 
concentrations of insulin, TAG, leptin and CRP, and lower concentrations of HDL-C. 
Although objectively assessed physical activity levels and sedentary time were similar 
between the ethnic groups, the lower cardiorespiratory fitness in the South Asian men 
may contribute to the heightened cardiometabolic heath risk in this population. Future 
research that targets the identification of additional parameters of CVD and T2D risk in 
South Asians should be prioritised.  
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Chapter 4 – Study 2: Investigation of Plasma Free Fatty Acids 
metabolic profile based on GC-MS and LC-MS in healthy South Asian 
compared with white European men and association with adiposity, 
physical activity and cardiorespiratory fitness 
 
4.1 Introduction 
Cardiovascular disease (CVD) and type 2 diabetes (T2D) have emerged as major causes 
of morbidity and mortality worldwide (WHO, 2017; IDF, 2019) particularly among 
individuals with South Asian background (Johns and Sattar, 2015). In this regard, South 
Asians who have migrated to western countries, including European or North American 
countries, as well as those living in the Indian subcontinent, exhibit a greater 
cardiometabolic risk compared to their western counterparts (Sattar and Gill, 2015; 
Khunti et al. 2013).  
 
The elevated adiposity, higher prevalence of insulin resistance and associated CVD risk 
factors including differences in markers of inflammation and metabolic health may act 
as catalysts inducing the elevated risk of CVD and T2D in South Asians (Benedetti et al. 
2019; Gholap et al. 2011; Joshi et al. 2007). However, these risk markers do not 
exhaustively explain the greater CVD and T2D susceptibility in South Asian than white 
European individuals and the mechanisms underlying progression to T2D remain unclear 
(Chandalia et al. 2003; Hall et al. 2010).   
In this regard, there is evidence that exercise related factors such as low levels of physical 
activity and reduced cardiorespiratory fitness play an important role in the insulin 
resistance phenotype in South Asians (Biddle et al. 2019; Williams et al. 2011b; Ghouri 
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et al. 2013; Yates et al. 2015; Hall et al. 2010). Additionally, physical activity and 
cardiorespiratory fitness are key factors associated with CVD and T2D with previous 
studies reporting lower physical activity engagement and fitness level amongst UK South 
Asians compared with white Europeans (Ghouri et al. 2013; Williams et al. 2011a; 
Benedetti et al. 2019; Yates et al. 2015). Nonetheless, a great deal of the data available 
on physical activity in South Asians have been acquired from self-reported 
questionnaires which have limited validity, while evidence examining the association of 
objectively-measured physical activity and cardiorespiratory fitness with fatty free acids 
in South Asian individuals remains limited. 
Elevated circulating free fatty acids (FFAs) play a central role in liver and skeletal muscle 
insulin resistance and may contribute to β-cell dysfunction (Boden, 2002; Boden and 
Shulman, 2002; Karpe et al. 2011). Previous evidence reported higher total FFAs 
concentration in South Asian than white European individuals, irrespective of total or 
abdominal adiposity (Chandalia et al. 2007; Abate et al. 2004) which suggests possible 
abnormalities in the adipose tissue in South Asians (Bakker et al. 2013). However, not 
all FFAs contribute equally to the insulin resistance process. Indeed, high concentrations 
of saturated fatty acids (SFA) and omega-6 polyunsaturated fatty acids (PUFA) have 
been associated with increased levels of glucose and insulin whereas specific PUFA, 
such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been shown 
to improve insulin sensitivity (Rasic-Milutinovic et al. 2012). However, while previous 
cross-sectional investigations have explored the association between individual fatty 
acids and markers of cardiometabolic risk (Imamura et al. 2012; Ferrucci et al. 2006), 
these studies have not investigated ethnic-specific between individual free fatty acids and 
markers of insulin resistance. To the author’s knowledge, only one study examined 
ethnic-specific associations between plasma fatty acids and fasting glucose and insulin 
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resistance, identifying significant associations in Caucasian, but not in South Asian 
individuals (Ralston et al. 2013). This study, however, looked at esterified fatty acids 
(EFS), instead of free fatty acids, by carrying out hydrolysis of plasma TAG post-
extraction and this ignores the fact the rate of lipolysis of triglycerides, which is 
controlled by glucocorticoids and catecholamines, might be important (Xu et al. 2009). 
Furthermore, while this study reported baseline levels of FFAs in South Asians and 
Caucasians, ethnic-differences in FFAs were not explicitly examined while associations 
between fatty acids and body composition and physical activity/fitness levels were not 
explored.  
Metabolomics method represents a promising approach to identify and quantify a large 
variety of metabolites within biological systems that are substrates and products in 
different metabolic or pathological pathways, including fatty acids (Gonzales-Franquesa 
et al. 2016). Particularly, previous research examining concentrations of individual free 
fatty acids in human plasma and associations with insulin resistance and T2D, has made 
considerable use of different analytical techniques for metabolomics analysis including 
gas chromatography (GC) and liquid chromatography (LC) coupled with mass-
spectrometry (MS) (Binbin et al. 2010; Yi et al. 2006; Dai et al. 2015; Liu et al. 2010; 
Ma et al. 2018; Lu et al. 2016; Feng et al. 2017). However, the examination of baseline 
individual concentrations of FFAs based on metabolomics methods between South Asian 
and white European remain unknown.  
Therefore, the aim of this study was to investigate ethnic differences in the free fatty acid 
metabolic profile based on GC-MS and LC-MS in South Asian compared with white 
European men. Furthermore, this study aims to explore associations of FFAs with 
adiposity, glycaemia, levels of physical activity and cardiorespiratory fitness. 
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4.2 Methods 
4.2.1 Participants and Study Design 
The present study was conducted in collaboration with the University of Strathclyde 
where the free fatty acids analysis based on LC-MS was performed. The plasma samples 
used for this analysis were collected at Kingston University from the same set of 
participants recruited in Study 1 (Chapter 3). Therefore, ethic code, full detail of 
participants including body composition, V̇O2 max and physical activity data and study 
design are reported in Chapters 3.2.1 and 3.2.2. Approval of the study was obtained prior 
commencement by the Kingston University’s and University of Strathclyde’s Ethics 
Advisory Committee (Ethic approval code: 1516/017). 
4.2.2 Body composition 
Details of the body composition assessment is reported in Chapter 3.2.3.1.  
4.2.3 Maximum oxygen uptake test 
Details of the protocol, cycle ergometer and gas analysis system used for the 
determination of the maximum oxygen uptake in South Asian and white European 
volunteers are reported in Chapter 3.2.4.1. 
4.2.4 Habitual physical activity and sedentary time 
An Actigraph GT3X+ accelerometer (ActiGraph, Pensacola, USA) was wore in the right 
hip for one week to examine habitual physical activity and sedentary time in South Asian 
and white European participants. Full detail of the device wearing condition, initialisation 
and data analysis are described in Chapter 3.2.5.  
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4.2.5 Plasma samples 
The details of blood sampling and collection have been reported in Chapters 3.2.3.2 and 
3.2.7. Briefly, after completion of the anthropometric and blood pressure measurement 
in Visit 1, a fasting venous blood sample was obtained for the measurement of FFAs. 
The blood sample was collected from the antecubital vein via venepuncture using a 25 g 
butterfly needle (BD Vacutainer, Plymouth, UK) into a precooled 6.0 mL heparin 
vacutainers (BD Vacutainer®, Plymouth, UK). The blood sample was immediately 
centrifuged at 1500 × g for 10 min at 4°C and the plasma supernatant was then dispensed 
into aliquots and stored at -80°C for later analysis. Using the finger-prick technique, a 
whole blood was collected during the OGTT every 30 min for two hours into a 20 µL 
heparin capillary tube (Sanguis Counting, Nümbrecht, Germany) and immediately mixed 
into a separate 1 mL haemolysing solution for glucose analysis.  
4.2.6 Glucose analysis  
Analysis of plasma glucose is described in Chapter 3.2.8. 
4.2.7 Free fatty acids analysis 
The examination of the free fatty acid metabolic profile was based initially on gas 
chromatography–mass spectrometry (GC-MS). However, due to inadequate results, 
liquid chromatography–mass spectrometry (LC-MS) was subsequently employed for the 
identification and quantification of FFAs in South Asian and white European 
participants. Therefore, this subsection describes (1) full details of the methods used for 
FFAs analysis in South Asian and white European men, based on GC-MS and LC-MS; 
and (2) explanation for employing LC-MS, instead of GC-MS for the metabolomics 
analysis. 
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4.2.7.1 Free fatty acids analysis based on GC-MS - Developmental work 
Heparin samples selected randomly from three participants were used for evaluating the 
validity of the sample preparation method and GC-MS conditions for the analysis of 
FFAs. 
The sample preparation included 300 µL aliquot of plasma which was added to 900 µL 
of chloroform/methanol solution (3/1, v/v). The mixture was then vortexed for 60 s and 
centrifuged for 10 min at 4000 g at 4°C to separate the upper organic phase and the lower 
chloroform layer containing the FFAs.  The upper phase was transferred to a different 
tube whereas the phase containing the FFAs was left in the same tube and dried under N2 
gas flow before the addition of the derivate reagent (0.5 mL of 5% H2SO4/HCl/CH3OH). 
The dried tubes were then sealed and placed in a water bath at 70°C for 30 min with the 
tubes mixed every 5 min to optimise the reaction. Then, 500 µL of hexane was added to 
obtain the fatty acid methyl esters (FAMEs), and the tubes were centrifuged for 3 min at 
4000 g at 4°C. The hexane phase containing the FAMEs was transferred to a clean glass 
tube for GC-MS analysis. 
GC-MS analysis was performed using an Agilent 6890N gas chromatograph coupled to 
an Agilent 5793 mass spectrometer (Agilent Technologies, Santa Clara, CA, USA). In 
the gas chromatography system, a BPX5 capillary column (30 m x 0.255 mm I.D. film 
thickness 0.25 µm; Trajan Scientific and Medical, Melbourne, Australia) was used and 
the GC-MS conditions were as follows: (1) initial temperature 50 °C for 1 min; (2) 
temperature was increased to 180°C at the rate of 25°C/min; (3) temperature was 
increased at a rate of 4°C/min to 230°C. The total GC run time was 28 min. Helium 
carrier gas was used at a constant flow rate of 1.0 ml ∙ min-1 and temperature of the 
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injector was 250°C. A sample of 1 µL was injected at a split ratio of 1:5 and the mass 
conditions were as follows: electron energy, 70 eV; ion source temperature, 230°C; full 
scan mode (m/z 45-600) with a scan time of 0.6 s. 
The results following the experiments based on the aforementioned methods were 
unsatisfactory as the chromatogram did not reveal any compounds of interest. Although 
the reasons for this were not clear, the poor results were ascribed to either a lack of 
concentration of fatty acids in the sample injected into the GC or a low sensitivity of the 
MS detection. Therefore, the GC-MS method was optimised by changing the injection 
mode from split to splitless, and subsequently by increasing the sensitivity of the MS 
detection by using SIM (m/z 55, 67, 74 and 79) instead of full SCAN mode (m/z 45-600), 
in splitless mode (Vasconcellos et al. 2015; Dai et al. 2015). However, although the 
attempts in changing the GC-MS methods, fatty acids were still not detected with the 
scarcity of the results linked possibly to the poor extraction yield. Therefore, to increase 
free fatty acid extraction, the sample preparation method was optimised by:  (1) 
increasing the aliquot of plasma to 500 µL, instead of  300 µL;  (2) mixing aliquots of 
500 µL with 0.5 mL of 0.4 mol/L KOH/CH3OH, in addition to 1500 µL of 
chloroform/methanol solution; and (3) extracting the methyl esters products of FFAs by 
adding 2 mL of hexane, instead of 500 µL. The remaining part of the sample preparation 
method was the same to the initial method described above. However, even after 
changing some aspects of the sample preparation method, results did not exhibit 
significant improvement with the FFAs eluding detection.  
Thus, efficacy of the sample preparation and GC-MS conditions were excluded as 
possible reasons causing unsatisfactory results which, instead, were most likely 
explained by the inadequacy of the BPX5 capillary column used in our experiments. 
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Particularly, previous studies examining fatty acids profile reported the use of different 
capillary columns including DB-23, DB-WAX or Agilent select FAMEs (Yi et al. 2006; 
Ma et al. 2018). However, given the paucity of the outcomes by the GC-MS and the 
uncertainty to achieve better results even changing the capillary column, LC-MS was 
then employed for the quantitation of FFAs in South Asians and white European 
participants. The free fatty acid analysis performed using LC-MS produced excellent 
results, reported in 4.3.4, which were subsequently published (Benedetti et al. 2019).  
4.2.7.2 Free fatty acids analysis based on LC-MS 
4.2.7.2.1 Chemicals and Solvents 
Full description of the chemical and solvents used for the free fatty acids analysis based 
on LC-MS is reported in Chapter 2.11.2.1. Briefly, HPLC grade acetonitrile (ACN), 
water, acetic acid and hexane were obtained from Fisher Scientific (Leicestershire, UK) 
whereas a mixture of fatty acid methyl ester standards (Supelco 37-component fatty acid 
methyl ester mix) was obtained from Sigma Aldrich (Dorset, UK). The methyl esters 
were hydrolysed with 1 M KOH by heating at 60ºC for 15 min, the mixture was acidified 
and extracted into hexane.  
4.2.7.2.2 Sample preparation and calibration series 
Full description of the LC-MS sample preparation and calibration series used for 
profiling the FFAs is reported in Chapter 2.11.2.1.  
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4.2.7.2.3 Instrumental technique and LC-MS conditions 
LC-MS analysis was carried out using a Dionex 3000 HPLC interfaced with and an 
Orbitrap Exactive mass spectrometer (Thermo Fisher Scientific, Bremen, Germany). The 
column characteristics and details for the mobile phase have been reported in Chapter 
2.11.2.2. The nitrogen sheath and auxiliary gas flow rates were maintained at 50 and 17 
arbitrary units. The electrospray ionisation (ESI) interface was operated in both positive 
and negative modes. The spray voltage was 4.5 kV for the positive mode and 4.0 kV for 
negative mode, while the ion transfer capillary temperature was 275°C. Full description 
of the LC-MS condition are displayed in Chapter 2.11.2.3.  
4.2.8 Data processing and statistical analysis 
Statistical analysis for participants characteristics, physical activity and plasma glucose 
concentrations is described in Chapter 3.2.9.  
With regard to the free fatty acid analysis, the Quan Browser in Xcalibur was used to 
plot calibration curves (weighted with 1/x) and quantify the responses for the samples 
against the calibration curves. Then the levels of FFAs in the samples were calculated 
from the calibration curves by Quan Browser. P values and ratios of the mean values for 
the fatty acids were determined by using Microsoft Excel (Microsoft Office 2013). 
SIMCA-P version 14.1 (Umetrics, Umeå, Sweden) was used for multivariate analysis 
(Trivedi et al. 2012) which included Principle Components Analysis (PCA), Orthogonal 
Partial Least Squares Discriminant Analysis (OPLS-DA) and Orthogonal Partial Least 
Square (OPLS). Specifically, the quantitative values for the samples were then mean 
centred, and Pareto scaled for PCA, OPLS-DA and OPLS to generate S-plots for 
visualisation of the components. 
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4.3 Results 
4.3.1 Participants Characteristics 
The physical and physiological characteristics of the South Asian and white European 
participants are reported in Table 3.1, Chapter 3.3.1. 
4.3.2 Habitual physical activity and sedentary time 
The habitual physical activity and sedentary time in South Asian and white European 
participants are reported in Table 3.2, Chapter 3.3.2. 
4.3.3 Plasma glucose concentrations during the OGTT 
Plasma glucose concentrations during the OGTT are displayed Table 3.5 and Figure 3.2, 
Chapter 3.3.5. 
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4.3.4 Free Fatty Acids metabolic profile based on LC-MS 
Figure 4.4 shows a comparison between the fatty acid standard mixture and the fatty 
acids present in a plasma sample. Out of the 37 fatty acids present in the standard, 19 of 
these could be detected in plasma and quantitative values are given in Table 4.1.  
 
 
 
 
 
 
 
Figure 4.4. Chromatogram for the fatty acids detected in plasma compared with a 
chromatogram for the calibration standards (concentration range 3.2 - 9.6 µg∙ml-1). 
 
 
 
 
 
 
Time	
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Table 4.1. Concentration of 19 FFAs in plasma from South Asian and white European men. 
Free fatty acid  
South Asians 
(n=16) 
White 
Europeans 
(n=16) 
RT 
(min) m/z 
P value 
SA/WE 
Ratio of 
Mean conc. 
SA/WE 
Laurate (12:0) 29.8 (12.2) 28.3 (14.5) 8.3 199.169 0.040a 1.092 
Myristate (14:0) 48.0 (44.8) 33.5 (34.3) 11.5 227.200 0.011a 1.478 
Pentadecenoate (16:0) 12.5 (7.9) 12.3 (4.5) 10.9 239.200 0.224 1.032 
Pentadecanoic (15:0) 13.5 (21.5) 12.5 (26.7) 13.3 241.216 0.214 1.111 
Palmitoleic (16:1n-7) 51.3 (66.8) 36.3 (60.5) 12.4 253.216 0.137 1.371 
Palmitate (16:0) 81.0 (33.3) 54.8 (30.6) 15.2 255.232 0.004a 1.487 γ-Linolenic (18:3n-6) 17.8 (30.1) 13.8 (35.0) 11.6 277.216 0.017a 1.328 
Linoleate (18:2n-6) 322.3 (31.2) 206.0 (44.7) 13.6 279.232 0.005a 1.621 
Oleate (18:1n-9) 633.8 (43.4) 473.5 (42.5) 16.1 281.247 0.081 1.317 
Stearic (18:0) 193.5 (29.8) 155.3 (28.6) 19.2 283.263 0.095 1.227 
Eicosapentaenoic (20:5n-3) 9.3 (19.7) 10.3 (37.9) 11.5 301.216 0.449 0.899 
Eicosatetraenoic (20:4n-3) 25 (30.9) 25.3 (35.9) 13.4 303.232 0.958 0.972 
Eicosatrienoic (20:3n-3) 7.0 (27.2) 6.5 (27.0) 14.8 305.247 0.554 1.059 
Eicosadienoic (20:2n-6) 12.2 (12.3) 11.5 (14.7) 17.1 307.263 0.215 1.068 
Eicosenoic (20:1n-9) 14.0 (24.9) 13.3 (37.6) 19.8 309.279 0.666 1.022 
Arachidate (20:4n-6) 35.3 (59.2) 49.0 (53.4) 23.1 311.294 0.074 0.681 
Docosahexaenoic (22:6n-3) 18.3 (43.0) 25.3 (69.9) 13.1 327.232 0.100 0.683 
Tricosanoate (23:0) 20.0 (53.3) 16.5 (47.2) 28.1 353.341 0.456 1.179 
Lignocerate (24:0) 13.4 (49.5) 10.8 (29.1) 29.6 367.357 0.250 1.225 
All values are mean (RSD %). 
RT, retention time; m/z, mass-to-charge ratio. 
a Significant difference between South Asians and white Europeans (P < 0.05). 
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The P values for the FFAs were validated using correction for multiple comparisons 
(Benjamini et al. 1995), which indicated for the number of variables used that all P values 
<0.05 could be regarded as significant. Linoleic and oleic acid were by some way the 
most abundant FFAs in plasma. Figure 4.5 shows the principal components analysis 
(PCA) plot for 16 South Asian and 16 white European samples based on peak quantities 
of 19 free fatty acids in plasma. PCA was employed as the first step in the analysis to 
explore how the free fatty acids clusters provide insights into separations between South 
Asian and white European men for a better interpretation of the data. However, as shown 
in figure 4.5, many samples were scattered but could not be clearly separated between 
the two ethnic groups. This is because PCA finds a lower dimensional space capturing 
the maximum amount of variance in an input data matrix without losing any useful data. 
Nonetheless, it is also possible the elevated number of samples could have resulted in 
confusion during the samples discrimination between the two groups (Liu et al. 2010). 
After the first screening by PCA, orthogonal partial least squares discriminant analysis 
(OPLS-DA) was used as an alternative method to identify reliable free fatty acids that 
have a strong association with separation between groups (Figure 4.6). Specifically, a 
strong OPLS-DA model (CVANOVA 5.9 x 10-7) could be built which differentiated 
clearly 13 of the South Asian samples from 13 of the white European samples based on 
four of the FFAs (Figure 4.6). The OPLS-DA model explained 54.5% of the variance 
which was greater than that explained by the PCA model (18.5%). As shown in figure 
4.6, the two groups were clearly separated in the OPLS-DA plot, with South Asian 
samples being clustered on the right side whereas the white European samples grouped 
on the left side of the plot. Furthermore, the distance between each participant within the 
same group along the Y axis represents the concentrations for the four fatty acids used in 
this model; participants with similar free fatty acid concentrations are displayed close to 
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each other in the OPLS-DA plot. The cross-validation plot for this model can be seen in 
Figure 4.7 and the loadings plot in Figure 4.8. The loadings are mainly towards the South 
Asian group and the majority of the FFAs in the model showed a higher trend or were 
significantly higher (laurate, myristate, palmitate, γ-linolenic and linoleate) in the South 
Asian group (Table 4.1). 
 
 
 
 
 
 
 
 
Figure 4.5. Principle components analysis (PCA) plot for South Asian (n = 16) and 
white European (n = 16) samples based on peak quantities of 19 fatty acids in plasma. 
The Y axis reflects the variation within the groups while the X axis reflects the variation 
between the groups.  
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Figure 4.6. Orthogonal partial least squares (OPLS-DA) plot showing separation of 13 South 
Asian samples from 13 white European samples based on the concentrations for four fatty 
acids (myristate, linoleate, linolenate and docosapentenoate) in plasma. The Y axis reflects the 
variation within the groups while the X axis reflects the variation between the groups.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7. Cross-validation plot corresponding to Figure 4.6. The Y axis represents R2 
(circles) and Q2 (square) for the model, and the X axis designates the correlation between 
original and permuted responses data. 
  125 
 
Figure 4.8. Loadings plot corresponding to the OPLS-DA plot shown Figure 4.6. The 
Y axis displays the loading of the predictive component while the X axis displays the 
loading of the orthogonal component. 
 
4.3.5 Correlations 
It was not possible to produce strong OPLS models when trying to fit the participant 
characteristics such as body mass, BMI or body fat percentage (full details of participant 
characteristics are reported in Table 3.1, Chapter 3.3.1) to the combined white European 
and South Asian groups. In addition, when the white European group was modelled in 
isolation, it was not possible to produce a strong model for any of the parameters in Table 
3.1 presented in Chapter 3.3.1. However, when the South Asian group was modelled on 
its own, valid models could be produced for body mass, BMI, body fat percentage and 
AUC glucose (Figures 4.9, 4.10, 4.11 and 4.14). Conversely, in white European but not 
in South Asian men there was a strong correlation between total step counts and fatty 
acids profile (Figure 4.15).  
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4.3.5.1  Correlations between fatty acids and body mass, BMI, body fat percentage 
and AUC glucose 
The strongest correlation was produced for body fat percentage (r2 = 0.92; Figure 4.11) 
where the loadings indicated that that the highest body fat percentage correlated with the 
highest levels of palmitic, linoleic, docosahexenoic and eicosatetraenoic acids (Figure 
4.12). Figure 4.13 shows extracted ion traces for palmitic and eicosatetraenoic acids for 
participants P31 and P8 (both South Asians) who had the highest and lowest body fat 
percentage, respectively. Body mass could also be modelled using an OPLS model and 
just three FFAs to produce a strong model (r2 = 0.86; Figure 4.9). Two of the FFAs, 
docosahexenoic acid and stearic acid, which correlated with body fat percentage were 
also used in the OPLS-DA model (Figure 4.6) for actual against predicted body mass and 
in addition the long chain fatty acid lignoceric acid was included. It was also, perhaps 
not surprisingly, possible to fit an OPLS model for predicted BMI against actual BMI 
using four FFAs; stearate, palmitate, myristate and arachidate (Figure 4.10) although the 
correlation (r2 = 0.79) between predicted and actual BMI was weaker than for OPLS plots 
for body fat percentage and body mass. In addition, for the South Asian group it was 
possible to correlate AUC glucose to four FFAs (palmitate, oleate, eicosatrienoic and 
docosahexenoic acid) (r2 = 0.89; Figure 4.14). 
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Figure 4.9. OPLS of predicted (X axis) vs. actual body mass (Y axis) based on three free 
fatty acids (lignoceric, docosahexenoic and stearic acid) for South Asian men. 
 
Figure 4.10. OPLS plot of predicted (X axis) vs. actual BMI (Y axis) based on four free 
fatty acids (stearate, palmitate, myristate and arachidate) for South Asian men. 
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Figure 4.11. OPLS plot of predicted (X axis) vs. actual body fat percentage (Y axis) based 
on five free fatty acids (palmitate, stearate, linoleate, eicosatetraenoic acid and 
docosahexaenoic acid) for South Asian men. 
 
 
 
 
 
 
 
 
 
 
 
 
 
              
 
 
       
 
Figure 4.12. Loadings plot for Figure 4.11. The Y axis displays the loading of the 
predictive component while the X axis displays the loading of the orthogonal component. 
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Figure 4.13. Extracted ion traces for two markers of higher body fat percentage, palmitic 
acid and eicosatetraenoic acid. The levels of the acids are highest in participant P31 
(South Asian) who had the highest body fat percentage and lowest in participant P8 (South 
Asian) who had the lowest body fat percentage. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14. OPLS of predicted (X axis) vs. actual area under the curve (Y axis) 
(AUC) for glucose based on four free fatty acids (palmitate, oleate, eicosatrienoic 
acid and docosahexenoic acid) for South Asian men. 
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It was not possible to produce a strong OPLS model predicting V̇O2 max, waist 
circumference or systolic and diastolic blood pressure for the South Asian or white 
European group. Partial Least Square (PLS) models could also be fitted to the variables 
used for modelling body fat percentage, body mass and AUC glucose, but the fit was not 
quite as strong as for the OPLS models. 
4.3.5.2  Correlations between free fatty acids and total step counts 
In white European but not in South Asian men there was a strong correlation between 
total step counts and fatty acids profile (r2 = 0.96; Figure 4.15) based on six FFAs: 
palmitoleic, linoleic, arachidate, laurate, erucate and nervonate (Figure 4.16). Lower step 
counts were also associated with elevated levels of FFAs, particularly palmitoleic and 
linoleic acids (Figure 4.17). 
 
 
 
 
 
 
 
 
 
 
Figure 4.15. OPLS of predicted (X axis) vs. actual total step counts (Y axis) based on 
six fatty acids (palmitoleic, linoleic, arachidate, laurate, erucate and nervonate) for 
white European men. 
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Figure 4.16. Loadings plot for Figure 4.15. The Y axis displays the loading of the 
predictive component while the X axis displays the loading of the orthogonal 
component. 
 
Figure 4.17. Extracted ion traces for palmitoleic acid and linoleic acid for participant P24 
(white European) who had the lowest step count and participant P14 (white European) who 
had the highest total step counts. 
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4.4 Discussion 
In this study, we conducted a cross-sectional analysis to determine whether the free fatty 
acid metabolic profile differed between healthy South Asian men and with white 
European men. This study also examined associations with physical activity and 
cardiorespiratory fitness levels, in addition to other T2D and CVD risk factors.  
The initial results based on the GC-MS method were unsatisfactory as we could not 
identify any compounds of interest. The sample preparation protocol initially employed 
for the lipid extraction as well as the GC-MS conditions were subsequently optimised to 
exclude that the unsatisfactory results were ascribed to either a lack of concentration of 
fatty acids in the sample injected into the GC or a low sensitivity of the MS detection. 
However, after these adjustments results did not exhibit significant improvement with 
the FFAs eluding detection, which most likely reflect the inadequacy of the capillary 
column used in our experiments. 
Conversely, we could separate majority of the South Asian from most of the white 
European men based on LC-MS method using a strong OPLS-DA model, which provided 
some confidence that these participants had markedly different fatty acid profiles. 
Furthermore, it was possible to fit OPLS models for the South Asian men to predict body 
mass, BMI, body fat percentage and AUC glucose whereas the same models were not a 
good fit for the white European men. Release of fatty acids from adipocytes is under the 
control of glucocorticoids and it might be that there are differences in either 
glucocorticoid concentration or glucocorticoid sensitivity within the two ethnic groups, 
although it has been found that cortisol levels are actually lower in South Asians in 
comparison with white Europeans (Reynolds et al. 2006). However, the lack of fit with 
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the data for the white European group lends some additional confidence that the data was 
not over-fitted which is possible when the sample size is small. 
The plasma free fatty acid composition has been reported to be linked to the risk of T2D 
and CVD (Lu et al. 2016; Warensjö et al. 2005). In the present study, lauric, myristic, 
palmitic, γ-linolenic and linoleic acid were significantly higher in South Asian compared 
with white European participants, which represents a novel finding of this study. 
Previous studies reported that individuals with insulin resistance typically exhibit higher 
levels of SFAs (i.e. palmitate, laurate or stearate), omega-6 PUFAs (i.e. linoleic acid) and 
low concentrations of omega-3 PUFAs such as eicosapentaenoic and docosahexaenoic 
acid (Lu et al. 2016; Warensjö et al. 2005). Given the greater risk of CVD and T2D in 
South Asian than white Europeans (Sattar and Gill, 2015), it was surprising that baseline 
concentrations of γ-linolenic and linoleic acid were higher in the South Asian group. To 
the author’s knowledge, only one previous study explored differences in baseline levels 
of FFAs between South Asians and other ethnic groups, in which γ-linolenic and linoleic 
acid were displayed to be also higher in the South Asian compared with the Caucasian 
group (Ralston et al. 2013). However, the study from Ralston and co-workers focused 
mainly on ethnic-specific associations between individual plasma FFAs and markers of 
insulin resistance, without explicitly examining ethnic differences in baseline 
concentrations of FFAs (Ralston et al. 2013). Although the reasons for this finding 
remain unclear it is possible that differences in habitual food intake between ethnic 
groups in this study may have influenced the results. South Asians typically increase 
consumption of fat intake when moving to western countries, particularly saturated fat-
rich food such as coconut oil, palm oil or semifluid clarified butter (ghee), which is 
reflected in the concentrations in plasma and cell membranes (Holmboe-Ottesen and 
Wandel, 2012). 
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The present study also identified positive associations between AUC glucose and four 
FFAs such as palmitate, oleate, eicosatrienoic and docosahexenoic acid in South Asian 
participants (Figure 4.14). The positive association between palmitate and AUC glucose 
in our study is in agreement with previous research, despite these studies being conducted 
in populations with different ethnic background (Lu et al. 2016; Ebbeson et al. 2010; 
Kusunoki et al. 2007). Although the mechanisms of saturated fatty acids-induced insulin 
resistance remain elusive, altered membrane phospholipid fatty acid composition and 
membrane fluidity and stability may play a role (Ebbeson et al. 2010). We also reported 
positive associations between AUC glucose and oleic acid, which seems to confirm the 
data from Ralston et al. (2013) who identified significant correlations between oleate and 
insulin markers, although in Caucasians but not in South Asian men (Ralston et al. 2013). 
The present study also revealed a strong correlation of FFAs with body fat percentage in 
the South Asian group and between FFAs and physical activity in the white European 
group. Particularly, in the South Asian group greater levels of palmitate, stearate, 
linoleate, eicosatetraenoic and docosahexaenoic acid were positively associated with 
body fat percentage (Figure 4.11). Higher levels of FFAs have been associated with both 
obesity and insulin resistance (Boden, 2011; Langin et al. 2005) thus, it may be possible 
that in the South Asian group a greater body fat percentage resulted in higher levels of 
FFAs, but not in the white European group. However, ethnic differences in factors 
involved in myocellular lipid mobilisation may underlie this response. Two key lipolytic 
enzymes involved in the intracellular triglyceride mobilisation in the body include the 
hormone sensitive lipase (HSL), which is regulated by catecholamine release, and the 
adipose triacylglycerol lipase (ATGL) which is not under the same hormonal control 
(Schreiber et al. 2018). In muscle cells, for example, lipolytic activity of ATGL is 
stimulated by perilipin 5 (PLIN-5), a lipid droplet-associated protein which regulates 
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basal lipolysis (Schreiber et al. 2018). According to previous research, South Asians 
exhibit higher PLIN-5 protein content in skeletal muscle in response to a 5-day high fat 
diet, compared with Caucasian males (Gemmink et al. 2017), which may reflect higher 
lipolysis rates in South Asian individuals. Thus, it is plausible that in our study ethnic 
differences in ATGL/PLIN-5-induced lipolysis may have contributed to the higher levels 
of FFAs linked to body fat in the South Asian group, although further research is required 
before any conclusion can be drawn. Conversely, six FFAs (palmitoleic, linoleic, 
arachidate, laurate, erucate and nervonate) were strongly associated with total step counts 
in the white European group only, and palmitoleic and linoleic acid were also associated 
with lower step counts suggesting that fatty acid metabolism is less responsive to physical 
activity in South Asian than white European men. This finding might reflect the fact that 
the FFAs release is promoted more by HSL, which responds to corticosteroids and 
catecholamine release (Schreiber et al. 2018). Catecholamines also promote peroxisome 
proliferation (Russel et al. 2013) which could result in lower levels of FFAs correlating 
with higher total step counts. 
The present study was limited by the small number of participants and the South Asian 
population was mostly limited to men originating from India. Additionally, the potential 
confounding effects of body fat percentage may have accentuated the differences in FFAs 
between ethnic groups. Therefore, further work should be performed to investigate 
differences in FFAs metabolic profile in other South Asian groups (e.g., Bangladeshis, 
Sri Lankan and Bhutanese) and in South Asian women compared with body fat-matched 
white European individuals. Furthermore, investigating FFAs in response to exercise 
and/or food intake and how and explore how these responses correlate with 
cardiometabolic risk markers may elucidate the role of exercise and energy intake in 
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modulating individual plasma FFAs concentrations and in optimising health outcomes in 
South Asians. 
In conclusion, the current study provides evidence that levels of circulating FFAs are 
different between South Asians and white European men. Using an OPLS models, FFAs 
were strongly correlated with body fat percentage and AUC for glucose in South Asian, 
whereas total step counts were strongly correlated with lower levels of FFAs in white 
European men. This may suggest that the different FFAs metabolic profile may be linked 
with the elevated T2D risk in South Asians than white Europeans and that fatty acid 
metabolism is less responsive to physical activity in South Asian men in comparison to 
white European men. 
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Chapter 5 – Study 3: Effects of moderate-vigorous cycling on appetite, 
ad libitum energy intake and appetite-related hormones in healthy 
South Asian and white European men 
5.1 Introduction 
Cardiovascular disease (CVD) represents the main cause of death globally (WHO, 2017) 
as well as in the United Kingdom (BHF, 2019) and type 2 diabetes (T2D) represents the 
main CVD risk factors (IDF, 2019). South Asians have a heightened risk of CVD and 
T2D compared to white Europeans, irrespective of their place of living, with both 
conditions manifesting at younger age in the South Asian population (Sattar and Gill, 
2015; Gholap et al. 2011; Tziomalos et al. 2008). Although there seems to be a shift in 
the pattern of mortality risk between ethnicities with diabetic UK South Asians 
experiencing lower cardiovascular and all-cause mortality rate than their white European 
counterparts, the rate of cardiovascular complications such as myocardial infarction or 
stoke in British South Asians with diabetes continue to be higher than white Europeans 
(Johns and Sattar, 2017).    
 
There is clear evidence that South Asians have a greater percentage of body fat and intra-
abdominal adipose tissue for a given body mass index (BMI) compared with white 
European individuals which contributes to the elevated CVD and T2D risk in this 
population (Lear et al. 2012; Hall et al. 2010).  The reasons for these are uncertain. It is 
possible that this innate phenotype of increased adiposity may be linked with differences 
in food intake and appetite regulation between South Asian and white European 
individuals. Several appetite-related hormones play a key role in energy homeostasis and 
weight control, including acylated ghrelin and peptide YY (PYY) which are mediators 
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of hunger and satiety, respectively (Hussain et al. 2013). Recent work from our 
laboratory reported lower concentrations of fasting acylated ghrelin, but not differences 
in fasting total PYY levels, in South Asian than white European men, which may be 
linked to the greater adiposity in South Asians (Study 1, Chapter 3), but further work is 
required to confirm this. 
 
Given the important role of physical activity in the management of obesity and weight 
control, there has been considerable interest in the effects of exercise on appetite 
perception and energy intake in response to exercise and in the underlying mechanisms 
linking physical activity, appetite and weight management. In this regard, a plethora of 
studies have investigated the appetite and energy intake responses during and after acute 
bouts of continuous aerobic exercise (50-70% V̇O2 max, 30-90 min), with the majority 
of these studies showing a transient suppression of appetite perceptions during and 
shortly after exercise, known as ‘exercise-induced anorexia’ (Deighton and Stensel, 
2014). Furthermore, single sessions of exercise have consistently been shown to suppress 
acylated ghrelin concentrations and increasing levels of anorexigenic appetite-related 
hormones including total PYY, without stimulating subsequent changes in absolute 
energy intakes (Shubert et al. 2014). 
However, it remains unknown how differences in individual ethnicity background 
modulate appetite perceptions, energy intake and appetite-related hormones in response 
to exercise. Furthermore, since observational evidence suggests that South Asian 
individuals engage in less habitual physical activity than white European individuals, 
which is likely to contribute to their elevated CVD and T2D risk (Rastogi et al. 2004; 
Williams et al. 2011b; Yates et al. 2015), research to examine the impact of exercise on 
appetite regulation, energy intake in this population is warranted. 
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Therefore, the aim of this study was to investigate the effects of acute exercise on 
subjective appetite ratings, appetite-related hormones and ad libitum energy intake in 
healthy South Asian and white European men. 
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5.2 Methods 
5.2.1  Participants 
Following approval from Kingston University’s Ethics Advisory Committee (approval 
ethic code: 1617/034), 15 South Asian and 15 white European men aged 19–50 years 
provided written informed consent to participate in this study. The present study has been 
also registered as a clinical trial according to the protocol registration and results system 
(PRS) (registration number: NCT03698786). Based on previous preliminary data 
reported in Study 1 (Chapter 3), it was estimated that a sample size of 15 participants per 
group would have 83% power at the 0.05 level to detect a between-group difference in 
fasting acylated ghrelin of 1.11 between-subject standard deviations (SDs). The sample 
size was calculated using G*Power (Faul et al. 2007). Groups were matched for age and 
BMI. The South Asian group comprised seven British Asians born in the UK (UK Indian 
n=4; UK Pakistani n=2; UK Bangladeshi n=1) and eight individuals born in South Asia 
(India n=4; Pakistan n=2; Bangladesh n=1; Nepal n=1). Conversely, the white European 
group comprised nine British born participants and six individuals originating from 
European countries (Germany n=3; Spain n=1; Italy n=1; France n=1). One South Asian 
participant dropped out without giving any specific reason, thus it was excluded from 
analysis. This participant was therefore replaced with another South Asian man in order 
to have 15 South Asians and 15 white Europeans. All participants were non-smokers, 
had no personal history of cardiovascular/metabolic disease, were not taking any 
anticoagulant or anti-inflammatory medication and were not dieting. Before physical 
testing, the Physical Activity Readiness Questionnaire (PAR-Q) (Thomas et al. 1992) 
was completed by all participants to screen for possible contraindications to exercise. 
Table 1 shows the key participant characteristics. 
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5.2.2  Preliminary testing 
Before the main trials, participants visited the laboratory to undergo preliminary 
assessments and to be familiarised with the laboratory environment and study 
procedures. Specifically, participants completed questionnaires assessing general health 
status, contraindications for blood sampling and habitual physical activity levels 
(International Physical Activity Questionnaire (IPAQ)) (Craig et al. 2003). At this visit, 
the participants verbally confirmed acceptability of the standardised breakfast and ad 
libitum buffet meal subsequently provided during the main experimental trials. 
Body mass, stature, waist circumference, BMI, body composition and blood pressure 
were then measured as described in Chapter 2.2 and 2.5. Participants then completed an 
incremental exercise test to volitional exhaustion on an electromagnetically braked cycle 
ergometer (Lode Excalibur Sport, Groningen, Netherlands) for the determination of peak 
oxygen uptake (V̇O2 peak) as described in Chapter 2.6. Throughout the cardiorespiratory 
test, heart rate was monitored every 3 min using a HR monitor (Polar FT1, Polar Electro, 
Kempele, Finland). Oxygen consumption, HR and peak watts were used to determine the 
exercise intensity of the main trial. 
5.2.3  Experimental procedure 
Participants completed two, 7 h trials (control and exercise) in a randomised crossover 
design with at least 7 days between each trial. Figure 5.1 shows the trial protocol. 
Participants were asked to refrain from consuming alcohol, caffeinated drinks and from 
participating in strenuous exercise during the 24 h prior to each trial. Participants were 
also asked to consume 500 mL of plain water the night before the exercise trial to ensure 
euhydration. A food diary was completed in the 24 h prior to the first trial, with 
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participants required to replicate food and drink intake as closely as possible for the 24 h 
prior to the subsequent trial. 
On the morning of each trial, volunteers arrived at the laboratory at approximately 08:30 
after a 9 h overnight fast. Particularly, all participants were informed to not ingest any 
food or drink, apart from water, after 11 pm of the night before attending the laboratory. 
Furthermore, participants were informed to exert themselves minimally when travelling 
to the laboratory, using motorised transport where possible. Upon arrival, participants 
rested in a semi-supine position whilst a cannula was inserted into the antecubital vein 
by a trained phlebotomist, and a standardised breakfast meal was then consumed within 
15 min. The 7 h trial commenced at the start of the breakfast (0 h). In the exercise trial, 
participants rested throughout apart from completing 60 min of continuous cycling at 
70% of V̇O2 peak between 2 and 3 h. Samples of expired air were collected at 15, 30, 45 
and 60 min during exercise using an online breath-by-breath gas analysis system (as 
described above) to monitor the exercise work-load. Heart rate and ratings of perceived 
exertion (RPE) (Borg, 1973) were also recorded at this time. Energy expenditure and 
non-protein respiratory exchange ratio (RER) for the estimation of substrate utilisation 
were calculated from oxygen uptake and carbon dioxide production (Weir, 1990) during 
the exercise bout. A buffet meal was provided at 4 h and participants were free to 
consume ad libitum for 30 min. Identical procedures were followed in the control trial 
except that no exercise was performed. 
 
 
 
  143 
 
 
 
 
 
 
 
 
 
 
 																	
 	
Fi
gu
re
 5
.1
.  
Sc
he
m
at
ic
 il
lu
str
at
io
n 
of
 th
e 
stu
dy
 p
ro
to
co
l 
Ti
m
e 
  144 
5.2.4  Self-reported physical activity 
Raw data from the long form IPAQ were assessed following the questionnaire guidelines 
(Craig et al. 2003) and expressed as metabolic equivalent (MET) minutes per day spent 
in walking, moderate-to-vigorous physical activity (MVPA) and total physical activity. 
Total time spent sitting expressed as minutes per day was also reported. Data from 
participants with the sum total of all walking, moderate and vigorous time greater than 
960 minutes (16 hours) were excluded from the analysis (Craig et al. 2003). 
5.2.5  Appetite perceptions 
During each trial (exercise and control) perceptions of appetite (hunger, satisfaction, 
fullness and prospective food consumption) were assessed before starting the 
standardised breakfast meal and at 30 min intervals using 100 mm visual analogue scales 
(VAS) (Flint et al. 2000). An overall appetite rating was calculated as the mean value of 
the four appetite perceptions after reversing the values for satisfaction and fullness 
(Stubbs et al. 2000). 
5.2.6  Standardised breakfast and ad libitum meal 
The standardised breakfast consisted of a sandwich (55 g white bread, 23 g cheese, 10g 
mayonnaise and 40 g ham), 60 g chocolate muffin and 250 ml orange juice. For five 
South Asian participants ham was replaced with isocaloric tuna due to religious beliefs. 
The energy and macronutrient content of this meal was 2853 kJ, 46% carbohydrate, 14% 
protein and 40% fat.  
The ad libitum buffet meal was set up identically for each trial and consisted of granola, 
oats, corn flakes, white bread, semi skimmed milk, orange juice, cheese, ham/tuna, 
butter, margarine, mayonnaise, salted crisps, chocolate bars, cereal bars, cookies, 
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muffins, apples, oranges and bananas. All food pre-weighted and being presented in 
excess of expected consumption. Participants were told to eat until satisfied and that 
additional food was available if required. The buffet meal was consumed in isolation 
with no distraction and the use of computers or mobile phones was prohibited to 
minimise any influence on food consumption. At the end of the buffet meal, leftover food 
was weighed, and absolute energy intake and macronutrient composition of the food 
consumed was determined by calculating the weighted difference of each food item 
before and after each meal. In the exercise trial, relative energy intake was calculated as 
follows: absolute energy intake minus the net energy expenditure of exercise. Water was 
available ad libitum throughout the trials. 
5.2.7  Blood sampling 
Venous blood samples were collected via a cannula (Vasofix® Safety, B. Braun, 
Melsungen, Germany) inserted into an antecubital vein. Blood samples were collected at 
0, 0.75, 2, 3, 4, 4.75 and 7 h for the determination of acylated ghrelin, PYY, insulin and 
glucose concentrations. Full details of blood sample collection are reported in Chapter 
2.10. 
5.2.8  Analytical methods 
Plasma concentrations of acylated ghrelin, total PYY, and insulin were measured using 
commercially available enzyme-linked immunosorbent assays. Specifications of the 
analysis and details of the commercially available enzyme-linked immunosorbent assay 
kits are reported in Chapter 2.11.3 and 2.11.4. Plasma glucose concentrations were 
analysed immediately in singular using a glucose analyser (specifications of the analysis 
and details of the glucose analyser are reported in Chapter 2.11.4). Haemoglobin and 
haematocrit were analysed immediately in duplicate using a haematology blood counter 
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(Yuminez H500-CT, HORIBA ABX Diagnostic, Northampton, UK). The within batch 
coefficients of variation for the assays were as follows: 7.3 % acylated ghrelin, 3.2 % 
total PYY, 2.4 % insulin and 3.3 % glucose. 
5.2.9  Statistical analysis 
All statistical analyses were conducted using the analytical software SPSS version 23.0 
for Windows (SPSS 23.0, IBM Corp, Armonk, NY, USA). Normality of the data was 
checked using Shapiro-Wilk tests. Normally distributed data are presented as mean (SD). 
Data for self-reported physical activity and fasting plasma concentrations were not 
normally distributed and were natural log-transformed before analysis. These data are 
presented as geometric mean (95% confidence interval) and analysis is based on ratios 
of the geometric mean and 95% confidence intervals (CI) for ratios. The trapezium rule 
was used to calculate the time averaged total under the curve (tAUC).  Concentrations of 
plasma appetite-related hormones and metabolic markers are presented relative to 
baseline concentrations (delta) and time-averaged total area under the curve (tAUC) for 
these markers are also presented as delta values for consistency. Correction of plasma 
values for plasma volume changes did not alter the interpretation of the results and the 
unadjusted data are reported for simplicity. Habitual physical activity expressed as 
walking, MVPA, total physical activity and total sitting were compared between ethnic 
groups using linear mixed models including awake time as a covariate.  
Participants characteristics, exercise responses and self-reported physical activity levels 
were compared between the South Asian and white European men using linear mixed 
models with ethnic group included as a fixed factor. Differences in fasting plasma 
concentrations, baseline appetite perceptions, time-averaged tAUC and 
energy/macronutrient intakes were examined using linear mixed models with ethnic 
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group (South Asian, white European) and trial (exercise, control) modelled as fixed 
factors. Differences in appetite perceptions, appetite-related hormones, glucose and 
insulin concentrations over time were examined using linear mixed models with ethnic 
group, trial and time as fixed factors. Ethnicity-specific Spearman’s correlation 
coefficients using the mean difference between trials were used to examine the 
magnitude of linear association between the various predictors (age, body fat percentage, 
V̇O2 peak, appetite ratings) and outcome measures (acylated ghrelin, total PYY and 
insulin). Bivariate Spearman’s correlations were also used to determine associations 
between total carbohydrate oxidation during exercise and absolute energy intake in South 
Asian and white European men. Absolute standardised effect sizes (ES) (Cohen’s d) were 
calculated for each variable by dividing the difference between the mean values (South 
Asian versus white European) with the pooled SD. An ES of 0.2 was considered the 
minimum important difference, 0.5 moderate and 0.8 large (Cohen, 1988). Statistical 
significance was accepted as P < 0.05. 
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5.3 Results 
5.3.1  Participant characteristics 
The physical and physiological characteristics of the South Asian and white European 
men are shown in Table 5.1. The 95% CI for age, body mass, BMI, fat mass, body fat 
percentage, waist circumference and resting diastolic blood pressure overlapped zero (all 
P ≥ 0.064). However, standardised ESs were small-to-moderate for age, body fat 
percentage, waist circumference and resting diastolic blood pressure (ES = 0.26–0.44) 
and a moderate-to-large ES was observed for body mass (ES = 0.73). Compared with 
white European men, South Asian men had lower stature (ES = 1.16, P = 0.003), fat free 
mass (ES = 1.09, P = 0.006), resting systolic blood pressure (ES = 0.90, P = 0.020) and 
V̇O2 peak expressed in absolute (ES = 1.70, P < 0.001) and relative (ES = 0.99, P = 
0.007) terms. 
5.3.2  Self-reported physical activity 
Awake time adjusted total physical activity was lower in South Asian than white 
European men (ES = 0.78, P = 0.030) whereas total MVPA was meaningfully, albeit not 
significantly, lower in South Asians than white Europeans (ES = 0.78, P = 0.051) (Table 
5.2). South Asian men exhibited, on average, greater sitting time than white Europeans 
(ES = 0.72, P = 0.064), although the difference did not reach significance (Table 5.2). 
Walking (ES = 0.54, P = 0.116) and awake time (ES = 0.52, P = 0.165) were similar 
between groups (Table 5.2). 
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Table 5.1.  Participant characteristics. 
 South Asians (n=15) White Europeans (n=15) 
White Europeans vs. South Asians 
Mean difference (95% CIa) Effect size 
Age (years) 29 (8) 33 (10) -4 (-11, 3) 0.44 
Stature (cm) 173.7 (6.8) 181.5 (6.6) -7.8 (-12.9, -2.8) b 1.16 
Body mass (kg) 76.0 (12.5) 85.5 (14.4) -9.5 (-19.5, 0.6) 0.73 
Body mass index (kg·m-2) 25.4 (4.5) 26.1 (3.8) -0.6 (-3.7, 2.4) 0.17 
Fat free mass (kg) 59.6 (8.8) 68.5 (7.5) -8.9 (-14.9, -2.8) b 1.09 
Fat mass (kg) 17.6 (8.0) 17.5 (10.7) 0.1 (-7.0, 7.1) 0.01 
Body fat (%) 22.4 (8.3) 19.3 (8.3) 3.2 (-3.0, 9.4) 0.37 
Waist Circumference (cm) 84.8 (9.8) 87.6 (11.5) -2.8 (-10.8, 5.1) 0.26 
Resting sBP (mmHg) 116 (12) 125 (8) -9 (-16, -1) b 0.90 
Resting dBP (mmHg) 77 (9) 75 (7) 2 (-4, 8) 0.26 
V̇O2 peak (L·min-1) 3.10 (0.61) 4.12 (0.59) -1.02 (-1.47, -0.57) b 1.70 
V̇O2 peak (mL·kg-1·min-1) 41 (7) 49 (9) -8 (-14, -2) b 0.99 
All values are mean (SD). Data were analysed using linear mixed models with group (South Asian vs. white European) included as a fixed 
factor.  
sBP, systolic blood pressure; dBP, diastolic blood pressure; V̇O2 peak, peak oxygen uptake 
a 95% confidence interval for the mean absolute difference between the groups. b Main effect of group (P < 0.05). 
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Table 5.2. Self-reported habitual physical activity levels and sitting time in South Asian and white European men. 
 South Asians  
(n=15) 
White Europeans 
(n=15) 
White Europeans vs. 
South Asians 
Mean difference (95% 
CIa) 
Effect 
size 
P value 
      
Walking (met∙min-1∙day-1) 90 (51, 158) 214 (120, 376) -44% (-73, 16%) 0.54 0.116 
Total MVPA (met∙min-1∙day-1) 184 (93, 357) 489 (249, 951) -63% (-86, 1%) 0.78 0.051 
Total PA (met∙min-1∙day-1) 395 (279, 558) 770 (545, 1090) -40 (-62, -5%) b 0.78 0.030 
Total sitting time (min∙day-1) 331 (264, 413) 265 (212, 332) 34% (-2, 84%) 0.72 0.064 
Awake time (min∙day-1) 589 (509, 681) 680 (588, 786) -13% (-30, 6%) 0.52 0.165 
All values are geometric mean (95% confidence interval). Statistical analyses are based on log-transformed data.  
Data were analysed using linear mixed models with group (South Asian vs. white European) included as a fixed factor.  Models for walking, 
total MVPA, total PA and total sitting included awake time as a covariate. 
MVPA moderate-to-vigorous physical activity; PA physical activity. 
a 95% confidence interval for the ratio difference of geometric means between the groups. 
b Main effect of group (P < 0.05). 
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5.3.3  Exercise responses  
Exercise net energy expenditure (ES = 1.54, P < 0.001), total fat oxidation (ES = 0.93, P 
= 0.018), total carbohydrate oxidation (ES = 1.07, P = 0.007) and absolute exercise work 
rate (ES = 1.69, P < 0.001) were lower in South Asian than white European men (Table 
5.3). All other exercise responses were similar between ethnic groups (all P ≥ 0.128) 
(Table 5.3).  
5.3.4  Ad libitum energy and macronutrient intakes 
Energy and macronutrient intakes during the ad libitum meal are shown in Table 5.4. 
Main effects of group revealed lower absolute energy intake (ES = 1.03, P = 0.003), 
relative energy intake (ES = 0.65, P = 0.017), carbohydrate intake (ES = 0.83, P = 0.015) 
and fat intake (ES = 1.02, P = 0.003) in South Asian compared with white European men. 
A main effect of trial for relative energy intake revealed exercise was lower than control 
(ES = 1.37, P < 0.001). A group-by-trial interaction for carbohydrate intake (P = 0.014) 
revealed lower intake in South Asians (mean difference (95% CI) -20 (-49, 10) g, ES = 
0.38, P = 0.184) and higher intake in white Europeans (mean difference (95% CI) 34 (5, 
64) g, ES = 0.50, P = 0.025) after exercise. No other main effects or group-by-trial 
interactions were identified for ad libitum energy and macronutrient intakes (all P ≥ 
0.063). 
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Table 5.3. Cycling exercise responses in South Asian and white European men.  
 South Asians 
(n=15) 
White Europeans 
(n=15) 
White Europeans vs. 
South Asians 
Mean difference 
(95% CIa) 
Effect size 
Heart rate (beats∙min-1) 159 (12) 154 (11) 5 (-4, 13) 0.43 
RPE (6-20) 13.7 (2.1) 13.9 (1.9) -0.3 (-1.8, 1.2) 0.20 
Respiratory exchange ratio 0.94 (0.02) 0.92 (0.04) 0.02 (-0.01, 0.04) 0.63 
Exercise intensity (% of V̇O2 peak) 67 (4) 69 (5) -3 (-6, 1) 0.56 
Work rate (Watts) 115 (21) 161 (32) -46 (-66, -25) b 1.69 
Work rate (% max power) 59 (6) 58 (7) 2 (-3, 6) 0.23 
Total fat oxidation (g) 13.7 (7.5) 21.9 (9.9) -8.2 (-14.9, -1.5) b 0.93 
Total carbohydrate oxidation (g) 106.7 (19.2) 136.5 (34.6) -29.8 (-50.9, -8.7) b 1.07 
Fat oxidation (% total energy expenditure) 20 (9) 22 (10) -2 (-9, 5) 0.21 
Carbohydrate oxidation (% total energy expenditure) 73 (8) 69 (10) 4 (-3, 11) 0.44 
Net energy expenditure (kJ) 2475 (469) 3324 (624) -849 (-1268, - 430) b 1.54 
All values are mean (SD). Data were analysed using linear mixed models with group (South Asian vs. white European) included as a fixed 
factor.  
RPE rating of perceived exertion; V̇O2 max maximum oxygen uptake. 
a 95% confidence interval for the mean absolute difference between the groups. 
b Main effect of group (P < 0.05). 
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Table 5.4.  Ad libitum energy and macronutrient intakes in South Asian and white European men. 
 South Asians  (n=15) 
 
White Europeans  
(n=15) 
 
White Europeans 
vs. South Asians 
Mean difference 
(95% CIa) 
Control vs. Exercise  
Mean difference 
(95% CIa) 
 Control Exercise  Control  Exercise  
Absolute Energy intake (kJ) 5902 (1564) 5773 (1244)  7441 (1901) 8010 (2478)  -1888 (-3088, -687) b 220 (-474, 914) 
Relative Energy intake (kJ) 5902 (1564) 3298 (1103)  7441 (1901) 4686 (2485)  -1464 (-2649, -278) b -2679 (-3369, -1989) c 
Carbohydrate intake (g) 166.4 (55.3) 146.8 (47)  190.7 (54.2) 224.8 (80.7)  -51.1 (-91.4, -10.8) b,d 7.2 (-13.7, 28.1) d 
Fat intake (g) 58.9 (15.5) 60.2 (14.2)  83.5 (30.5) 82.3 (28.1)  -23.3 (-37.8, -8.8) b 0.1 (-9.5, 9.6) 
Protein intake (g) 53.7 (18.8) 62.7 (35.1)  65.9 (20.3) 68.7 (20.5)  -9.1 (-24.1, 5.8) 5.9 (-4.8, 16.6) 
All values are mean (SD). Data were analysed using linear mixed models with group (South Asian vs. white European) and trial (exercise vs. 
control) included as fixed factors.  
a 95% confidence interval for the mean absolute difference between the groups or trials. 
b Main effect of group (P < 0.05) 
c Main effect of trial (P < 0.001) 
d Group-by trial interaction (P = 0.014) 
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5.3.5  Appetite perceptions 
Fasting overall appetite ratings at baseline were similar across groups and trials (main 
effect group P = 0.156; main effect trial P = 0.871; group-by-trial interaction P = 0.323) 
(Table 5.5). Linear mixed models for overall appetite identified a main effect of time (P 
< 0.001), group-by-time interaction (P = 0.013) and trial-by-time interaction (P = 0.014), 
but not a main effect of group (mean difference (95% CI) -2 (-7, 4) mm, ES = 0.07, P = 
0.521) or trial (mean difference (95% CI) -1 (-2, 1) mm, ES = 0.02, P = 0.590) (Figure 
5.2). Post hoc analysis of the group-by-time interaction revealed lower overall appetite 
in South Asian than white European participants at 6.5 h (mean difference (95% CI) -8 
(-18, -0.1) mm, ES = 0.58, P = 0.047). Post hoc analysis of the trial-by-time interaction 
revealed that overall appetite ratings were lower at 4.5 h (mean difference (95% CI) -11 
(-18, -3) mm, ES = 0.51, P = 0.004) and higher at 6.5 h (mean difference (95% CI) 8 (1, 
15) mm, ES = 0.53, P = 0.024) in the exercise than in the control trial. Time-averaged 
total area under the curve for overall appetite ratings were similar across groups and trials 
(main effect group P = 0.483; main effect trial P = 0.637; group-by-trial interaction P = 
0.452) (Table 5.6). 
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    Table 5.5. Fasting overall appetite, appetite-related hormone and glucose concentrations in South Asian and white European men. 
 
 South Asians  (n=15) 
 
White Europeans  
(n=15) 
 
White Europeans 
vs. South Asians 
Mean difference 
(95% CIa) 
 
Control vs. Exercise  
Mean difference 
(95% CIa)  Control Exercise  Control  Exercise  
   Overall appetite (mm)  82 (13) 79 (18)  73 (14) 76 (12)  6 (-3, 16) -1 (-6, 5) 
   Acylated ghrelin (pg·mL-1) 38.6 (28.9, 51.5) 34.8 (26.1, 46.5)  52.2 (39.1, 69.7) 42.7 (32.0, 57.0)  -22% (-48, 16%) -14% (-22, -5%) c 
   Total peptide YY (pg·mL-1) 90.3 (74.9, 108.9) 94.0 (77.9, 113.3)  88.5 (73.4, 106.7) 88.9 (73.8, 107.2)  4% (-19, 33%) 2% (-8, 14%) 
   Insulin (µU·L-1) 6.5 (5.0, 8.4) 8.0 (6.1, 10.3)  4.8 (3.7, 6.3) 4.2 (3.3, 5.5)  59% (12, 125%) b,d 4% (-11, 21%) d 
   Glucose (mmol·L-1) 5.5 (5.3, 5.8) 5.8 (5.5, 6.1)  5.6 (5.4, 5.9) 5.8 (5.5, 6.0)  0% (-6, 6%) 4% (0, 7%) c 
Values for overall appetite ratings are mean (SD). Values for appetite-related hormones and glucose are geometric mean (95% confidence interval) and statistical 
analyses are based on log-transformed data.  
Data were analysed using linear mixed models with group (South Asian vs white European) and trial (exercise vs control) included as fixed factors.   
a Normally distributed data: 95% confidence interval for the mean absolute difference between the groups or trials; and log transformed data: 95% confidence 
interval for the ratio difference of geometric means between the groups or trials.  
b Main effect of group (P < 0.05). 
c Main effect of trial (P < 0.05). 
d Group-by trial interaction (P = 0.030). 
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Figure 5.2. Overall appetite perceptions in South Asian (n=15) and white European (n=15) men during the control (South Asian -○-; white European -□-) 
and exercise (South Asian -●-; white European -■-) trials. Values are mean (s.e.m.). Black rectangle indicates standardised breakfast, open rectangle 
indicates exercise, and grey rectangle indicates ad libitum buffet meal. aLower in exercise than control trial (trial-by-time interaction, P = 0.004), bHigher 
in exercise than control trial (trial-by-time interaction, P = 0.024), cLower in South Asian than white European men (group-by-time interaction, P = 0.047). 
 
 
a 
b, c 
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Table 5.6. Time averaged total area under the curve for overall appetite, appetite-related hormone and glucose concentrations in South Asian and white 
European men. 
 
 South Asians  (n=15) 
 
White Europeans  
(n=15) 
 White Europeans vs. 
South Asians  
Mean difference 
(95% CIa) 
Control vs. 
Exercise  
Mean difference 
(95% CIa) 
  Control Exercise  Control  Exercise  
Overall appetite 22.8 (4.5) 21.9 (3.9)  23.2 (4.3) 23.4 (4.6)  -0.9 (-3.8, 1.9) -0.4 (-1.8, 1.2) 
Acylated ghrelin (pg·mL-1 h) -5.26 (7.70) -4.27 (5.59)  -5.67 (5.60) -3.52 (5.70)  -0.17 (-4.40, 4.06) 1.57 (-0.35, 3.50) 
Total peptide YY (pg·mL-1 h) 7.80 (6.93) 9.79 (9.58)  6.11 (13.14) 9.80 (8.13)  0.83 (-4.77, 6.44) 2.84 (-1.87, 7.54) 
Insulin (µU·L-1 h) 15.57 (8.19) 15.98 (12.85)  5.81 (2.76) 7.56 (3.95)  9.10 (3.70, 14.50)b 1.08 (-1.47, 3.63) 
Glucose (mmol·L-1 h) 0.27 (0.23) 0.28 (0.28)  0.04 (0.31) 0.19 (0.25)  0.15 (0.02, 0.29)b 0.08 (-0.07, 0.23) 
All values are mean (SD). Data were analysed using linear mixed models. Data for appetite-related hormone and glucose are reported as delta values. 
a 95% confidence interval for the mean absolute difference between the groups or trials. 
b Main effect of group (P < 0.05).
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5.3.6  Plasma concentrations of appetite-related hormones and glucose 
5.3.6.1 Acylated ghrelin 
Fasting acylated ghrelin concentrations were not significantly different between groups (ES = 
0.46; P = 0.211) but were lower in the exercise than the control trial (ES = 0.27, P = 0.006) 
(Table 5.5). Delta acylated ghrelin concentrations are displayed in Figure 5.3 and linear mixed 
models identified a main effect of trial (P = 0.006), time (P < 0.001) and group-by-time 
interaction (P < 0.001). Delta acylated ghrelin concentrations were similar between groups 
(mean difference (95% CI) 0.1 (-9.3, 9.4) pg mL-1, ES = 0.01; P = 0.986) (Figure 5.3) whereas 
absolute acylated ghrelin concentrations were meaningfully, albeit not significantly, lower in 
South Asian than white European men (mean difference (95% CI) -25.5 (-46.3, 3.4) pg mL-1, 
ES = 0.54; P = 0.076) (Table 5.7). The main effect of trial revealed higher delta acylated ghrelin 
in the exercise than in the control trial (mean difference (95% CI) 3.6 (1.1, 6.2) pg mL-1, ES = 
0.18, P = 0.006) (Figure 5.3), whereas absolute acylated ghrelin levels were lower in the 
exercise than in the control trial (main effect of trial; mean difference (95% CI) -10.1 (-14.6, 
5.3) pg mL-1, ES = 0.19, P < 0.001) (Table 5.7).  Post hoc analysis of the group-by-time 
interaction revealed lower delta acylated ghrelin in the South Asian compared with the white 
European men at 4 h (mean difference (95% CI) -18.6 (-29.7, -7.4) pg mL-1, ES = 0.84; P = 
0.001). Likewise, a group-by-time interaction was identified for absolute acylated ghrelin 
concentrations (P = 0.006), with South Asian revealing lower acylated ghrelin at 3 h and 4 h 
than white European men (all ES ≥ 0.75, P ≤ 0.038) (Table 5.7). Time-averaged tAUC for delta 
acylated ghrelin was similar across groups and trials (main effect group ES = 0.03, P = 0.934; 
main effect trial ES = 0.26, P = 0.105; group-by-trial interaction P = 0.539) (Table 5.6). 
5.3.6.2 Total PYY 
Total PYY concentrations at baseline were similar across trials and groups (main effect group 
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P = 0.760, main effect trial P = 0.681, group-by-trial interaction P = 0.749) (Table 5.5). Linear 
mixed models for delta total PYY identified a main effect of trial (P = 0.012), time (P < 0.001) 
but not group (mean difference (95% CI) 2.3 (-10.5, 15.1) pg mL-1, ES = 0.07, P = 0.716) or 
any interaction effects (P ≥ 0.317) (Figure 5.3). The main effect of trial revealed higher delta 
total PYY concentrations in the exercise than in the control trial (mean difference (95% CI) 6.2 
(1.4, 11.0) pg mL-1, ES = 0.19, P = 0.012). Absolute concentrations of total PYY were higher 
in the exercise than in the control trial (main effect of trial; mean difference (95% CI) 5.0 (1.5, 
8.7) pg mL-1, ES = 0.14, P = 0.004) but similar between groups (ES = 0.09, P = 0.756) (Table 
5.7). Time-averaged tAUC for delta total PYY was similar across groups and trials (main effect 
group ES = 0.09, P = 0.763; main effect trial ES = 0.29, P = 0.227; group-by-trial interaction P 
= 0.714) (Table 5.6). 
5.3.6.3 Insulin  
Fasting insulin concentrations were similar between trials (ES = 0.07, P = 0.614) but were 
higher in South Asian than white European men (ES = 0.92, P = 0.011) (Table 5.5). A group-
by-trial interaction (P = 0.030) for fasting insulin revealed higher concentrations in South 
Asians (ratio difference (95% CI) 23 (-1, 52)%, ES = 0.40, P = 0.058) and lower values in white 
Europeans (ratio difference (95% CI) -12 (-29, 9)%, ES = 0.26 , P = 0.220) (Table 5.5) in the 
exercise compared with the control trial. Linear mixed models for delta insulin identified a main 
effect of group (P = 0.003), time (P < 0.001), and group-by-time interaction (P < 0.001) but 
were similar between trials (mean difference (95% CI) 2.6 (-2.1, 7.4) µU L-1, ES = 0.07; P = 
0.276) (Figure 5.3). The main effect of group revealed higher insulin concentrations in South 
Asian than white European men (mean difference (95% CI) 19.8 (7.4, 32.1) µU L-1, ES = 0.54, 
P = 0.003) (Figure 5.3). Post hoc analysis of the group-by-time interaction revealed higher 
insulin concentrations in the South Asian than white European participants at 0.75 h, 2 h, 4.75 
h and 7 h (all ES ≥ 0.57, P ≤ 0.011). Absolute concentrations of insulin were also higher in 
South Asians (main effect of group; mean difference (95% CI) 96.6 (39.7, 177.7) µU L-1, ES = 
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0.63, P < 0.001) (Table 5.7). Particularly, South Asians exhibited greater absolute 
concentrations of insulin at 0h, 0.75h, 2 h, 3h, 4h, 4.75 h and 7 h (group-by-time interaction; all 
ES ≥ 0.65, P ≤ 0.038) (Table 5.7). Time averaged tAUC for delta insulin was higher in South 
Asian than white European men (ES = 1.16, P = 0.002) but similar between trials (ES = 0.12, 
P = 0.393) (Table 5.6). 
5.3.6.4  Glucose 
Fasting glucose concentrations were similar between groups (ES = 0.05; P = 0.869) but were 
higher in the exercise than in the control trial (ES = 0.38, P = 0.043) (Table 5.5). Linear mixed 
models for delta glucose identified a main effect of group (P = 0.027), trial (P = 0.052), time 
(P < 0.001), group-by-time (P = 0.008), and trial-by-time (P = 0.011) interactions (Figure 5.3). 
Delta glucose concentrations were higher in South Asian than white European men (mean 
difference (95% CI) 0.35 (0.04, 0.65) mmol L-1, ES = 0.27, P = 0.027) and higher in the exercise 
trial than the control trial (mean difference (95% CI) 0.19 (-0.001, 0.38) mmol L-1, ES = 0.15, 
P = 0.052) (Figure 5.3). Post hoc analysis of the group-by-time interaction revealed higher delta 
glucose in South Asians than white Europeans at 0.75 h and 2 h (both ES ≥ 0.72, P = 0.001) 
whereas post hoc analysis of the trial-by-time interaction revealed higher delta glucose in the 
exercise than in the control trial at 3 h and 4.75 h (both ES ≥ 0.60, P ≤ 0.039). Absolute glucose 
concentrations were also higher in the South Asian than white European men at 0.75h and 2h 
(group-by-time interaction; all ES ≥ 0.67, P ≤ 0.008), and in the exercise than in the control 
trial (mean difference (95% CI) 6.6 (3.7, 9.5) mmol L-1, ES = 0.31, P < 0.001), particularly at 
3h, 4.75h and 7h (trial-by-time interaction; all ES ≥ 0.55, P ≤ 0.038) (Table 5.7). Time-averaged 
tAUC for delta glucose was higher in South Asian than white European men (ES = 0.55, P = 
0.024) but similar between trials (ES = 0.28, P = 0.297) (Table 5.6). 
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5.3.7  Correlations 
Age was positively associated with fasting insulin in South Asian (r = 0.520, P = 0.047) and 
with time averaged tAUC for insulin in white European men (r = 0.714, P = 0.003) (Table 5.7). 
There were no other significant correlations between the various predictors and baseline or 
exercise-induced changes in tAUC values for acylated ghrelin and total PYY (P ≥ 0.089). Total 
carbohydrate oxidation during exercise was positively associated with absolute energy intake 
at the subsequent buffet meal in South Asian (r = 0.722, P = 0.002) but not in white European 
men (r = 0.240, P = 0.409). 
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Figure 5.3. Plasma concentrations of (a) delta acylated ghrelin (top panel), (b) delta total PYY (bottom panel), (c) delta insulin (top panel) and (d) delta 
glucose (bottom panel) in South Asian (n=15) and white European (n=15) men during the control (South Asian -○-; white European -□-) and exercise (South 
Asian -●-; white European -■-) trials. Values are mean (s.e.m.). Black rectangle indicates standardized breakfast, open rectangle indicates exercise, and 
grey rectangle indicates ad libitum buffet meal. aLower in South Asian than white European men (group-by-time interaction, P = 0.001), bHigher in South 
Asian than white European men (group-by-time interaction, all P ≤ 0.011), cHigher in exercise than control trial (trial-by-time interaction, P ≤ 0.039).  
   
a 
b 
b 
b 
b 
b 
b 
c 
c 
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Table 5.7: Plasma Absolute concentrations of appetite-related hormone and glucose in South Asian and white European men during the control and exercise trial. 
 South Asians  (n=15) 
 
White Europeans  
(n=15) 
 
White Europeans vs. 
South Asians 
Mean difference 
(95% CIa) 
 
Control vs. Exercise  
Mean difference 
(95% CIa)  Control Exercise  Control  Exercise  
   Acylated ghrelin (pg·mL-1) 28.9 (22.9,36.6) 26.4 (20.9. 33.4)  39.4 (31.2, 49.8) 34.9 (27.6, 44.2)  -25.5% (-46.3, 3.4%)d -10.1% (-14.6, -5.3%)c 
   Total peptide YY (pg·mL-1) 107.6 (93.1, 124.2) 115.4 (99.9, 133.2)  106.5 (92.2, 123.0) 109.5 (94.8, 126.5)  3.1% (-15.6, 26.1%) 5.0% (1.5, 8.7%)c 
   Insulin (µU·L-1) 23.5 (18.3, 30.3) 25.2 (19.6, 32.4)  11.6 (9.1, 14.9) 13.2 (10.3, 16.9)  96.6% (39.7, 177.0%)b,d 10.2% (0.2, 21.2%)c 
   Glucose (mmol·L-1) 6.0 (5.7, 6.4) 6.3 (6.0, 6.7)  5.6 (5.3, 5.9) 6.1 (5.7, 6.4)  5.8% (-1.6, 13.8%)d 6.6% (3.7, 9.5%)c,e 
All values are geometric mean (95% confidence interval) and statistical analyses are based on log-transformed data. 
Data were analysed using linear mixed models with group (South Asian vs white European), trial (exercise vs control) and time (7 h trial) included as 
fixed factors.   
a95% confidence interval for the ratio difference of geometric means between the groups or trials. 
bMain effect of group (P < 0.05). 
cMain effect of trial (P < 0.05). 
dGroup-by time interaction (P < 0.05). 
eTrial-by time interaction (P < 0.05). 
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Table 5.8. Ethnicity-specific Spearman’s correlation coefficients between the various predictors and appetite-related hormones. 
          Fasting                          Delta AUC                        Fasting                         Delta AUC                         Fasting                        Delta AUC       acylated ghrelin              acylated ghrelin                  total PYY                       total PYY                           insulin                            insulin 
 South Asian 
White 
European 
South 
Asian 
White 
European 
South 
Asian 
White 
European 
South 
Asian 
White 
European 
South 
Asian 
White 
European 
South 
Asian 
White 
European 
Age 0.21 0.19 -0.061 -0.19 -0.14 0.22 -0.45 -0.24 0.52a 0.04 0.22 0.03 
Body fat -0.27 0.27 -0.025 0.375 0.25 0.24 -0.28 0.27 0.19 0.30 0.26 0.71a 
V̇O2 max 0.05 0.01 -0.11 -0.24 -0.05 0.01 0.38 0.08 -0.20 -0.02 0.14 0.11 
Baseline appetite 0.41 -0.45 0.36 0.36 -0.01 -0.31 0.06 0.21 -0.26 -0.14 -0.01 0.05 
AUC appetite -0.03 0.34 -0.12 -0.29 0.23 0.17 0.18 -0.32 -0.41 0.25 -0.28 0.26 
   AUC, area under the curve; V̇O2 max, maximum oxygen uptake; MVPA moderate-to-vigorous physical activity 
    a P < 0.05  
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5.4 Discussion 
The primary finding of this study was that appetite perceptions, energy intake and 
appetite-related hormones in response to acute exercise were similar between South 
Asians and white European men. However, subtle differences in appetite-measures 
between the groups were detected with South Asian men exhibiting lower: (1) appetite 
perceptions 2 hours after the buffet meal; (2) delta acylated ghrelin concentrations at 4 h; 
and (3) carbohydrate ingestion at the buffet in response to exercise. Furthermore, 60 min 
of moderate-to-vigorous intensity cycling increased concentrations of delta acylated 
ghrelin and total PYY and induced subtle changes in appetite perceptions such as 
transient suppression in appetite perceptions at 4.5 h and stimulation at 6.5 h, without 
provoking energy compensation in South Asian and white European men. Overall, these 
findings demonstrate that exercise induces an energy deficit irrespective of ethnicity and 
suggest similar exercise-induced responses in appetite perceptions and appetite-related 
hormones between South Asian and white European men. 
To the authors’ knowledge, the present study is the first to compare acute exercise effects 
on appetite responses between healthy South Asian and white European men. Our results 
demonstrate that subjective feelings of appetite were similar between the ethnic groups 
in response to 60 min moderate-to-vigorous cycling. However, a subtle difference in 
appetite perceptions between ethnicities was detected at 2 h after the ad libitum buffet 
meal with South Asians exhibiting lower appetite ratings than white European men across 
both trials. Although this represents a subtle difference in appetite feelings between 
groups, this difference may be the result of the greater appetite feelings in white European 
participants due to their greater net energy expenditure during exercise. Compared with 
the control trial, subtle differences in appetite perceptions including a transient appetite 
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suppression at 4.5 h (1.5 h post-exercise) and stimulation at 6.5 h (3.5 h post-exercise) 
were observed with exercise in both ethnic groups. Existing evidence suggests transient 
appetite suppressions during and immediately after moderate-to-high intensity exercise, 
which typically returns to resting control values within 30 to 60 min of exercise cessation 
(Broom et al. 2007; Becker et al. 2012; Martins et al. 2007; Douglas et al. 2017). In most 
of these studies, however, exercise was performed following an overnight fast whereas 
studies investigating appetite feelings in response to postprandial exercise revealed a 
prolonged and more substantial appetite suppression after exercise compared with the 
fasted exercise and control trial (Deighton et al. 2012; Cheng et al. 2009). In this regard, 
Cheng et al. (2009) demonstrated that cycling for 50 min at 60% of V̇O2 max 2 h after a 
standardised meal suppressed appetite feelings for a longer period of time than 
performing the same exercise after an overnight fast. Likewise, Deighton et al. (2012) 
demonstrated that running for 60 min at 70% of V̇O2 max approximately 2 h after a 
standardised breakfast also prolonged appetite suppression than performing the exercise 
trial after an overnight fast. Therefore, it is plausible that the transient appetite 
suppression at 4.5 h (1.5 h post-exercise) in the exercise than control trial in our study 
reflects the prolonged appetite suppression effects induced by exercise performed 
postprandially. In contrast, the transient appetite stimulation at 6.5 h (3.5 h post-exercise), 
may relate to the extra energy expended during the exercise.   
The present study investigated differences in circulating acylated ghrelin in South Asian 
and white European individuals in response to exercise. Although the mechanisms 
underlying appetite responses to exercise are still unclear, previous studies suggest that 
suppression of circulating acylated ghrelin concentrations during exercise, with 
perturbations typically returning to control values within 30 min, may contribute to the 
acute exercise-induced appetite suppression (Deighton and Stensel, 2014). In the present 
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study, however, delta acylated ghrelin was not decreased during or immediately after 
exercise which may be explained by the timing of exercise after the standardised 
breakfast given that at 2 h acylated ghrelin values were still lower than baseline and this 
may have influenced the response of this gut hormone during exercise. Furthermore, the 
present study revealed greater delta acylated ghrelin concentrations in the exercise 
compared with the control trial which differs from previous studies reporting lower or no 
change in absolute or delta acylated ghrelin concentrations during or shortly after 
exercise (Broom et al. 2017; Wasse et al. 2013; Deighton et al. 2013a). This disparity, 
however, is most likely induced by the elevated fasting (baseline) acylated ghrelin 
concentrations in the control than in the exercise trial, and by the method used to 
represent the data (delta change instead of absolute concentrations). Indeed, normalising 
the acylated ghrelin values across the 7 h for the baseline levels (delta) resulted in a 
downwards shift of the control values, particularly after both meals, which accentuated 
the difference in delta acylated ghrelin across 7 h between trials.  In support of this, the 
examination of the absolute data revealed lower absolute acylated ghrelin concentrations 
over the 7 h trial in the exercise than in the control trial, which seems to reflect the lower 
fasting (baseline) acylated ghrelin in the exercise than in the control trial. In this regard, 
although individual variability in fasting acylated ghrelin concentrations has been 
previously reported (Larson-Meyer et al. 2012), it remains unknown how baseline 
concentrations were different between trials. 
The present study also examined differences in acylated ghrelin between South Asian 
and white European men. Preliminary evidence from our laboratory reported lower 
fasting acylated ghrelin concentrations in South Asian than white European men at rest 
(Study 1, Chapter 3), whereas in the present study fasting values were not statistically 
different between groups, although values were visibly lower in South Asian than white 
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Europeans. In our previous research South Asians exhibited an elevated adiposity than 
white European men and the ethnic group difference in fasting acylated ghrelin levels 
was mitigated after controlling for body fat percentage.  Conversely, in the present study 
body fat percentage did not differ significantly between groups which may explain why 
fasting acylated ghrelin levels were not statistically lower in South Asian compared to 
white European participants. Delta acylated ghrelin concentrations were similar between 
ethnic groups suggesting no differences in this gut peptide across both trials between 
South Asian and white European men. However, it is possible that these data also result 
from the use of delta change to represent the data as the absolute data revealed a 
meaningfully, albeit not significant, lower acylated ghrelin concentrations in South Asian 
than white European men across both trials. The different results of the absolute data 
compared with the delta values, however, may reflect the tendency for resting acylated 
ghrelin concentration to be lower in South Asians than white Europeans at baseline 
(fasting), which influenced the absolute concentrations throughout the trials. Indeed, 
normalising the acylated ghrelin values throughout for the baseline (delta), shifted the 
curves down for the white European, due to their higher fasting values, more than for the 
South Asian group. Furthermore, the grater meal induced suppression particularly after 
breakfast (0.75 h) was cancelled out by the greater elevation before the buffet meal (4 h) 
in white European men, resulting in similar mean delta acylated ghrelin concentrations 
across the 7 h trial between groups, thus no main effect of ethnicity for delta values. The 
lower concentration of delta acylated ghrelin in South Asian men observed before the ad 
libitum buffet meal, in line with the absolute data, represents an important finding of the 
present study. Based on previous studies, insulin resistance and compensatory 
hyperinsulinemia are shown to be inversely associated with acylated ghrelin 
concentration, independently of BMI and adiposity (Flanagan et al. 2003; McLaughlin et 
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al. 2004; Becker et al. 2012; Hazell et al. 2015). In this study, South Asians exhibited 
higher fasting insulin and elevated postprandial glucose and insulin concentrations 
compared with BMI-matched white European men, which are indicative of a greater 
degree of insulin resistance. Therefore, it is plausible that the different levels of acylated 
ghrelin before the buffet meal in this study reflects the insulin resistance phenotype in 
South Asians (Sattar and Gill, 2015). Furthermore, the inversely association between 
insulin and acylated ghrelin concentrations irrespective of adiposity, would support the 
trend of lower fasting acylated ghrelin in South Asian than white European men with 
similar body fat percentage observed in the present study. 
It is well-established that South Asian individuals are more insulin resistant than white 
Europeans which has been linked to their greater percent body fat (Sattar and Gill, 2015; 
Gholap et al. 2011). However, it has been suggested that the greater insulin resistance in 
South Asians is only partly explained by differences in adiposity with studies showing 
greater fasting or postprandial insulin in South Asians even after adjustment for adiposity 
(Ghouri et al. 2013; Sattar and Gill, 2015; Chandalia et al. 1999). This is in agreement 
with our findings where South Asians exhibited higher fasting insulin and elevated 
glucose and insulin post-prandial despite having similar levels of body fat than white 
European men. There is evidence that exercise-related factors such as low levels of 
physical activity and cardiorespiratory fitness and reduced capacity for fat oxidation 
during exercise are key features of the insulin resistance phenotype in South Asians (Afaq 
et al. 2019; Biddle et al. 2019; Ghouri et al. 2013; Yates et al. 2018; Hall et al. 2010). 
Specifically, Hall and colleagues (2010) demonstrated positive associations of 
cardiorespiratory fitness and fat oxidation during submaximal exercise with insulin 
sensitivity index in South Asian men (Hall et al. 2010). Additionally, in the same study 
the lower insulin sensitivity index in South Asians than white European participants was 
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abolished after adjusting for cardiorespiratory fitness and fat oxidation during exercise, 
although the mechanisms explaining the lower capacity for fat oxidation in South Asians 
and how this relates to their insulin resistance remain unclear. Regardless of the 
mechanisms, the reduced cardiorespiratory fitness and fat oxidation during exercise in 
South Asians in this study supports previous work regarding the differential 
cardiorespiratory fitness and capacity for fat oxidation during exercise between South 
Asians and white European men. 
Concentrations of fasting total PYY and across the 7 h trial were similar between South 
Asian and white European men supporting our previous findings (Benedetti et al. 2019). 
Furthermore, in agreement with previous investigations, delta PYY concentrations were 
greater in the exercise than in the control trial (Martins et al. 2007; Kawano et al. 2013; 
Douglas et al. 2017), over the 7 h trial. In this study the greater delta total PYY in the 
exercise compared with the control trial appears to be driven by the increase of total PYY 
after the exercise bout and the ad libitum buffet meal, although we did not identify any 
exercise by time effect. Considering previous studies reporting increase in total PYY 
concentrations concomitantly with a reduction in hunger (Douglas et al. 2017), it is 
possible that the increase in total PYY concentrations contributed to the appetite 
suppression observed in this study immediately after the buffet meal, although 
perturbations in PYY appear to not explain the transient appetite stimulation at 6.5 h,	
since PYY did not change at this time point. However, it warrants mention that other 
satiating hormones as well as physiological factors not examined in the present study, 
mediate exercise-induced appetite responses (Hussain and Bloom, 2013) which may 
contribute to explain the transient appetite changes observed in the present study. 
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An important consideration in the context of the benefits of physical activity for the 
management of weight and fat loss concerns subsequent energy intake response. For 
weight/fat loss to occur, a sustained negative energy balance is required, and the majority 
of previous evidence has demonstrated no energy compensation in response to an acute 
bout of exercise during the following meal (Deighton et al. 2014; Alajmi et al. 2015; 
Douglas et al. 2017). In agreement with this, in the present study South Asian and white 
European participants did not exhibit exercise-induced changes in absolute energy intake 
at the ad libitum meal, whereas relative energy intake was lower after exercise. Taken 
together, these data suggest that exercise induces a short-term energy deficit in South 
Asian and white European men. However, our finding that carbohydrate intake after 
exercise was reduced in South Asian men and increased in white European men is 
intriguing. Although this difference may be merely related to the lower net energy 
expenditure over the 60 min cycling in South Asian than white European men, previous 
evidence demonstrated a positive association between carbohydrate oxidation during 
exercise and energy intake at a test meal provided 60 min after a bout of cycling 
performed at 70% of maximum heart rate (Hopkins et al. 2014). In agreement with these 
findings, we identified a strong positive association, in South Asian but not in white 
European men, between total carbohydrate oxidation during exercise and absolute energy 
intake at subsequent the buffet meal. Therefore, the lower carbohydrate oxidation in 
South Asian men during exercise may be speculatively linked with lower glycogen 
depletion which elicited a lower compensatory drive to ingest food and restore glycogen 
stores at the buffet meal. The present study also revealed lower absolute energy intake 
across both trials in South Asian than white European men which may be explained by 
the ethnic differences in fat free mass. Specifically, in the present study South Asian 
exhibited a lower fat free mass (also known as lean body mass) than white European men 
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which is in agreement with previous data (Hall. et al. 2010; Ghouri et al. 2013; Sattar and 
Gill; 2015). Furthermore, several studies have shown that fat free mass is an important 
determinant of resting metabolic rate, daily energy expenditure and day-to-day food 
intake (Blundell et al. 2011; Weise et al. 2013; Hopkins et al. 2017). In this regard, Weise 
et al. (2013) demonstrated that ad libitum energy intake (measured objectively in a 
laboratory environment) were positively associated with fat free mass in lean and obese 
individuals. These data were in line with those by Blundell et al. (2011), who reported 
that self-selected meal size and total daily energy intake were positively correlated with 
lean body mass in overweight and obese individuals. Thus, it is possible that the lower 
absolute energy intake in South Asian men in our study may reflect their lower fat free 
mass which induced a lower drive to ingest food at the buffet meal than white European 
counterpart. 
Although this research provides novel findings on the effects of exercise on appetite 
regulation and food intake in healthy South Asian men compared with white European 
men, a limitation of this study is that acylated ghrelin and total PYY were the only gut 
hormones related to appetite examined. Thus, additional gut hormones should be 
considered for further research comparing exercise-induced appetite responses in South 
Asian and white European individuals. Secondly, the timing of the exercise 2 h after the 
standardised breakfast may have influenced acylated ghrelin responses as the 
concentrations of this hormone was still lower than the fasting values at the start of 
exercise. Lastly, the population sample was mostly limited to South Asian men 
originating from India and Pakistan, therefore, further investigations are required in other 
South Asian groups (e.g., Bangladeshis, Sri Lankan, Nepalese and Bhutanese) and in 
South Asian and white European women.  
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In conclusion, overall a single bout of acute moderate-to-vigorous intensity exercise 
induced similar appetite responses between South Asian and white European men 
although some subtle differences were observed where South Asians exhibited lower 
appetite feelings 2 h after the buffet meal and lower levels of delta acylated ghrelin before 
the buffet meal compared with white European men. Furthermore, exercise did not 
provoke any compensatory changes in energy intake in both groups on the day of 
exercise. These findings provide evidence that acute exercise induces a short-term energy 
deficit irrespective of ethnicity and suggest similar exercise-induced responses in 
appetite perceptions and appetite-related hormones between South Asian and white 
European men. 
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Chapter 6 – General discussion 
 
This final chapter aims to integrate and discuss the main findings of the studies presented 
in this thesis. Previous research suggests that South Asians have an elevated risk of CVD 
and T2D than white European individuals, which has been associated to the higher 
prevalence of different risk factors including greater adiposity, insulin resistance or 
dyslipidaemia (Gholap et al. 2011; Khunti et al. 2013).  However, these traditional risk 
factors have been reported to not fully explain the elevated risk of CVD and T2D in South 
Asian compared with white European individuals (Forouhi et al. 2006). Therefore, this 
thesis investigated ethnic differences in traditional and unconventional CVD and T2D 
risk markers such as CRP, IL-6, leptin, FFAs as well as appetite-related hormones in 
relation to physical activity/cardiorespiratory fitness and compared appetite measures in 
response to acute exercise in South Asian and white European men. 
6.1 Acylated ghrelin and total PYY 
Ethnic differences in the short-term regulation of appetite and energy intake may underlie 
the well-established elevated adiposity and associated in South Asian than white 
European men. In this regard, the first Study 1 (Chapter 3) revealed lower fasting acylated 
ghrelin concentrations in the South Asian compared with the white European group, 
which represents a novel finding of this study. Although the reason for this finding is 
unclear, it may be linked to the ethnic group differences in adiposity observed. In this 
regard, previous research has demonstrated that individuals with obesity exhibit lower 
circulating concentrations of fasting ghrelin compared with lean individuals (Le Roux et 
al. 2005). Although our findings only revealed a large inverse correlation between body 
fat percentage and acylated ghrelin in the white European men, the ethnic group 
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difference in fasting acylated ghrelin concentrations was mitigated after controlling for 
body fat percentage. Therefore, it was suggested that the lower acylated ghrelin 
concentration in the South Asian men may be associated to the higher body fat levels 
observed in this group. The findings from Study 3 (Chapter 5) appear to support these 
results, where concentrations of fasting acylated ghrelin were not statistically different 
between South Asian and white European men, with both groups exhibiting similar 
percentage of body fat. Thus, it is plausible that ethnic differences in fasting 
concentrations of this gut hormone observed in Study 1 (Chapter 3) may reflect the 
differences in adiposity between ethnic groups. This thesis also examined ethnic 
differences in plasma total PYY between South Asian and white European men. Despite 
the between-group differences in acylated ghrelin in Study 1 (Chapter 3), the same study 
did not reveal significant differences in fasting total PYY and this finding was supported 
in Study 3 (Chapter 5), suggesting no ethnic-differences in concentrations of this gut 
peptide.  
However, whereas the mechanisms explaining the fluctuation of ghrelin concentrations 
related to changes in body weight/fat remain unclear,	 there is evidence showing that 
decreased ghrelin levels observed in obesity may be related more to insulin resistance 
than to higher BMI or fat mass (Flanagan et al. 2003; McLaughlin et al. 2004). In this 
regard, McLaughlin and colleagues (2004) demonstrated lower ghrelin concentrations in 
the obese insulin-resistant group compared with the obese insulin-sensitive group 
(McLaughlin et al. 2004). Additionally, the same study exhibited negative correlations 
of ghrelin with insulin resistance and insulin concentrations, with these data suggesting 
that insulin resistance and hyperinsulinemia may be associated with ghrelin suppression 
independently of adiposity (McLaughlin et al. 2004). In line with this, Study 1 (Chapter 
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3) revealed elevated fasting insulin in South Asian than white European participants, 
which may have contributed to the lower acylated ghrelin in the South Asian group.  
6.2  Glucose and insulin  
Study 1 (Chapter 3) also revealed higher glucose and insulin OGTT concentrations in 
South Asian than white European men, supporting previous research (Gholap et al. 2011; 
Tziomalos et al. 2008; Peters et al 2013). These differences are indicative of a greater 
degree of insulin resistance and were further supported by the higher HOMA-IR and 
lower insulin sensitivity index observed in Study 1 (Chapter 3) in the South Asian 
participants. One factor suggested to contribute to the excess insulin resistance in South 
Asian individuals represents their greater total/abdominal adiposity and lower lean mass 
compared with white Europeans (Sattar and Gill, 2015). In support of this, the findings 
of Study 1 (Chapter 3), revealed higher levels of body fat and lower lean body mass for 
a given BMI compared with white European individuals (Lear et al. 2007). However, the 
greater insulin resistance in South Asians may persist after adjustment for total and 
abdominal adiposity (Sattar and Gill, 2015), as shown in study 1 (Chapter 3) where 
insulin sensitivity index and insulin OGTT remained significantly higher in South Asian 
than white European participants after controlling for body fat percentage. This was also 
demonstrated in Study 3 (Chapter 5) where South Asians exhibited markedly higher 
fasting insulin and elevated glucose and insulin post-prandial concentrations despite 
having similar levels of body fat than white European men. 
6.3  Leptin 
Discriminating only for total and abdominal adipose tissue may hide other factors 
intrinsic of the adipose tissue in South Asian individuals. Particularly, previous evidence 
suggests greater fat accumulation in the deep subcutaneous adipose tissue (DSAT) and 
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visceral adipose tissue (VAT) in South Asians, which has been linked with insulin 
resistance and associated adverse metabolic effects (Sniderman et al. 2007). Furthermore, 
South Asians exhibit dysfunctional adipocytes characterised by defect in adipose tissue 
cells maturation and hypertrophic adipocytes compared with white Europeans, which has 
been associated with greater risk of insulin resistance and T2D (Sniderman et al. 2007; 
Bakker at al. 2013; Sattar and Gill, 2015). Dysfunctional adipocytes have also been 
related to greater levels of plasma leptin in South Asians than Caucasians, independent 
of total and abdominal adiposity (Bakker et al. 2013; Abate et al. 2004; Chandalia et al. 
2007). In support of this, in Study 1 (Chapter 3) we demonstrated substantial elevated 
fasting concentrations of plasma leptin in South Asian compared with white European 
men, with the between-group difference in leptin level diminishing, but not eliminated 
completely, after controlling for body fat percentage. Additionally, according to previous 
evidence, hyperinsulinemia may induce an increase in leptin levels suggesting that 
insulin resistance and higher concentrations of insulin may have a role in promoting 
hyperleptinemia (Wang et al. 1999). While the mechanisms explaining the link between 
hyperleptinemia and insulin resistance is not completely understood, it is plausible that 
the elevated insulin concentrations observed In Study 1 (Chapter 3) may have contributed 
to the higher leptin concentrations in the South Asian compared with the white European 
group. Consequently, it is possible that irregularities in adipose tissue metabolism 
concomitant with insulin resistance may exacerbate the CVD and T2D risk in South 
Asians. 
6.4  Free fatty acids 
Dysfunctions in adipose tissue metabolism have been also associated with elevated 
concentrations of FFAs in South Asian compared with white European individuals, 
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which has been proposed to be an important link between adipose tissue and skeletal 
muscle/liver insulin resistance in the South Asian population (Abate et al. 2004; 
Chandalia et al. 2007). Particularly, high levels of circulating FFAs may cause a chronic 
supply of lipids to skeletal muscle leading to an accumulation of intramuscular 
triglyceride and fatty acids metabolites, which inhibit insulin action (Hall et al. 2008). 
Nonetheless, not all FFAs contribute equally to the development of insulin resistance 
(Rasic-Milutinovic et al. 2012) and metabolomics analytical methods represent the most 
advanced and frequently used techniques for the identification and quantification of 
individual metabolites such as FFAs in human plasma (Patti et al. 2012). Although the 
initial results based on the GC-MS method were unsatisfactory, probably due to the 
inadequacy of the capillary column used in our experiments, we could separate the 
majority of the South Asian from most of the white European men based on the LC-MS 
method. To the author’s knowledge, only one previous study examined ethnic differences 
in individual FFAs concentrations (Ralston et al. 2013). However, the study from Ralston 
and co-workers focused mainly on ethnic-specific associations between individual 
plasma FFAs and markers of insulin resistance, without explicitly examining ethnic 
differences in the baseline concentrations of FFAs (Ralston et al. 2013). Study 2 (Chapter 
4) investigated ethnic differences in the FFAs metabolic profile with LC-MS and 
revealed higher concentrations of five FFAs (laurate, myristate, palmitate, γ-linolenic and 
linoleate) in the South Asian group. Given that insulin resistant individuals typically 
exhibit higher levels of SFAs and low concentrations of PUFAs such as linoleic acid, γ-
linolenic acid or EPA and DHA (Warensjö et al. 2005), it was surprising that baseline 
concentrations of γ-linolenic and linoleic acid were higher in the South Asian group, who 
exhibited greater levels of fasting insulin and elevated glucose and insulin OGTT than 
white European participants. However, our findings appear to support the data from 
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Ralston and colleagues (2013) where elevated γ-linolenic and linoleic acid were observed 
in the South Asian compared with the Caucasian group. Study 2 (Chapter 4) also 
demonstrated positive associations between AUC glucose and four FFAs such as 
palmitate, oleate, eicosatrienoic and docosahexenoic acid in South Asian participants. 
The association between AUC glucose and oleate, eicosatrienoic and docosahexenoic 
acid appears to be in contrast with previous epidemiological evidence reporting positive 
effects of these unsaturated fatty acids on insulin sensitivity (Warensjö et al. 2005). 
Conversely, the association between palmitate and AUC glucose confirms previous 
studies reporting saturated fatty acids-induced insulin resistance, although this evidence 
is not related directly to South Asian populations (Ebbeson et al. 2010). The present study 
also revealed a strong correlation of FFAs with body fat percentage in the South Asian 
group and between FFAs and physical activity in the white European group. Whereas the 
associations of FFAs with body fat percentage in South Asians may simply reflect their 
greater body fat percentage, ethnic differences in factors involved in myocellular lipid 
mobilisation may underlie these responses. South Asians exhibit higher perilipin 5 
(PLIN-5), a lipid droplet-associated protein in skeletal muscle, in response to a 5-day 
high fat diet compared with Caucasian males (Gemmink et al. 2017). Perilipin 5 plays a 
key role in the activation of the adipose triacylglycerol lipase (ATGL), which is involved 
in the intracellular triglyceride mobilisation (Schreiber et al. 2018). Thus, it may be 
possible that in our study ethnic differences in ATGL/PLIN-5-induced lipolysis may 
have contributed to the higher levels of FFAs linked to body fat in the South Asian group. 
Conversely, the associations between FFAs and total step counts in the white European 
group only seems to suggest that fatty acid metabolism is less responsive to physical 
activity in South Asian than white European men. These data may reflect the fact that the 
FFAs release is also promoted by the hormone sensitive lipase (HSL), which responds to 
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corticosteroids and catecholamine release (Schreiber et al. 2018). Thus, ethnic 
differences in levels of hormones controlling HSL activation may have influenced these 
results.  
Although the current study provided evidence that levels of circulating FFAs are different 
between South Asians and white European men, the potentially confounding effects of 
body fat percentage may have accentuated the differences in FFAs between ethnic 
groups. Thus, it may be beneficial for future research to investigate FFAs metabolic 
profile in South Asian and white European individuals matched by body fat percentage. 
Furthermore, investigating FFAs in response to exercise and/or food intake and explore 
how these responses correlate with cardiometabolic risk markers may elucidate the role 
of exercise and energy intake in modulating individual plasma FFAs concentrations and 
in optimising health outcomes in South Asians. 
6.5 Inflammatory and lipid markers 
The present thesis also measured circulating concentrations of fasting IL-6 and CRP 
which represent key indicators of chronic low-grade inflammation and have been 
implicated in explaining the excess CHD risk in South Asian individuals (Tziomalos et 
al. 2008). Particularly, in Study 1 (Chapter) we demonstrated elevated fasting IL-6 and 
CRP concentration in South Asian compared with white European men which supports 
several previous studies (Anand et al. 2004; Arjunan et al. 2015; Bastard et al. 1999), 
although this finding is not universal (Peters et al. 2013). The divergent inflammatory 
profiles between ethnicities in the present study were diminished after controlling for 
body fat percentage supporting previous findings (Chambers et al. 2001; Arjunan et al. 
2015) although South Asian individuals have shown to exhibit higher CRP 
concentrations than Caucasians despite similar levels of body fat (Chandalia et al. 2003). 
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Thus, future work is required to determine the independent contribution of ethnicity and 
adiposity on inflammatory markers in South Asians. Consistent with previous studies 
(Arjunan et al. 2013; Anand et al. 2004; Anand et al. 2000), in Study 1 (Chapter 3) we 
also demonstrated a more unfavourable fasted lipid profile in South Asians compared 
with the white European men including lower concentrations of HDL-C coupled with an 
elevated TC/HDL-C ratio and higher TAG concentration. These findings highlight that 
South Asian men exhibit an adverse inflammatory and lipid marker profile, which may 
contribute to the their heightened cardiometabolic health risk compared with individuals 
of white European descent.  
6.6  Physical activity and cardiorespiratory fitness 
Several studies conducted in UK South Asians reveal lower levels of physical activity 
than their white European counterparts, which is likely to contribute to the excess T2D 
and CHD risk in this population (Fischbacher et al. 2004; Williams et al. 2011a; Williams 
et al. 2011b). The existing evidence on habitual physical activity levels in South Asians 
has largely been gleaned from self-report questionnaires which carries a limitation due 
to issues of participant recall bias (Yates et al. 2015; Williams et al 2011a), but data using 
accelerometry are emerging (Celis-Morales et al. 2013; Afaq et al. 2019; Ghouri et al. 
2013; Iliodromiti et al. 2016). In Study 1 (Chapter 3), we reported similar physical 
activity levels between South Asian and white European men using an accelerometery 
device, which represents a strength of this study. Although these findings appear to 
contradict the aforementioned studies, the South Asian participants accumulated less 
total activity (CPM) and fewer steps, and stark differences in CVD and T2D risk markers 
were still apparent between the ethnic groups. This is supported by previous studies 
suggesting that South Asian individuals are more insulin resistant than white European 
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individuals even after adjustment for habitual physical activity levels (Ghouri et al. 
2013).  
A contributing factor that may relate to ethnic differences in cardiometabolic risk is the 
association between physical activity and cardiorespiratory fitness. Increasing evidence 
suggests that South Asians have lower cardiovascular fitness levels compared white 
European people, which has been suggested to be a key feature of the insulin resistance 
phenotype in this ethnic group independent of physical activity levels (Hall et al. 2010; 
Ghouri et al. 2010; Arjunan et al. 2013; Arjunan et al. 2015). In support of this, despite 
the similar levels of objectively-measured physical activity between the groups, in Study 
1 (Chapter 3) we demonstrated markedly lower cardiorespiratory fitness in South Asian 
compared with white European participants. Similar data were observed in study 3 
(Chapter 5) with South Asians exhibiting lower cardiorespiratory fitness than white 
European participants despite similar self-reported habitual physical activity levels and 
sitting time between ethnic groups. However, the reasons explaining the lower 
cardiorespiratory fitness in South Asians are not completely understood. In addition, it 
has been demonstrated that low cardiorespiratory fitness was the strongest predictor of 
the excess insulin resistance seen in UK South Asian compared with white European men 
(Ghouri et al. 2013), although the findings reported in Study 1 (Chapter 3) only revealed 
a positive association between V̇O2 max and insulin sensitivity index in the white 
European men. Low skeletal muscle fat oxidation may also exacerbate insulin resistance 
in South Asian individuals. Indeed, there is evidence demonstrating positive associations 
of cardiorespiratory fitness – an index of oxidative capacity at the whole-body level – 
and fat oxidation during submaximal exercise with insulin sensitivity index in South 
Asian men (Hall et al. 2010). In the same study the lower insulin sensitivity index in 
South Asian than white European participants was abolished after adjusting for 
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cardiorespiratory fitness and fat oxidation during exercise. Low lipid oxidation in skeletal 
muscle may lead to an accumulation of intramuscular lipids, which inhibit insulin action 
(Hall et al. 2008). Although the mechanisms explaining the lower capacity for fat 
oxidation in South Asians and how this relates to their insulin resistance remain unclear, 
the reduced cardiorespiratory fitness and fat oxidation during exercise observed in South 
Asians in Study 3 (Chapter 5) supports the findings from Hall et al. (2010). Given the 
importance of physical activity as a method of enhancing cardiovascular fitness levels, 
our findings add further weight to the proposition that there may be a requirement for 
South Asians to engage in greater physical activity levels than white Europeans to 
optimise health outcomes.  
6.7 Exercise and appetite  
Physical activity has been also proposed as an effective strategy in the management of 
obesity and weight control with a growing interest by the research community in 
examining the underlying mechanisms linking physical activity, appetite and weight 
management. A plethora of studies have investigated the appetite and energy intake 
responses during and after acute bouts of continuous aerobic exercise (50-70% V̇O2 max, 
30-90 min). In this regard, the majority of these studies have shown a transient 
suppression of appetite perceptions during exercise, known as ‘exercise-induced 
anorexia’, with appetite feelings typically return to resting control values within 30-60 
min of exercise termination (Deighton and Stensel, 2014). Furthermore, single sessions 
of exercise have consistently shown to reduce orexigenic hormone acylated ghrelin 
concentrations and increase levels of anorexigenic appetite-related hormones such as 
total PYY, without stimulating subsequent changes in absolute energy intakes (Shubert 
et al. 2013). However, it remains unknown to date how differences in individual ethnicity 
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background modulate appetite perceptions, energy intake and appetite-related hormones 
in response to exercise, which seems relevant and may extend findings from Study 1, 
since lower levels of fasting acylated ghrelin were found at rest (Chapter 3). In study 3 
(Chapter 5), we demonstrated similar appetite perceptions, energy intake and appetite-
related hormones in response to acute exercise between South Asians and white European 
men, although subtle differences in appetite-measures between the groups were detected. 
Particularly, South Asians exhibited lower appetite ratings than white European men 2 h 
after the ad libitum buffet meal across both trials. Although this represents a subtle 
difference in appetite feelings between groups, this difference may be driven by the 
greater appetite feelings in white European participants due to their greater net energy 
expenditure during exercise. Study 3 (Chapter 5) also identified lower concentrations of 
delta acylated ghrelin in South Asian than white European men before the ad libitum 
buffet meal (4 h), which may be related to the different concentrations in plasma insulin 
observed between groups. However, no significant main effect of group for delta acylated 
ghrelin concentrations was observed. It is possible that these results are influenced by the 
use of delta change to represent the ghrelin concentration as the absolute data revealed a 
significantly lower mean acylated ghrelin concentration across both trials in South Asian 
than white European men. This may provide some support to the data in Study 1 (Chapter 
3) reporting lower fasting acylated ghrelin in South Asian than white European men 
(Study 1, Chapter 3). Furthermore, Study 3 (Chapter 5) revealed subtle changes in 
appetite feelings between trials including a transient suppression in appetite perceptions 
at 4.5 h (1.5 h post-exercise) and stimulation at 6.5 h (3.5 h post-exercise) in the exercise 
than control trial. While the stimulation of appetite 3.5 h post-exercise may relate to the 
extra energy expended during the exercise, the lower appetite perceptions 1.5 h post 
exercise may reflect a prolonged appetite suppression which has been previously reported 
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when exercise is performed after a meal (Deighton et al. 2012; Cheng et al. 2009), instead 
of following an overnight fast of 9 h (Broom et al. 2007; Becker et al. 2012; Martins et 
al. 2007; Douglas et al. 2017). In this regard, Cheng et al. (2009) demonstrated that 
cycling for 50 min at 60% of V̇O2 max 2 h after a standardised meal suppressed appetite 
feelings for a longer period of time than performing the same exercise after an overnight 
fast of 9 h. Likewise, Deighton et al. (2012) demonstrated that running for 60 min at 70% 
of V̇O2 max approximately 2 h after a standardised breakfast also prolonged appetite 
suppression than performing the exercise trial after an overnight fast of 10 h. Thus, these 
data suggest that manipulation of the exercise protocols in appetite studies may represent 
a potential avenue for future investigations. Differences in appetite-related hormones 
between trials were also observed including increased concentrations of delta acylated 
ghrelin and total PYY in the exercise compared with the control trial. Whereas the greater 
total PYY concentrations in the exercise trial is in agreement with the absolute total PYY 
concentrations and with previous investigations (Martins et al. 2007; Kawano et al. 2013; 
Douglas et al. 2017), the elevated delta acylated ghrelin concentrations in the exercise 
trial differed from the absolute acylated ghrelin concentrations and from previous studies 
reporting lower or no change in absolute or delta acylated ghrelin concentrations during 
or shortly after exercise (Broom et al. 2017; Wasse et al. 2013; Deighton et al. 2013a). 
However, as reported in Chapter 5.4, this finding may reflect the differences in fasting 
acylated ghrelin concentrations between trials, but also the method used to express 
acylated ghrelin (delta change instead of absolute concentrations) as the absolute acylated 
ghrelin concentrations were greater in the exercise than in the control trial. However, the 
greater elevation in acylated ghrelin, delta and absolute concentrations, in white 
European than South Asian men before the ad libitum buffet meal, represented an 
important finding of the present study. Despite the mechanisms explaining the lower pre-
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prandial acylated ghrelin concentrations in South Asians than white European men 
observed in this study remains unclear, these data provide additional evidence regarding 
the differential acylated ghrelin concentrations between South Asian and white European 
men. Despite subtle differences in appetite perceptions between trials and an increase in 
appetite-related hormones in the exercise trial, South Asian and white European 
participants did not exhibit exercise-induced changes in absolute energy intake at the ad 
libitum meal, which suggests that exercise induces a short-term energy deficit 
irrespective of ethnicity. The lower absolute energy intake across both trials in South 
Asian than white European men was speculatively linked with the lower fat free mass in 
South Asian than white European men, which is in agreement with previous data. 
Previous studies have shown that fat free mass is lower in South Asian than white 
Europeans (Hall. et al. 2010; Ghouri et al. 2013; Sattar and Gill; 2015) and that it is an 
important determinant of resting metabolic rate, daily energy expenditure and day-to-day 
food intake (Blundell et al. 2011; Weise et al. 2013; Hopkins et al. 2017). Thus, it is 
possible that the lower absolute energy intake in South Asian men in our study may 
reflect their lower fat free mass which induced a lower drive to ingest food at the buffet 
meal than white European counterpart. 
6.8 General conclusions 
Taken together, the findings of the present thesis suggest lower levels of acylated ghrelin 
and an adverse CVD and T2D risk marker profile in South Asian compared with white 
European men including higher concentrations of insulin, TAG, leptin and CRP, and 
lower HDL-C. Although objectively assessed and self-reported physical activity levels 
and sedentary time were similar between the ethnic groups, the lower cardiorespiratory 
fitness and fat oxidation in the South Asian men may contribute to the heightened cardio-
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metabolic heath risk in this population. Levels of acylated ghrelin appear to be lower in 
South Asian men, but further work is required to determine the independent contribution 
of ethnicity and adiposity on this gut hormone. The current thesis also provides evidence 
that levels of circulating FFAs are different between South Asian and white European 
men, which may contribute to the elevated CVD and T2D risk in South Asians. Finally, 
we provided evidence that 60 min moderate-to-vigorous cycling induces a short-term 
energy deficit irrespective of ethnicity and suggests similar exercise-induced responses 
in appetite perceptions and appetite-related hormones between South Asian and white 
European men. These findings may represent a valid strategy of exercise to induce 
weight/fat loss and optimise health outcomes in South Asians. 
In summary, compared with white European, South Asian men revealed: 
• lower circulating acylated ghrelin but higher leptin concentrations; 
• an adverse inflammatory and metabolic risk profile including elevated 
concentrations of fasting insulin, TAG, CRP, and lower HDL-C; 
• a different FFA metabolic profile including greater levels of laurate, myristate, 
palmitate, γ-linolenate and linoleate and positive associations between individual 
FFA concentrations and markers of cardiometabolic risk; 
• lower levels of total physical activity and cardiorespiratory fitness; 
• similar exercise-induced responses in appetite perceptions, energy deficit and 
appetite-related hormones. 
 
6.9 Limitations and future directions 
The studies conducted in this thesis have a few limitations. The number of participants 
in the studies was small, and was mostly limited to South Asian men, but not women, 
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originating from India. Additionally, the potentially confounding effects of body fat 
percentage may have accentuated the differences in FFAs between ethnic groups. Lastly, 
acylated ghrelin and total PYY were the only gut hormones with appetite-regulating 
capabilities examined in response to exercise, and the timing of the exercise 2 h after the 
standardised breakfast may have influenced the changes in acylated ghrelin in response 
to exercise, as the concentrations of this hormones were still lower than the fasting values 
at the start of exercise. Therefore, below are a few suggestions for further research: 
• An examination of chronic effects of exercise on appetite measures and CVD and 
T2D risk markers based on longitudinal studies. 
• An examination of unconventional parameters for CVD and T2D risk with a 
larger sample size and in additional South Asian groups (e.g., Bangladeshis, Sri 
Lankan and Bhutanese) and in South Asian women.  
• An investigation into unconventional parameters for CVD and T2D risk, such as 
FFAs in South Asian and white European individuals matched by body fat 
percentage but also in response to exercise/food intake to clarify the role of 
adiposity, energy intake and exercise in modulating individual plasma FFAs 
concentrations between South Asian and white European individuals. 
• Finally, from a mechanistic point of view, an investigation into additional 
appetite-related gut hormones such as GLP-1 or PP.  
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APPENDIX A 
 
          Informed Consent Form 
 
Title of the study:  
Ethics Code:  
Statement by participant 
 
I ................................................................... give my consent to the research procedures that are outlined 
above, the aim, procedures and possible consequences of which have been outlined to me  
• I confirm that I have read and understood the information sheet/letter of invitation for this study. I 
have been informed of the purpose, risks, and benefits of taking part. 
Study title:  
• I understand what my involvement will entail and any questions have been answered to my 
satisfaction. 
 
• I understand that my participation is entirely voluntary, and that I can withdraw at any time without 
prejudice. 
 
• I understand that all information obtained will be confidential. 
 
• I consent the Cheek Buccal Swab sample collection for genotyping analysis1                                     
 
• I understand that although the genotyping analysis that will be performed will not give me 
significant information about the risk of disease, I would like to be informed about the results 
anyway 
 
• I agree that research data gathered for the study may be published provided that I cannot be 
identified as a participant. 
 
• Contact information has been provided should I (a) wish to seek further information from the 
investigator at any time for purposes of clarification (b) wish to make a complaint. 
1Genotyping is the process of determining differences in a specific sequence of the DNA, known as 
Single Nucleotide Polymorphisms (SNPs) associated with Type 2 diabetes (T2D).  
Participant Signature: ............................................ Date: ..........................................  
Participant Name: …………………………………... 
Participant ID: ………………………………………. 
Statement by investigator 
• I have explained this project and the implications of participation in it to this participant without 
bias and I believe that the consent is informed and that he/she understands the implications of 
participation. 
Researcher Signature: ............................................. Date: ………………………….. 
Researcher Name: …………………………….. 
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           APPENDIX B 
 
 
 
 
 
Health Screening questionnaire 
 
Participants number/code: ………………………………… 
Date of birth: ……………………………………  
Occupation………………………………………………………………………….  
Blood Pressure…………………………………………………………………….. 
Pulse (HR) ………………………………………………………………………….. 
Height……………………………………………………………………………………. 
Weight………………………………………………………………………………… 
Waist circumference ………………………………………………………………. 
1. General health screening questionnaire 
 
Do you consider yourself to be healthy? Yes / No 
Are you vegetarian (no meat or fish) Yes / No 
Do you eat a special diet? Yes / No 
 
If yes, specify 
Do you exercise regularly? Yes / No 
 
If yes, answer questions on next page 
Have you been sick within the past 4 weeks? Yes / No 
If yes, when 
Describe illness 
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Do you have high blood pressure? Yes / No 
Are you exposed to any hazardous chemicals in your job? Yes / No 
If yes, what?  
Do you use tobacco? Yes / No 
 
If yes, answer questions on next page 
Do you drink alcoholic beverages? Yes / No 
 
If yes, answer questions on next page 
Are you currently under a doctor’s care? Yes / No 
If yes, why?  
Have you been hospitalised in the last 6 months? Yes / No 
If yes, why and when?  
Are there any inherited health problems in your family? Yes / No 
 
If yes, describe 
Have you taken aspirin or any pain relievers in the past 4 
weeks? 
Yes / No 
 
If yes, what and when? 
Are you taking any prescribed medication? 
 
Including diet pills, antacids / stomach medicine, cold  or 
allergy medicine 
Yes / No 
If yes, what?  
 
 
 
 
 
 
 
Do you take vitamin supplements or herbal remedies? Yes / No 
If yes, what?  
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2. Lifestyle screening questionnaire 
 
 
Alcohol 
 
1: Have you had a drink in the last 48 hours Y/N 
 
If yes, what ………………………….. 
 
2: How much do you drink in a typical week? 
Nothing ……. 
Beer …….pints  litres 
 
Cider …….pints  litres 
 
Wine …….glasses (assume 6 glasses per standard sized bottle 
 
Spirits ……..bottles 
 
For how many years has this been typical…..... 
 
Smoking 
 
1: How many cigarette pack years have you smoked? ................ 
 
A pack year is 20 cigarettes per day for one year 
 
2: If you roll your cigarettes how many ounces per week do you smoke? ................ 
3: If you smoke cigars and pipes, how many days per week do you smoke ................ 
How many years have you smoked for? ................ 
 
Exercise 
 
1: How many days in the past week have you performed physical activity where your heart beats faster and your breathing 
is harder than normal for 30 minutes or more? (In 3 ten minutes bouts or one 30 minute bout). 
 
2: How many days in a typical week have you performed activity such as this? 
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3. Ethnicity monitoring questionnaire 
 
A : White  
British  
Irish  
Any other White background (please write in) 
B : Mixed  
White and Black Caribbean  
White and Black African  
White and Asian  
Any other mixed background (please write in) 
C : Asian or Asian British  
Indian  
Pakistani  
Bangladeshi  
Any other Asian background (please write in) 
D : Black or Black British  
Caribbean  
African  
Any other Black background (please write in) 
E : Chinese or other ethnic group  
Chinese  
Any other (please write in)  
Not stated  
Not stated  
 
 
Time  of  sample  collection  …………………………………………………………………………… 
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APPENDIX C            
 
Pre Screening for Blood Sampling 
This form must be completed prior to any work involving blood sampling                                                   
Title of the study:  
Ethics Code:  
 
£ Fingertip capillary blood 
£ Earlobe capillary blood 
£ Venous whole blood 
•  Please indicate the trained phlebotomist who will be performing the venepuncture:  
.......................................................................................... 
  
£   Lactate (Biosen/Lactate Pro) 
£ Glucose (Biosen /Accutrend) 
£ HCt measurement (Hawksley capillary tubes and centrifuge) 
£ Hemoglobin (HemoCue) 
£ Cholesterol 
£ Other chemistries  
£ Any other; please specify .......................................................... 
 
Please answer the following questions:   YES NO 
1. Are you suffering from any known active, serious infection? £ £ 
2. Have you had jaundice within the previous year?  £ £ 
3. Have you ever had any form of hepatitis?   £ £ 
4. Have you any reason to think you may be HIV positive?  £ £ 
5. Have you ever been involved in intravenous drug use?  £ £ 
6. Are you a haemophiliac?      £ £ 
7. Is there any other reason you are aware of why taking blood  £ £ 
might be hazardous to your health? 
8. Is there any other reason you are aware of why taking your  £ £ 
blood might be hazardous to the health of the technician?  
I have been fully informed of and understand: 
§ The procedure for the sampling and analysis of blood for the above 
§ The possible risks of contamination to myself and participants 
§ The benefit of being inoculated against Hepatitis B 
 
I agree to undertake all necessary health and safety procedures and precautions during blood sampling 
to avoid contamination and accept that I will be excluded from the laboratory should I neglect to 
demonstrate sufficient care and responsibility. 
 
I have read and understood the University guidelines on the management of needlestick injuries and am 
aware of what to do in the event of such an accident. 
 
Signed:  ...........................................................  Date: ..................................... 
Name: ...................................................................... 
Signed by supervising member of staff: ………………........................................................... 
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APPENDINX E 
 
 
Meals form 
 
Project title:  
Ethics code:  
Date: 
Participant ID: 
 
Standardised breakfast 
 
You will be provided with a standardised breakfast upon arrival to the laboratory consisting 
of: 
• Sandwich with cheese, mayo, tuna or Ham   
• 1 Chocolate muffin 
• 1 glass orange juice 
 
Ad libitum buffet meal 
You will be given also 30 minutes to access to a buffet meal made of the following items: 
Orange juice, semi skimmed milk, Granola, Oats, Corn Flakes, white bread, brown bread, 
butter, margarine, mayonnaise, cheese, ham, tuna, salted crisps, chocolate bars, cereals bar, 
cookies, muffin, apple, oranges and bananas.  
 
I confirm acceptance of the food listed above and I have informed the investigators about any 
allergy/intolerance. 
 
Name and Surname: 
Participant’s signature: 
 
Name of Researcher: Simone Benedetti 
Email: k1442446@kingston.ac.uk   
Tel: 020 8417 2476 
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     FOOD DIARY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 DAY 1 
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   DAY 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   DAY 3 
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APPENDINX H 
 
 
 
Subject Number: ______ Trial__________          Date: _______ 	
Please indicate how hungry you are now by circling a relevant number 	
Not Hungry       Fairly Hungry         Hungry            Very Hungry 	
0   1   2   3   4   5   6   7   8   9   10   11   12   13   14   15 	
 Place a mark on the horizontal lines below after considering the following questions: 	
 
Visual Analogue Scale	 	
Time Point: 	 	 	 Time:	 	  	 Temp:	 	  	 Humidty	:	 	
 	  	
